{"title": "The Party Drug That Could Help Stop Depression", "tfidf": {"tfidf": {"question": 6.612244897949999, "degrad": 15.5190615836, "made": 2.14077669902, "bladder": 77.067961165, "bodi": 1.8618505922400002, "market": 2.36602086438, "ago": 6.05954198473, "medic": 9.82628429958, "from": 1.00056721497, "food": 2.9613878007800003, "side": 9.593715379199999, "areaswhil": 1443.27272727, "but": 6.09794507394, "under": 1.0781663837, "should": 1.6643254009900001, "professor": 4.31061634537, "great": 1.26592775696, "all": 2.02293577982, "into": 1.01502461479, "higher": 2.1218925421, "concern": 7.541147132160001, "real": 2.28103448276, "possibl": 1.4173734488, "and": 27.00170078751, "though": 1.36076112111, "mani": 3.13280273631, "khole": 1443.27272727, "hour": 6.77882152008, "lifesav": 273.724137931, "hope": 5.01769911504, "statementth": 1443.27272727, "restrict": 3.1062414400300002, "compani": 1.5523613963, "notmani": 1443.27272727, "realli": 4.7476076555, "distribut": 2.7396031061299997, "when": 1.02076769755, "act": 5.727272727280001, "recommend": 7.828402366860001, "pharmaci": 38.911764705900005, "prefront": 226.8, "improv": 4.08753861998, "first": 4.03046458492, "patient": 57.279615153360005, "serious": 2.583984375, "evalu": 13.901926444839999, "credit": 3.04312823462, "wherea": 4.13868613139, "call": 2.1353059852, "type": 2.0281042411900003, "ani": 1.13383802314, "strict": 4.7235941684, "health": 10.86281217928, "move": 1.29125660838, "steven": 6.17262830482, "nasal": 50.2405063291, "increas": 1.32024948025, "who": 8.50234301784, "estim": 2.34991119005, "decis": 2.16, "esketamin": 7216.363636349999, "dose": 64.0161290322, "initi": 2.7, "have": 3.0446845234199995, "troublesom": 54.3698630137, "receiv": 2.6109694926400002, "don": 6.02733485194, "between": 1.03453668708, "treatmentresist": 4329.81818181, "name": 1.10211732037, "excitatori": 453.6, "richard": 2.20041580042, "member": 1.32068879461, "advisori": 15.0056710775, "neurochem": 1443.272727272, "magnitud": 15.6568047337, "psychiatrist": 32.0080645161, "attempt": 1.4721810088999998, "took": 1.4009883515700001, "contrast": 2.88339992735, "potenti": 2.52080025405, "anesthet": 392.0, "save": 2.8178913737999998, "high": 2.2955465587, "aren": 481.09090909099996, "basi": 2.42122922068, "pharmacist": 84.8983957219, "sever": 1.07241286139, "touch": 5.45567010309, "limit": 3.0373062942400004, "rural": 5.2155059132699995, "remark": 3.8515283842800003, "releas": 1.8377126982299998, "time": 1.01127460348, "smithblockedunblockfollowfollowingmar": 1443.27272727, "addit": 1.24634950542, "johnson": 9.84558139534, "serotoninnorepinephrin": 1443.27272727, "one": 3.01882487166, "were": 1.02458857696, "administ": 20.66290672452, "two": 3.04137931035, "that": 10.0398406375, "might": 2.1561863370900003, "place": 1.1004366812200002, "must": 5.766101694929999, "stress": 5.52978056426, "drug": 142.49214659688, "this": 4.01517450684, "fairview": 217.479452055, "could": 7.226217569399999, "unabl": 3.3081892060799998, "can": 4.70504556568, "includ": 1.0190641247799999, "depressionth": 1443.27272727, "after": 1.02070207021, "ketamin": 10380.461538455002, "tradeoff": 208.89473684200001, "peopl": 21.83768913348, "win": 2.75290445639, "treatment": 7.74250182882, "divis": 2.32854209446, "their": 3.0464372521500005, "cortex": 81.83505154640001, "hand": 1.6152202665600002, "efficaci": 113.6706443913, "same": 1.11857958148, "care": 4.98853102906, "visit": 2.20622568093, "with": 8.009585671919998, "publish": 1.36885669943, "colleg": 2.5511811023599997, "major": 2.29704116328, "inhibitor": 173.5081967214, "rule": 1.7415533128599998, "result": 1.14611608432, "report": 1.3634489866, "base": 1.14628158845, "whom": 2.30320615117, "has": 5.218248751, "look": 1.9086318826599997, "whole": 2.29488291414, "dissoci": 135.6923076924, "wonder": 7.265903890160001, "becaus": 1.1495184997499999, "approv": 5.71902017292, "divert": 14.7272727273, "fail": 1.9281029876099998, "opioid": 217.479452055, "safeti": 8.8470325996, "profession": 2.6389627659599997, "ill": 4.93196644921, "longterm": 512.129032258, "greater": 4.29603571912, "synaps": 423.36, "number": 1.10142916609, "prozac": 2886.54545454, "dana": 28.1489361702, "over": 1.02525024217, "week": 3.61064362066, "parti": 4.12738853504, "out": 1.06016694491, "administr": 2.3898840885099997, "take": 2.27923336444, "think": 5.81431972166, "had": 2.0951501154799996, "cornel": 17.738547485999998, "like": 5.745928338750001, "gaertnergetti": 1443.27272727, "insubstanti": 567.0, "start": 1.26673581744, "get": 1.78562591385, "spravato": 1443.27272727, "switch": 4.97368421053, "offic": 3.17774219376, "norepinephrin": 311.294117647, "abusebecaus": 1443.27272727, "anecdot": 26.241322314, "live": 1.30591428806, "subsidiari": 12.7313552526, "what": 1.25343439128, "problem": 1.76674827509, "the": 67.0, "qualiti": 2.9329392204, "differ": 2.4730898045, "diseas": 5.2120814182499995, "dopamin": 162.0, "servic": 1.51300867245, "brain": 35.716535433080004, "tamp": 882.0, "without": 1.29547123623, "communiti": 1.96121062384, "how": 1.60250328051, "signific": 2.9058295964200003, "certifi": 12.782608695699999, "there": 4.16365066876, "altern": 2.1390460792200003, "depress": 58.583025830299995, "surround": 2.49858356941, "plan": 3.0713871155000003, "desper": 11.7687175686, "risk": 32.767801857600006, "resist": 3.2294548413300004, "stop": 2.1783754116400003, "symptom": 17.9389830508, "group": 1.20996875238, "posit": 1.37252528746, "benefit": 9.20525705451, "right": 1.4054532577899999, "use": 2.0592775147599998, "part": 1.04330682789, "mitig": 22.8103448276, "through": 1.07074930869, "suicid": 23.648460774569998, "howev": 1.0945191313299998, "therapeut": 39.2, "cell": 7.1033557047, "refer": 1.30024570025, "where": 2.13430127042, "anymor": 35.1238938053, "serotonin": 364.965517242, "everi": 1.47917637194, "worth": 5.210370856580001, "studi": 4.59552296412, "also": 2.02953020134, "choic": 3.1319786940200003, "far": 3.42044597652, "farchion": 1443.27272727, "score": 4.2884927066500005, "system": 4.16219522853, "provid": 3.64658142561, "will": 7.34886591576, "sure": 7.453521126760001, "clinic": 50.592734225499996, "balanc": 4.45329593268, "avail": 3.4576935642, "gain": 1.84819557625, "they": 4.12069301148, "recreat": 6.536023054759999, "review": 2.2099109131400003, "treat": 7.18046132972, "hometh": 1443.27272727, "pressur": 2.9887048192799996, "fertil": 10.0544648512, "prescrib": 16.3333333333, "not": 5.07836990595, "proven": 9.818181818180001, "pretti": 15.75, "are": 6.17943561468, "some": 1.04036697248, "becom": 2.24984057252, "clinician": 127.008, "march": 1.37980184252, "than": 1.03278688525, "hallucin": 75.961722488, "brand": 5.5259310824900005, "for": 18.00567072018, "sold": 2.7935949322500004, "minimum": 6.02962400304, "activ": 1.46403541129, "cymbalta": 1443.27272727, "say": 8.7722400265, "black": 1.94917127072, "target": 6.437956204380001, "befor": 1.10036041031, "mean": 2.89813800658, "monitor": 12.11446012972, "often": 1.29452054795, "much": 1.1942229577299999, "connect": 3.7687833827800006, "psychiatri": 117.16605166059999, "specialti": 19.6485148515, "regrow": 441.0, "measur": 2.41093394077, "plus": 4.6914893617, "reuptak": 705.6, "imag": 2.70137825421, "led": 1.33782758911, "livesresearch": 1443.27272727, "damag": 2.7808723068799996, "particular": 2.7629655412400003, "popular": 1.50769230769, "version": 2.0083491461099996, "burden": 12.5900079302, "compar": 3.7324556247800005, "open": 1.24556723678, "placebo": 384.096774195, "abus": 12.5700712589, "folk": 7.6658619024600005, "month": 1.5079787234, "respond": 6.34659204478, "said": 3.09503850278, "untreat": 181.44, "doe": 1.70581282905, "follow": 1.04640126549, "believ": 1.6450108797, "onsit": 429.081081081, "onli": 3.0769429549800007, "product": 1.62264922322, "five": 1.37740760021, "director": 5.25260545906, "wear": 4.41367806505, "show": 2.5340782123, "option": 8.09793420046, "new": 5.0894402770000005, "wait": 4.55421686747, "may": 1.05201775893, "those": 2.39096385542, "down": 1.35889754344, "involv": 2.8997260274000003, "tradit": 1.60802187785, "year": 1.0485436893200002, "present": 1.25551601423, "rais": 1.9733996271, "least": 1.6165359943000002, "homean": 1443.27272727, "rush": 7.65477338476, "current": 1.5325803649, "experi": 1.87062566278, "liter": 5.468825353080001, "worri": 10.302401038300001, "offlabel": 1443.27272727, "clear": 1.85423966363, "friedman": 149.4211764704, "about": 3.19458045477, "revers": 4.29894394801, "weill": 244.246153846, "feel": 9.407070906570002, "notabl": 1.82840032247, "percent": 11.70796460178, "meisel": 3402.0, "other": 4.03969465648, "prevent": 2.16117615029, "rough": 3.29582727839, "trial": 8.08350305498, "see": 1.27242125511, "club": 2.92375690608, "known": 1.0859097127200001, "them": 2.19752231988, "effect": 12.5667546174, "committe": 6.474714518759999, "notorieti": 45.36, "select": 2.02345144022, "sedat": 84.8983957219, "antidepress": 1134.0, "florian": 126.0, "well": 1.0655748708, "psychoact": 441.0, "need": 1.4372623574099999, "dramat": 7.969879518080001, "singl": 1.60948905109, "three": 1.06621893889, "which": 3.015575535, "num": 11.00346544011, "spray": 58.909090909, "janssen": 337.787234042, "order": 1.24625166811, "blood": 4.74902781932, "research": 3.8840366972400004, "sinc": 1.08368600683, "form": 2.25511363636, "exact": 3.46864758575, "offici": 1.40483143085, "more": 3.0515120451, "minor": 4.46143037796, "few": 2.63458347162, "wellknown": 1443.27272727, "glutam": 223.605633803, "relaps": 98.6086956522, "nasti": 65.8755186722, "remain": 1.16598119859, "develop": 1.1955719557200002, "doctor": 7.8789081885800005, "help": 4.19888918277, "tiffani": 82.2590673575, "access": 1.8734953976900002, "offput": 1443.27272727, "chang": 1.1808985421, "outweigh": 54.5567010309, "these": 4.29661705008, "center": 1.7423178226499998, "twice": 3.7638691322900004, "classifi": 5.2937645882, "lost": 1.74634253657, "pharmaceut": 24.767550701999998, "pathway": 25.4423076923, "primari": 2.2373167981999997, "entir": 1.59365589239, "off": 1.5121440137200002, "learningscientist": 1443.27272727, "veri": 1.25880114177, "speak": 2.89127663449}, "idf": {"question": 2.20408163265, "degrad": 15.5190615836, "made": 1.07038834951, "bladder": 77.067961165, "bodi": 1.8618505922400002, "market": 2.36602086438, "ago": 6.05954198473, "medic": 3.27542809986, "from": 1.00056721497, "food": 2.9613878007800003, "side": 1.5989525632, "areaswhil": 1443.27272727, "but": 1.01632417899, "under": 1.0781663837, "should": 1.6643254009900001, "professor": 4.31061634537, "great": 1.26592775696, "all": 1.01146788991, "into": 1.01502461479, "higher": 2.1218925421, "concern": 1.8852867830400002, "real": 2.28103448276, "possibl": 1.4173734488, "and": 1.00006299213, "though": 1.36076112111, "mani": 1.04426757877, "khole": 1443.27272727, "hour": 2.25960717336, "lifesav": 273.724137931, "hope": 2.50884955752, "statementth": 1443.27272727, "restrict": 3.1062414400300002, "compani": 1.5523613963, "notmani": 1443.27272727, "realli": 4.7476076555, "distribut": 2.7396031061299997, "when": 1.02076769755, "act": 1.4318181818200002, "recommend": 3.9142011834300003, "pharmaci": 38.911764705900005, "prefront": 226.8, "improv": 2.04376930999, "first": 1.00761614623, "patient": 9.54660252556, "serious": 2.583984375, "evalu": 6.9509632224199995, "credit": 3.04312823462, "wherea": 4.13868613139, "call": 1.0676529926, "type": 2.0281042411900003, "ani": 1.13383802314, "strict": 4.7235941684, "health": 2.71570304482, "move": 1.29125660838, "steven": 6.17262830482, "nasal": 50.2405063291, "increas": 1.32024948025, "who": 1.06279287723, "estim": 2.34991119005, "decis": 2.16, "esketamin": 1443.27272727, "dose": 32.0080645161, "initi": 1.35, "have": 1.0148948411399998, "troublesom": 54.3698630137, "receiv": 1.3054847463200001, "don": 6.02733485194, "between": 1.03453668708, "treatmentresist": 1443.27272727, "name": 1.10211732037, "excitatori": 453.6, "richard": 2.20041580042, "member": 1.32068879461, "advisori": 15.0056710775, "neurochem": 721.636363636, "magnitud": 15.6568047337, "psychiatrist": 32.0080645161, "attempt": 1.4721810088999998, "took": 1.4009883515700001, "contrast": 2.88339992735, "potenti": 2.52080025405, "anesthet": 196.0, "save": 2.8178913737999998, "high": 1.14777327935, "aren": 481.09090909099996, "basi": 2.42122922068, "pharmacist": 84.8983957219, "sever": 1.07241286139, "touch": 5.45567010309, "limit": 1.5186531471200002, "rural": 5.2155059132699995, "remark": 3.8515283842800003, "releas": 1.8377126982299998, "time": 1.01127460348, "smithblockedunblockfollowfollowingmar": 1443.27272727, "addit": 1.24634950542, "johnson": 4.92279069767, "serotoninnorepinephrin": 1443.27272727, "one": 1.00627495722, "were": 1.02458857696, "administ": 6.88763557484, "two": 1.01379310345, "that": 1.00398406375, "might": 2.1561863370900003, "place": 1.1004366812200002, "must": 1.9220338983099996, "stress": 5.52978056426, "drug": 5.93717277487, "this": 1.00379362671, "fairview": 217.479452055, "could": 1.2043695949, "unabl": 3.3081892060799998, "can": 1.17626139142, "includ": 1.0190641247799999, "depressionth": 1443.27272727, "after": 1.02070207021, "ketamin": 610.615384615, "tradeoff": 208.89473684200001, "peopl": 1.21320495186, "win": 2.75290445639, "treatment": 3.87125091441, "divis": 2.32854209446, "their": 1.01547908405, "cortex": 81.83505154640001, "hand": 1.6152202665600002, "efficaci": 37.8902147971, "same": 1.11857958148, "care": 2.49426551453, "visit": 2.20622568093, "with": 1.0011982089899998, "publish": 1.36885669943, "colleg": 2.5511811023599997, "major": 1.14852058164, "inhibitor": 86.7540983607, "rule": 1.7415533128599998, "result": 1.14611608432, "report": 1.3634489866, "base": 1.14628158845, "whom": 2.30320615117, "has": 1.0436497502, "look": 1.9086318826599997, "whole": 2.29488291414, "dissoci": 67.8461538462, "wonder": 7.265903890160001, "becaus": 1.1495184997499999, "approv": 2.85951008646, "divert": 14.7272727273, "fail": 1.9281029876099998, "opioid": 217.479452055, "safeti": 4.4235162998, "profession": 2.6389627659599997, "ill": 4.93196644921, "longterm": 512.129032258, "greater": 2.14801785956, "synaps": 211.68, "number": 1.10142916609, "prozac": 1443.27272727, "dana": 28.1489361702, "over": 1.02525024217, "week": 1.80532181033, "parti": 2.06369426752, "out": 1.06016694491, "administr": 2.3898840885099997, "take": 1.13961668222, "think": 2.90715986083, "had": 1.0475750577399998, "cornel": 17.738547485999998, "like": 1.14918566775, "gaertnergetti": 1443.27272727, "insubstanti": 567.0, "start": 1.26673581744, "get": 1.78562591385, "spravato": 1443.27272727, "switch": 4.97368421053, "offic": 1.58887109688, "norepinephrin": 311.294117647, "abusebecaus": 1443.27272727, "anecdot": 26.241322314, "live": 1.30591428806, "subsidiari": 12.7313552526, "what": 1.25343439128, "problem": 1.76674827509, "the": 1.0, "qualiti": 2.9329392204, "differ": 1.23654490225, "diseas": 5.2120814182499995, "dopamin": 162.0, "servic": 1.51300867245, "brain": 8.929133858270001, "tamp": 882.0, "without": 1.29547123623, "communiti": 1.96121062384, "how": 1.60250328051, "signific": 1.4529147982100001, "certifi": 12.782608695699999, "there": 1.04091266719, "altern": 2.1390460792200003, "depress": 5.8583025830299995, "surround": 2.49858356941, "plan": 1.5356935577500002, "desper": 11.7687175686, "risk": 4.095975232200001, "resist": 3.2294548413300004, "stop": 2.1783754116400003, "symptom": 17.9389830508, "group": 1.20996875238, "posit": 1.37252528746, "benefit": 3.06841901817, "right": 1.4054532577899999, "use": 1.0296387573799999, "part": 1.04330682789, "mitig": 22.8103448276, "through": 1.07074930869, "suicid": 7.882820258189999, "howev": 1.0945191313299998, "therapeut": 39.2, "cell": 7.1033557047, "refer": 1.30024570025, "where": 1.06715063521, "anymor": 35.1238938053, "serotonin": 182.482758621, "everi": 1.47917637194, "worth": 5.210370856580001, "studi": 1.53184098804, "also": 1.01476510067, "choic": 3.1319786940200003, "far": 1.71022298826, "farchion": 1443.27272727, "score": 4.2884927066500005, "system": 1.38739840951, "provid": 1.21552714187, "will": 1.22481098596, "sure": 7.453521126760001, "clinic": 10.1185468451, "balanc": 4.45329593268, "avail": 1.7288467821, "gain": 1.84819557625, "they": 1.03017325287, "recreat": 6.536023054759999, "review": 2.2099109131400003, "treat": 3.59023066486, "hometh": 1443.27272727, "pressur": 2.9887048192799996, "fertil": 10.0544648512, "prescrib": 16.3333333333, "not": 1.01567398119, "proven": 9.818181818180001, "pretti": 15.75, "are": 1.02990593578, "some": 1.04036697248, "becom": 1.12492028626, "clinician": 127.008, "march": 1.37980184252, "than": 1.03278688525, "hallucin": 75.961722488, "brand": 5.5259310824900005, "for": 1.00031504001, "sold": 2.7935949322500004, "minimum": 6.02962400304, "activ": 1.46403541129, "cymbalta": 1443.27272727, "say": 1.7544480053, "black": 1.94917127072, "target": 3.2189781021900004, "befor": 1.10036041031, "mean": 1.44906900329, "monitor": 6.05723006486, "often": 1.29452054795, "much": 1.1942229577299999, "connect": 1.8843916913900003, "psychiatri": 58.583025830299995, "specialti": 19.6485148515, "regrow": 441.0, "measur": 2.41093394077, "plus": 4.6914893617, "reuptak": 352.8, "imag": 2.70137825421, "led": 1.33782758911, "livesresearch": 1443.27272727, "damag": 2.7808723068799996, "particular": 1.3814827706200001, "popular": 1.50769230769, "version": 2.0083491461099996, "burden": 12.5900079302, "compar": 1.8662278123900002, "open": 1.24556723678, "placebo": 128.032258065, "abus": 6.28503562945, "folk": 7.6658619024600005, "month": 1.5079787234, "respond": 3.17329602239, "said": 1.54751925139, "untreat": 90.72, "doe": 1.70581282905, "follow": 1.04640126549, "believ": 1.6450108797, "onsit": 429.081081081, "onli": 1.0256476516600002, "product": 1.62264922322, "five": 1.37740760021, "director": 2.62630272953, "wear": 4.41367806505, "show": 1.26703910615, "option": 4.04896710023, "new": 1.0178880554, "wait": 4.55421686747, "may": 1.05201775893, "those": 1.19548192771, "down": 1.35889754344, "involv": 1.4498630137000001, "tradit": 1.60802187785, "year": 1.0485436893200002, "present": 1.25551601423, "rais": 1.9733996271, "least": 1.6165359943000002, "homean": 1443.27272727, "rush": 7.65477338476, "current": 1.5325803649, "experi": 1.87062566278, "liter": 5.468825353080001, "worri": 10.302401038300001, "offlabel": 1443.27272727, "clear": 1.85423966363, "friedman": 37.3552941176, "about": 1.06486015159, "revers": 4.29894394801, "weill": 244.246153846, "feel": 3.1356903021900004, "notabl": 1.82840032247, "percent": 3.9026548672600003, "meisel": 1134.0, "other": 1.00992366412, "prevent": 2.16117615029, "rough": 3.29582727839, "trial": 4.04175152749, "see": 1.27242125511, "club": 2.92375690608, "known": 1.0859097127200001, "them": 1.09876115994, "effect": 1.3963060686000002, "committe": 3.2373572593799995, "notorieti": 45.36, "select": 2.02345144022, "sedat": 84.8983957219, "antidepress": 162.0, "florian": 126.0, "well": 1.0655748708, "psychoact": 220.5, "need": 1.4372623574099999, "dramat": 3.9849397590400004, "singl": 1.60948905109, "three": 1.06621893889, "which": 1.005191845, "num": 1.00031504001, "spray": 29.4545454545, "janssen": 168.893617021, "order": 1.24625166811, "blood": 4.74902781932, "research": 1.9420183486200002, "sinc": 1.08368600683, "form": 1.12755681818, "exact": 3.46864758575, "offici": 1.40483143085, "more": 1.0171706817, "minor": 2.23071518898, "few": 1.31729173581, "wellknown": 1443.27272727, "glutam": 223.605633803, "relaps": 98.6086956522, "nasti": 65.8755186722, "remain": 1.16598119859, "develop": 1.1955719557200002, "doctor": 3.9394540942900003, "help": 1.39962972759, "tiffani": 82.2590673575, "access": 1.8734953976900002, "offput": 1443.27272727, "chang": 1.1808985421, "outweigh": 54.5567010309, "these": 1.07415426252, "center": 1.7423178226499998, "twice": 3.7638691322900004, "classifi": 5.2937645882, "lost": 1.74634253657, "pharmaceut": 24.767550701999998, "pathway": 25.4423076923, "primari": 2.2373167981999997, "entir": 1.59365589239, "off": 1.5121440137200002, "learningscientist": 1443.27272727, "veri": 1.25880114177, "speak": 2.89127663449}, "logidf": {"question": 0.790310929014, "degrad": 2.7420690479500003, "made": 0.0680215260973, "bladder": 4.34468764511, "bodi": 0.6215709351609999, "market": 0.8612095839370001, "ago": 1.80163421715, "medic": 1.18644857806, "from": 0.000567054168866, "food": 1.08565801008, "side": 0.46934876686899996, "areaswhil": 7.2746685411000005, "but": 0.0161923720719, "under": 0.07526180538319999, "should": 0.509419876758, "professor": 1.46108089746, "great": 0.235805258079, "all": 0.011402632097799998, "into": 0.0149128632287, "higher": 0.752308398995, "concern": 0.634079948873, "real": 0.824629060574, "possibl": 0.348805474891, "and": 6.29901420636e-05, "though": 0.308044191079, "mani": 0.0433157581221, "khole": 7.2746685411000005, "hour": 0.815190981077, "lifesav": 5.61212080336, "hope": 0.919824304455, "statementth": 7.2746685411000005, "restrict": 1.13341345513, "compani": 0.439777253097, "notmani": 7.2746685411000005, "realli": 1.5576408397, "distribut": 1.00781305813, "when": 0.0205549888584, "act": 0.358945092473, "recommend": 1.36461126863, "pharmaci": 3.6612966394999997, "prefront": 5.4240685718499995, "improv": 0.7147958039319999, "first": 0.0075872898121599995, "patient": 2.25618533471, "serious": 0.949332539075, "evalu": 1.9388802431299998, "credit": 1.11288601088, "wherea": 1.4203783778999999, "call": 0.0654627744488, "type": 0.707101485387, "ani": 0.125608358366, "strict": 1.55256998618, "health": 0.9990508682320001, "move": 0.255615859253, "steven": 1.82012472855, "nasal": 3.9168216003199996, "increas": 0.277820718929, "who": 0.0609002329859, "estim": 0.854377535975, "decis": 0.7701082216959999, "esketamin": 7.2746685411000005, "dose": 3.4659878871800007, "initi": 0.30010459245, "have": 0.0147850023412, "troublesom": 3.9958100116300006, "receiv": 0.266574424922, "don": 1.7963049316, "between": 0.033953681165299995, "treatmentresist": 7.2746685411000005, "name": 0.09723316638430002, "excitatori": 6.117215752409999, "richard": 0.788646342695, "member": 0.278153414599, "advisori": 2.70842820148, "neurochem": 6.58152136054, "magnitud": 2.75090562975, "psychiatrist": 3.4659878871800007, "attempt": 0.38674498075099994, "took": 0.337177952953, "contrast": 1.0589701282, "potenti": 0.9245764122419999, "anesthet": 5.278114659230001, "save": 1.03598886547, "high": 0.13782378654000002, "aren": 6.17605625244, "basi": 0.884275353639, "pharmacist": 4.44145519705, "sever": 0.06991112039689999, "touch": 1.6966554537399998, "limit": 0.41782385463, "rural": 1.6516360949200002, "remark": 1.34847005245, "releas": 0.608521699544, "time": 0.0112115188626, "smithblockedunblockfollowfollowingmar": 7.2746685411000005, "addit": 0.220218882972, "johnson": 1.5938755846700001, "serotoninnorepinephrin": 7.2746685411000005, "one": 0.0062553516455, "were": 0.024291143681099997, "administ": 1.92972785847, "two": 0.0136988443582, "that": 0.00397614837964, "might": 0.7683410765340001, "place": 0.0957070839572, "must": 0.653383947388, "stress": 1.71014813378, "drug": 1.78123305624, "this": 0.0037864490525, "fairview": 5.38210437275, "could": 0.18595627229000003, "unabl": 1.19640097204, "can": 0.162341096394, "includ": 0.0188846813905, "depressionth": 7.2746685411000005, "after": 0.020490694648099998, "ketamin": 6.414467275880001, "tradeoff": 5.34183047362, "peopl": 0.193265578473, "win": 1.01265652029, "treatment": 1.3535776885100002, "divis": 0.845242361205, "their": 0.015360505122700001, "cortex": 4.40470565484, "hand": 0.479471335336, "efficaci": 3.63469289398, "same": 0.112059649604, "care": 0.9139943029109999, "visit": 0.791283218833, "with": 0.00119749171339, "publish": 0.313975865467, "colleg": 0.9365564293340001, "major": 0.138474663439, "inhibitor": 4.46307766106, "rule": 0.554777423537, "result": 0.136378908381, "report": 0.31001750903700004, "base": 0.13652330228700002, "whom": 0.8343021310169999, "has": 0.0427239448548, "look": 0.6463866936, "whole": 0.8306818244059999, "dissoci": 4.21724269855, "wonder": 1.98319270637, "becaus": 0.139343158825, "approv": 1.0506503117200001, "divert": 2.6897010624299997, "fail": 0.656536611573, "opioid": 5.38210437275, "safeti": 1.48693492276, "profession": 0.970385948273, "ill": 1.5957377825999999, "longterm": 6.238576609419999, "greater": 0.764545491118, "synaps": 5.35507570037, "number": 0.0966085784186, "prozac": 7.2746685411000005, "dana": 3.3375095624, "over": 0.0249367214957, "week": 0.5907388641619999, "parti": 0.724497710444, "out": 0.0584263909193, "administr": 0.8712448662379999, "take": 0.130691962197, "think": 1.06717661175, "had": 0.0464780244111, "cornel": 2.8757400956299994, "like": 0.139053576545, "gaertnergetti": 7.2746685411000005, "insubstanti": 6.340359303730001, "start": 0.236443369291, "get": 0.579769005782, "spravato": 7.2746685411000005, "switch": 1.60416085533, "offic": 0.463023762098, "norepinephrin": 5.74073818118, "abusebecaus": 7.2746685411000005, "anecdot": 3.2673353558700002, "live": 0.266903399347, "subsidiari": 2.54406786822, "what": 0.225887296827, "problem": 0.569140724273, "the": 0.0, "qualiti": 1.07600506711, "differ": 0.212321121312, "diseas": 1.6509792804499999, "dopamin": 5.08759633523, "servic": 0.41410016674500005, "brain": 2.18931939783, "tamp": 6.7821920560099995, "without": 0.258874517941, "communiti": 0.673561947791, "how": 0.47156695693000006, "signific": 0.373571744332, "certifi": 2.54808555141, "there": 0.0400978929255, "altern": 0.760359972282, "depress": 1.76785990003, "surround": 0.915723999073, "plan": 0.428982108147, "desper": 2.4654449577, "risk": 1.4100048408899999, "resist": 1.1723133432200001, "stop": 0.778579374963, "symptom": 2.8869761689, "group": 0.190594534797, "posit": 0.316652318608, "benefit": 1.12116245116, "right": 0.34035985417, "use": 0.0292080197316, "part": 0.04239531098280001, "mitig": 3.1272141535699998, "through": 0.0683586918849, "suicid": 2.06468574062, "howev": 0.0903151173475, "therapeut": 3.6686767468, "cell": 1.9605673068599998, "refer": 0.262553246798, "where": 0.0649921387457, "anymor": 3.5588816340699996, "serotonin": 5.206655695249999, "everi": 0.391485427421, "worth": 1.65065103492, "studi": 0.426470272221, "also": 0.0146571578, "choic": 1.14166497543, "far": 0.536623764503, "farchion": 7.2746685411000005, "score": 1.4559353207700003, "system": 0.327430345585, "provid": 0.19517784432500002, "will": 0.202786534915, "sure": 2.0086865552, "clinic": 2.31437006117, "balanc": 1.4936444810499998, "avail": 0.547454586289, "gain": 0.6142097989249999, "they": 0.0297269947676, "recreat": 1.8773288849, "review": 0.7929522039210001, "treat": 1.27821645249, "hometh": 7.2746685411000005, "pressur": 1.09484012275, "fertil": 2.30801679965, "prescrib": 2.7932080094400003, "not": 0.0155524130075, "proven": 2.28423595433, "pretti": 2.75684036527, "are": 0.0294674735827, "some": 0.0395735090645, "becom": 0.11771217648900001, "clinician": 4.8442500766, "march": 0.32193989648000004, "than": 0.0322608622182, "hallucin": 4.33022956194, "brand": 1.7094517549200001, "for": 0.00031499039539700004, "sold": 1.02732927261, "minimum": 1.79668465441, "activ": 0.381196603284, "cymbalta": 7.2746685411000005, "say": 0.562154280552, "black": 0.667404292867, "target": 1.1690639496200002, "befor": 0.0956377718795, "mean": 0.37092128352, "monitor": 1.80125261058, "often": 0.258140393351, "much": 0.17749572930100002, "connect": 0.633605058682, "psychiatri": 4.07044499302, "specialti": 2.97800175538, "regrow": 6.08904487545, "measur": 0.880014199726, "plus": 1.54575009318, "reuptak": 5.86590132413, "imag": 0.99376210729, "led": 0.29104709623799996, "livesresearch": 7.2746685411000005, "damag": 1.02276465794, "particular": 0.323157393804, "popular": 0.41058020877499996, "version": 0.697313064259, "burden": 2.53290347794, "compar": 0.6239191809269999, "open": 0.219591038029, "placebo": 4.8522822483, "abus": 1.83817151099, "folk": 2.03677695251, "month": 0.410770160338, "respond": 1.15477080241, "said": 0.436653165815, "untreat": 4.50777783998, "doe": 0.5340417297169999, "follow": 0.045356911094199995, "believ": 0.497746997996, "onsit": 6.0616459012599995, "onli": 0.025324268329099998, "product": 0.484060136536, "five": 0.320203181906, "director": 0.965577050854, "wear": 1.48470837021, "show": 0.236682766013, "option": 1.39846181161, "new": 0.0177299468511, "wait": 1.51605358782, "may": 0.050709995284400004, "those": 0.17854939087299998, "down": 0.306673741186, "involv": 0.371469078658, "tradit": 0.47500477629199994, "year": 0.047402238894600005, "present": 0.227546654799, "rais": 0.6797577544760001, "least": 0.480285584745, "homean": 7.2746685411000005, "rush": 2.0353294251099996, "current": 0.42695282784500005, "experi": 0.626272953933, "liter": 1.6990638498800001, "worri": 2.3323769785799997, "offlabel": 7.2746685411000005, "clear": 0.617474727198, "friedman": 3.6204746449800003, "about": 0.0628434774746, "revers": 1.45836939905, "weill": 5.4981765440100006, "feel": 1.1428493419299999, "notabl": 0.603441443842, "percent": 1.3616570567299997, "meisel": 7.033506484289999, "other": 0.00987474791976, "prevent": 0.7706525875229999, "rough": 1.1926572072700001, "trial": 1.3966781444299998, "see": 0.240921585492, "club": 1.07286940097, "known": 0.0824180805992, "them": 0.0941833269093, "effect": 0.333830227158, "committe": 1.17475733629, "notorieti": 3.8146306594199997, "select": 0.704804687133, "sedat": 4.44145519705, "antidepress": 5.08759633523, "florian": 4.83628190695, "well": 0.0635144383156, "psychoact": 5.3958976948899995, "need": 0.362740163442, "dramat": 1.3825221952000002, "singl": 0.475916769059, "three": 0.06411868822490001, "which": 0.00517841384543, "num": 0.00031499039539700004, "spray": 3.38284824299, "janssen": 5.129269031630001, "order": 0.22014038079300002, "blood": 1.5579399274799999, "research": 0.663727818138, "sinc": 0.0803681994577, "form": 0.120053184191, "exact": 1.2437647732500001, "offici": 0.339917317543, "more": 0.017024931599999998, "minor": 0.802322246604, "few": 0.275577913653, "wellknown": 7.2746685411000005, "glutam": 5.40988393686, "relaps": 4.591159448919999, "nasti": 4.18776688041, "remain": 0.15356296309, "develop": 0.178624694913, "doctor": 1.37104215896, "help": 0.336207721344, "tiffani": 4.409873625, "access": 0.627805882716, "offput": 7.2746685411000005, "chang": 0.166275625058, "outweigh": 3.9992405467300003, "these": 0.0715336194008, "center": 0.555216308776, "twice": 1.32544745286, "classifi": 1.6665296351499999, "lost": 0.557523621781, "pharmaceut": 3.2095343569800003, "pathway": 3.2364134455299998, "primari": 0.805277289914, "entir": 0.46603068026999994, "off": 0.41352852038800003, "learningscientist": 7.2746685411000005, "veri": 0.230159793238, "speak": 1.06169814662}, "freq": {"question": 3, "degrad": 1, "made": 2, "bladder": 1, "bodi": 1, "market": 1, "ago": 1, "medic": 3, "from": 1, "food": 1, "side": 6, "areaswhil": 1, "but": 6, "under": 1, "should": 1, "professor": 1, "great": 1, "all": 2, "into": 1, "higher": 1, "concern": 4, "real": 1, "possibl": 1, "and": 27, "though": 1, "mani": 3, "khole": 1, "hour": 3, "lifesav": 1, "hope": 2, "statementth": 1, "restrict": 1, "compani": 1, "notmani": 1, "realli": 1, "distribut": 1, "when": 1, "act": 4, "recommend": 2, "pharmaci": 1, "prefront": 1, "improv": 2, "first": 4, "patient": 6, "serious": 1, "evalu": 2, "credit": 1, "wherea": 1, "call": 2, "type": 1, "ani": 1, "strict": 1, "health": 4, "move": 1, "steven": 1, "nasal": 1, "increas": 1, "who": 8, "estim": 1, "decis": 1, "esketamin": 5, "dose": 2, "initi": 2, "have": 3, "troublesom": 1, "receiv": 2, "don": 1, "between": 1, "treatmentresist": 3, "name": 1, "excitatori": 1, "richard": 1, "member": 1, "advisori": 1, "neurochem": 2, "magnitud": 1, "psychiatrist": 1, "attempt": 1, "took": 1, "contrast": 1, "potenti": 1, "anesthet": 2, "save": 1, "high": 2, "aren": 1, "basi": 1, "pharmacist": 1, "sever": 1, "touch": 1, "limit": 2, "rural": 1, "remark": 1, "releas": 1, "time": 1, "smithblockedunblockfollowfollowingmar": 1, "addit": 1, "johnson": 2, "serotoninnorepinephrin": 1, "one": 3, "were": 1, "administ": 3, "two": 3, "that": 10, "might": 1, "place": 1, "must": 3, "stress": 1, "drug": 24, "this": 4, "fairview": 1, "could": 6, "unabl": 1, "can": 4, "includ": 1, "depressionth": 1, "after": 1, "ketamin": 17, "tradeoff": 1, "peopl": 18, "win": 1, "treatment": 2, "divis": 1, "their": 3, "cortex": 1, "hand": 1, "efficaci": 3, "same": 1, "care": 2, "visit": 1, "with": 8, "publish": 1, "colleg": 1, "major": 2, "inhibitor": 2, "rule": 1, "result": 1, "report": 1, "base": 1, "whom": 1, "has": 5, "look": 1, "whole": 1, "dissoci": 2, "wonder": 1, "becaus": 1, "approv": 2, "divert": 1, "fail": 1, "opioid": 1, "safeti": 2, "profession": 1, "ill": 1, "longterm": 1, "greater": 2, "synaps": 2, "number": 1, "prozac": 2, "dana": 1, "over": 1, "week": 2, "parti": 2, "out": 1, "administr": 1, "take": 2, "think": 2, "had": 2, "cornel": 1, "like": 5, "gaertnergetti": 1, "insubstanti": 1, "start": 1, "get": 1, "spravato": 1, "switch": 1, "offic": 2, "norepinephrin": 1, "abusebecaus": 1, "anecdot": 1, "live": 1, "subsidiari": 1, "what": 1, "problem": 1, "the": 67, "qualiti": 1, "differ": 2, "diseas": 1, "dopamin": 1, "servic": 1, "brain": 4, "tamp": 1, "without": 1, "communiti": 1, "how": 1, "signific": 2, "certifi": 1, "there": 4, "altern": 1, "depress": 10, "surround": 1, "plan": 2, "desper": 1, "risk": 8, "resist": 1, "stop": 1, "symptom": 1, "group": 1, "posit": 1, "benefit": 3, "right": 1, "use": 2, "part": 1, "mitig": 1, "through": 1, "suicid": 3, "howev": 1, "therapeut": 1, "cell": 1, "refer": 1, "where": 2, "anymor": 1, "serotonin": 2, "everi": 1, "worth": 1, "studi": 3, "also": 2, "choic": 1, "far": 2, "farchion": 1, "score": 1, "system": 3, "provid": 3, "will": 6, "sure": 1, "clinic": 5, "balanc": 1, "avail": 2, "gain": 1, "they": 4, "recreat": 1, "review": 1, "treat": 2, "hometh": 1, "pressur": 1, "fertil": 1, "prescrib": 1, "not": 5, "proven": 1, "pretti": 1, "are": 6, "some": 1, "becom": 2, "clinician": 1, "march": 1, "than": 1, "hallucin": 1, "brand": 1, "for": 18, "sold": 1, "minimum": 1, "activ": 1, "cymbalta": 1, "say": 5, "black": 1, "target": 2, "befor": 1, "mean": 2, "monitor": 2, "often": 1, "much": 1, "connect": 2, "psychiatri": 2, "specialti": 1, "regrow": 1, "measur": 1, "plus": 1, "reuptak": 2, "imag": 1, "led": 1, "livesresearch": 1, "damag": 1, "particular": 2, "popular": 1, "version": 1, "burden": 1, "compar": 2, "open": 1, "placebo": 3, "abus": 2, "folk": 1, "month": 1, "respond": 2, "said": 2, "untreat": 2, "doe": 1, "follow": 1, "believ": 1, "onsit": 1, "onli": 3, "product": 1, "five": 1, "director": 2, "wear": 1, "show": 2, "option": 2, "new": 5, "wait": 1, "may": 1, "those": 2, "down": 1, "involv": 2, "tradit": 1, "year": 1, "present": 1, "rais": 1, "least": 1, "homean": 1, "rush": 1, "current": 1, "experi": 1, "liter": 1, "worri": 1, "offlabel": 1, "clear": 1, "friedman": 4, "about": 3, "revers": 1, "weill": 1, "feel": 3, "notabl": 1, "percent": 3, "meisel": 3, "other": 4, "prevent": 1, "rough": 1, "trial": 2, "see": 1, "club": 1, "known": 1, "them": 2, "effect": 9, "committe": 2, "notorieti": 1, "select": 1, "sedat": 1, "antidepress": 7, "florian": 1, "well": 1, "psychoact": 2, "need": 1, "dramat": 2, "singl": 1, "three": 1, "which": 3, "num": 11, "spray": 2, "janssen": 2, "order": 1, "blood": 1, "research": 2, "sinc": 1, "form": 2, "exact": 1, "offici": 1, "more": 3, "minor": 2, "few": 2, "wellknown": 1, "glutam": 1, "relaps": 1, "nasti": 1, "remain": 1, "develop": 1, "doctor": 2, "help": 3, "tiffani": 1, "access": 1, "offput": 1, "chang": 1, "outweigh": 1, "these": 4, "center": 1, "twice": 1, "classifi": 1, "lost": 1, "pharmaceut": 1, "pathway": 1, "primari": 1, "entir": 1, "off": 1, "learningscientist": 1, "veri": 1, "speak": 1}, "logtfidf": {"question": 2.3709327870420003, "degrad": 2.7420690479500003, "made": 0.1360430521946, "bladder": 4.34468764511, "bodi": 0.6215709351609999, "market": 0.8612095839370001, "ago": 1.80163421715, "medic": 3.55934573418, "from": 0.000567054168866, "food": 1.08565801008, "side": 2.8160926012139997, "areaswhil": 7.2746685411000005, "but": 0.0971542324314, "under": 0.07526180538319999, "should": 0.509419876758, "professor": 1.46108089746, "great": 0.235805258079, "all": 0.022805264195599997, "into": 0.0149128632287, "higher": 0.752308398995, "concern": 2.536319795492, "real": 0.824629060574, "possibl": 0.348805474891, "and": 0.0017007338357172, "though": 0.308044191079, "mani": 0.1299472743663, "khole": 7.2746685411000005, "hour": 2.4455729432310003, "lifesav": 5.61212080336, "hope": 1.83964860891, "statementth": 7.2746685411000005, "restrict": 1.13341345513, "compani": 0.439777253097, "notmani": 7.2746685411000005, "realli": 1.5576408397, "distribut": 1.00781305813, "when": 0.0205549888584, "act": 1.435780369892, "recommend": 2.72922253726, "pharmaci": 3.6612966394999997, "prefront": 5.4240685718499995, "improv": 1.4295916078639999, "first": 0.030349159248639998, "patient": 13.53711200826, "serious": 0.949332539075, "evalu": 3.8777604862599997, "credit": 1.11288601088, "wherea": 1.4203783778999999, "call": 0.1309255488976, "type": 0.707101485387, "ani": 0.125608358366, "strict": 1.55256998618, "health": 3.9962034729280003, "move": 0.255615859253, "steven": 1.82012472855, "nasal": 3.9168216003199996, "increas": 0.277820718929, "who": 0.4872018638872, "estim": 0.854377535975, "decis": 0.7701082216959999, "esketamin": 36.3733427055, "dose": 6.9319757743600015, "initi": 0.6002091849, "have": 0.0443550070236, "troublesom": 3.9958100116300006, "receiv": 0.533148849844, "don": 1.7963049316, "between": 0.033953681165299995, "treatmentresist": 21.824005623300003, "name": 0.09723316638430002, "excitatori": 6.117215752409999, "richard": 0.788646342695, "member": 0.278153414599, "advisori": 2.70842820148, "neurochem": 13.16304272108, "magnitud": 2.75090562975, "psychiatrist": 3.4659878871800007, "attempt": 0.38674498075099994, "took": 0.337177952953, "contrast": 1.0589701282, "potenti": 0.9245764122419999, "anesthet": 10.556229318460002, "save": 1.03598886547, "high": 0.27564757308000004, "aren": 6.17605625244, "basi": 0.884275353639, "pharmacist": 4.44145519705, "sever": 0.06991112039689999, "touch": 1.6966554537399998, "limit": 0.83564770926, "rural": 1.6516360949200002, "remark": 1.34847005245, "releas": 0.608521699544, "time": 0.0112115188626, "smithblockedunblockfollowfollowingmar": 7.2746685411000005, "addit": 0.220218882972, "johnson": 3.1877511693400002, "serotoninnorepinephrin": 7.2746685411000005, "one": 0.0187660549365, "were": 0.024291143681099997, "administ": 5.78918357541, "two": 0.041096533074600004, "that": 0.039761483796399995, "might": 0.7683410765340001, "place": 0.0957070839572, "must": 1.960151842164, "stress": 1.71014813378, "drug": 42.749593349760005, "this": 0.01514579621, "fairview": 5.38210437275, "could": 1.1157376337400002, "unabl": 1.19640097204, "can": 0.649364385576, "includ": 0.0188846813905, "depressionth": 7.2746685411000005, "after": 0.020490694648099998, "ketamin": 109.04594368996001, "tradeoff": 5.34183047362, "peopl": 3.478780412514, "win": 1.01265652029, "treatment": 2.7071553770200003, "divis": 0.845242361205, "their": 0.046081515368100005, "cortex": 4.40470565484, "hand": 0.479471335336, "efficaci": 10.90407868194, "same": 0.112059649604, "care": 1.8279886058219998, "visit": 0.791283218833, "with": 0.00957993370712, "publish": 0.313975865467, "colleg": 0.9365564293340001, "major": 0.276949326878, "inhibitor": 8.92615532212, "rule": 0.554777423537, "result": 0.136378908381, "report": 0.31001750903700004, "base": 0.13652330228700002, "whom": 0.8343021310169999, "has": 0.213619724274, "look": 0.6463866936, "whole": 0.8306818244059999, "dissoci": 8.4344853971, "wonder": 1.98319270637, "becaus": 0.139343158825, "approv": 2.1013006234400002, "divert": 2.6897010624299997, "fail": 0.656536611573, "opioid": 5.38210437275, "safeti": 2.97386984552, "profession": 0.970385948273, "ill": 1.5957377825999999, "longterm": 6.238576609419999, "greater": 1.529090982236, "synaps": 10.71015140074, "number": 0.0966085784186, "prozac": 14.549337082200001, "dana": 3.3375095624, "over": 0.0249367214957, "week": 1.1814777283239999, "parti": 1.448995420888, "out": 0.0584263909193, "administr": 0.8712448662379999, "take": 0.261383924394, "think": 2.1343532235, "had": 0.0929560488222, "cornel": 2.8757400956299994, "like": 0.6952678827250001, "gaertnergetti": 7.2746685411000005, "insubstanti": 6.340359303730001, "start": 0.236443369291, "get": 0.579769005782, "spravato": 7.2746685411000005, "switch": 1.60416085533, "offic": 0.926047524196, "norepinephrin": 5.74073818118, "abusebecaus": 7.2746685411000005, "anecdot": 3.2673353558700002, "live": 0.266903399347, "subsidiari": 2.54406786822, "what": 0.225887296827, "problem": 0.569140724273, "the": 0.0, "qualiti": 1.07600506711, "differ": 0.424642242624, "diseas": 1.6509792804499999, "dopamin": 5.08759633523, "servic": 0.41410016674500005, "brain": 8.75727759132, "tamp": 6.7821920560099995, "without": 0.258874517941, "communiti": 0.673561947791, "how": 0.47156695693000006, "signific": 0.747143488664, "certifi": 2.54808555141, "there": 0.160391571702, "altern": 0.760359972282, "depress": 17.6785990003, "surround": 0.915723999073, "plan": 0.857964216294, "desper": 2.4654449577, "risk": 11.280038727119999, "resist": 1.1723133432200001, "stop": 0.778579374963, "symptom": 2.8869761689, "group": 0.190594534797, "posit": 0.316652318608, "benefit": 3.36348735348, "right": 0.34035985417, "use": 0.0584160394632, "part": 0.04239531098280001, "mitig": 3.1272141535699998, "through": 0.0683586918849, "suicid": 6.19405722186, "howev": 0.0903151173475, "therapeut": 3.6686767468, "cell": 1.9605673068599998, "refer": 0.262553246798, "where": 0.1299842774914, "anymor": 3.5588816340699996, "serotonin": 10.413311390499999, "everi": 0.391485427421, "worth": 1.65065103492, "studi": 1.2794108166629998, "also": 0.0293143156, "choic": 1.14166497543, "far": 1.073247529006, "farchion": 7.2746685411000005, "score": 1.4559353207700003, "system": 0.982291036755, "provid": 0.585533532975, "will": 1.2167192094900001, "sure": 2.0086865552, "clinic": 11.571850305849999, "balanc": 1.4936444810499998, "avail": 1.094909172578, "gain": 0.6142097989249999, "they": 0.1189079790704, "recreat": 1.8773288849, "review": 0.7929522039210001, "treat": 2.55643290498, "hometh": 7.2746685411000005, "pressur": 1.09484012275, "fertil": 2.30801679965, "prescrib": 2.7932080094400003, "not": 0.0777620650375, "proven": 2.28423595433, "pretti": 2.75684036527, "are": 0.17680484149620002, "some": 0.0395735090645, "becom": 0.23542435297800002, "clinician": 4.8442500766, "march": 0.32193989648000004, "than": 0.0322608622182, "hallucin": 4.33022956194, "brand": 1.7094517549200001, "for": 0.005669827117146001, "sold": 1.02732927261, "minimum": 1.79668465441, "activ": 0.381196603284, "cymbalta": 7.2746685411000005, "say": 2.81077140276, "black": 0.667404292867, "target": 2.3381278992400003, "befor": 0.0956377718795, "mean": 0.74184256704, "monitor": 3.60250522116, "often": 0.258140393351, "much": 0.17749572930100002, "connect": 1.267210117364, "psychiatri": 8.14088998604, "specialti": 2.97800175538, "regrow": 6.08904487545, "measur": 0.880014199726, "plus": 1.54575009318, "reuptak": 11.73180264826, "imag": 0.99376210729, "led": 0.29104709623799996, "livesresearch": 7.2746685411000005, "damag": 1.02276465794, "particular": 0.646314787608, "popular": 0.41058020877499996, "version": 0.697313064259, "burden": 2.53290347794, "compar": 1.2478383618539999, "open": 0.219591038029, "placebo": 14.5568467449, "abus": 3.67634302198, "folk": 2.03677695251, "month": 0.410770160338, "respond": 2.30954160482, "said": 0.87330633163, "untreat": 9.01555567996, "doe": 0.5340417297169999, "follow": 0.045356911094199995, "believ": 0.497746997996, "onsit": 6.0616459012599995, "onli": 0.0759728049873, "product": 0.484060136536, "five": 0.320203181906, "director": 1.931154101708, "wear": 1.48470837021, "show": 0.473365532026, "option": 2.79692362322, "new": 0.08864973425549999, "wait": 1.51605358782, "may": 0.050709995284400004, "those": 0.35709878174599996, "down": 0.306673741186, "involv": 0.742938157316, "tradit": 0.47500477629199994, "year": 0.047402238894600005, "present": 0.227546654799, "rais": 0.6797577544760001, "least": 0.480285584745, "homean": 7.2746685411000005, "rush": 2.0353294251099996, "current": 0.42695282784500005, "experi": 0.626272953933, "liter": 1.6990638498800001, "worri": 2.3323769785799997, "offlabel": 7.2746685411000005, "clear": 0.617474727198, "friedman": 14.481898579920001, "about": 0.18853043242380002, "revers": 1.45836939905, "weill": 5.4981765440100006, "feel": 3.4285480257899996, "notabl": 0.603441443842, "percent": 4.084971170189999, "meisel": 21.100519452869996, "other": 0.03949899167904, "prevent": 0.7706525875229999, "rough": 1.1926572072700001, "trial": 2.7933562888599996, "see": 0.240921585492, "club": 1.07286940097, "known": 0.0824180805992, "them": 0.1883666538186, "effect": 3.0044720444219997, "committe": 2.34951467258, "notorieti": 3.8146306594199997, "select": 0.704804687133, "sedat": 4.44145519705, "antidepress": 35.613174346609995, "florian": 4.83628190695, "well": 0.0635144383156, "psychoact": 10.791795389779999, "need": 0.362740163442, "dramat": 2.7650443904000004, "singl": 0.475916769059, "three": 0.06411868822490001, "which": 0.01553524153629, "num": 0.0034648943493670007, "spray": 6.76569648598, "janssen": 10.258538063260001, "order": 0.22014038079300002, "blood": 1.5579399274799999, "research": 1.327455636276, "sinc": 0.0803681994577, "form": 0.240106368382, "exact": 1.2437647732500001, "offici": 0.339917317543, "more": 0.05107479479999999, "minor": 1.604644493208, "few": 0.551155827306, "wellknown": 7.2746685411000005, "glutam": 5.40988393686, "relaps": 4.591159448919999, "nasti": 4.18776688041, "remain": 0.15356296309, "develop": 0.178624694913, "doctor": 2.74208431792, "help": 1.008623164032, "tiffani": 4.409873625, "access": 0.627805882716, "offput": 7.2746685411000005, "chang": 0.166275625058, "outweigh": 3.9992405467300003, "these": 0.2861344776032, "center": 0.555216308776, "twice": 1.32544745286, "classifi": 1.6665296351499999, "lost": 0.557523621781, "pharmaceut": 3.2095343569800003, "pathway": 3.2364134455299998, "primari": 0.805277289914, "entir": 0.46603068026999994, "off": 0.41352852038800003, "learningscientist": 7.2746685411000005, "veri": 0.230159793238, "speak": 1.06169814662}}, "url": "https://onezero.medium.com/the-party-drug-that-could-help-stop-depression-2e57c195b294", "html": "<!DOCTYPE html>\n<html xmlns:cc=\"http://creativecommons.org/ns#\"><head prefix=\"og: http://ogp.me/ns# fb: http://ogp.me/ns/fb# medium-com: http://ogp.me/ns/fb/medium-com#\"><meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/><meta content=\"width=device-width, initial-scale=1.0, viewport-fit=contain\" name=\"viewport\"/><title>The Party Drug That Could Help Stop Depression \u2013 OneZero</title><link href=\"https://onezero.medium.com/the-party-drug-that-could-help-stop-depression-2e57c195b294\" rel=\"canonical\"/><meta content=\"The Party Drug That Could Help Stop Depression \u2013 OneZero\" name=\"title\"/><meta content=\"origin\" name=\"referrer\"/><meta content=\"The U.S. Food and Drug Administration (FDA) on March 5 approved a form of ketamine to be prescribed for treatment-resistant depression. The drug, called esketamine, is administered as a nasal spray\u2026\" name=\"description\"/><meta content=\"#000000\" name=\"theme-color\"/><meta content=\"The Party Drug That Could Help Stop Depression\" property=\"og:title\"/><meta content=\"The Party Drug That Could Help Stop Depression\" property=\"twitter:title\"/><meta content=\"https://onezero.medium.com/the-party-drug-that-could-help-stop-depression-2e57c195b294\" property=\"og:url\"/><meta content=\"https://cdn-images-1.medium.com/focal/1200/632/65/20/1*fIp9beyYlYnV-0ubLCBIGQ.jpeg\" property=\"og:image\"/><meta content=\"542599432471018\" property=\"fb:app_id\"/><meta content=\"The anesthetic ketamine receives official FDA approval to treat depression. Is the tradeoff worth it?\" property=\"og:description\"/><meta content=\"The anesthetic ketamine receives official FDA approval to treat depression. Is the tradeoff worth it?\" name=\"twitter:description\"/><meta content=\"https://cdn-images-1.medium.com/focal/1200/632/65/20/1*fIp9beyYlYnV-0ubLCBIGQ.jpeg\" name=\"twitter:image:src\"/><link href=\"https://plus.google.com/103654360130207659246\" rel=\"publisher\"/><link href=\"https://onezero.medium.com/@smithdanag\" rel=\"author\"/><meta content=\"Dana G Smith\" property=\"author\"/><meta content=\"article\" property=\"og:type\"/><meta content=\"summary_large_image\" name=\"twitter:card\"/><meta content=\"https://www.facebook.com/medium\" property=\"article:publisher\"/><meta content=\"https://onezero.medium.com/@smithdanag\" property=\"article:author\"/><meta content=\"index, follow\" name=\"robots\"/><meta content=\"2019-03-06T00:36:47.707Z\" property=\"article:published_time\"/><meta content=\"@SmithDanaG\" name=\"twitter:creator\"/><meta content=\"@Medium\" name=\"twitter:site\"/><meta content=\"OneZero\" property=\"og:site_name\"/><meta name=\"twitter:label1\" value=\"Reading time\"/><meta name=\"twitter:data1\" value=\"5 min read\"/><meta content=\"Medium\" name=\"twitter:app:name:iphone\"/><meta content=\"828256236\" name=\"twitter:app:id:iphone\"/><meta content=\"medium://p/2e57c195b294\" name=\"twitter:app:url:iphone\"/><meta content=\"Medium\" property=\"al:ios:app_name\"/><meta content=\"828256236\" property=\"al:ios:app_store_id\"/><meta content=\"com.medium.reader\" property=\"al:android:package\"/><meta content=\"Medium\" property=\"al:android:app_name\"/><meta content=\"medium://p/2e57c195b294\" property=\"al:ios:url\"/><meta content=\"medium://p/2e57c195b294\" property=\"al:android:url\"/><meta content=\"https://onezero.medium.com/the-party-drug-that-could-help-stop-depression-2e57c195b294\" property=\"al:web:url\"/><link href=\"/osd.xml\" rel=\"search\" title=\"Medium\" type=\"application/opensearchdescription+xml\"><link href=\"android-app://com.medium.reader/https/medium.com/p/2e57c195b294\" rel=\"alternate\"><script type=\"application/ld+json\">{\"@context\":\"http://schema.org\",\"@type\":\"NewsArticle\",\"image\":{\"@type\":\"ImageObject\",\"width\":1920,\"height\":1280,\"url\":\"https://cdn-images-1.medium.com/max/2600/1*fIp9beyYlYnV-0ubLCBIGQ.jpeg\"},\"url\":\"https://onezero.medium.com/the-party-drug-that-could-help-stop-depression-2e57c195b294\",\"dateCreated\":\"2019-03-06T00:36:47.707Z\",\"datePublished\":\"2019-03-06T00:36:47.707Z\",\"dateModified\":\"2019-03-06T00:50:28.644Z\",\"headline\":\"The Party Drug That Could Help Stop Depression\",\"name\":\"The Party Drug That Could Help Stop Depression\",\"articleId\":\"2e57c195b294\",\"thumbnailUrl\":\"https://cdn-images-1.medium.com/max/2600/1*fIp9beyYlYnV-0ubLCBIGQ.jpeg\",\"keywords\":[\"Tag:Depression\",\"Tag:Treatment\",\"Tag:Antidepressants\",\"Tag:FDA\",\"Tag:Science And Medicine\",\"Topic:Mental Health\",\"Topic:Science\",\"Topic:Health\",\"Publication:one-zero\",\"LockedPostSource:2\",\"Elevated:false\",\"LayerCake:1\"],\"author\":{\"@type\":\"Person\",\"name\":\"Dana G Smith\",\"url\":\"https://onezero.medium.com/@smithdanag\"},\"creator\":[\"Dana G Smith\"],\"publisher\":{\"@type\":\"Organization\",\"name\":\"OneZero\",\"url\":\"https://onezero.medium.com\",\"logo\":{\"@type\":\"ImageObject\",\"width\":234,\"height\":60,\"url\":\"https://cdn-images-1.medium.com/max/468/1*RxCcqX5oOebo9NLExQ6rgw.png\"}},\"mainEntityOfPage\":\"https://onezero.medium.com/the-party-drug-that-could-help-stop-depression-2e57c195b294\"}</script><meta content=\"https://onezero.medium.com/the-party-drug-that-could-help-stop-depression-2e57c195b294\" name=\"parsely-link\"/><link class=\"js-glyph-\" href=\"https://glyph.medium.com/css/e/sr/latin/e/ssr/latin/e/ssb/latin/m2.css\" id=\"glyph-8\" rel=\"stylesheet\" type=\"text/css\"><link href=\"https://cdn-static-1.medium.com/_/fp/css/main-branding-base.95h6LstxJX8UWgJm7QqR7A.css\" rel=\"stylesheet\"/><script>!function(n,e){var t,o,i,c=[],f={passive:!0,capture:!0},r=new Date,a=\"pointerup\",u=\"pointercancel\";function p(n,c){t||(t=c,o=n,i=new Date,w(e),s())}function s(){o>=0&&o<i-r&&(c.forEach(function(n){n(o,t)}),c=[])}function l(t){if(t.cancelable){var o=(t.timeStamp>1e12?new Date:performance.now())-t.timeStamp;\"pointerdown\"==t.type?function(t,o){function i(){p(t,o),r()}function c(){r()}function r(){e(a,i,f),e(u,c,f)}n(a,i,f),n(u,c,f)}(o,t):p(o,t)}}function w(n){[\"click\",\"mousedown\",\"keydown\",\"touchstart\",\"pointerdown\"].forEach(function(e){n(e,l,f)})}w(n),self.perfMetrics=self.perfMetrics||{},self.perfMetrics.onFirstInputDelay=function(n){c.push(n),s()}}(addEventListener,removeEventListener);</script><script>if (window.top !== window.self) window.top.location = window.self.location.href;var OB_startTime = new Date().getTime(); var OB_loadErrors = []; function _onerror(e) { OB_loadErrors.push(e) }; if (document.addEventListener) document.addEventListener(\"error\", _onerror, true); else if (document.attachEvent) document.attachEvent(\"onerror\", _onerror); function _asyncScript(u) {var d = document, f = d.getElementsByTagName(\"script\")[0], s = d.createElement(\"script\"); s.type = \"text/javascript\"; s.async = true; s.src = u; f.parentNode.insertBefore(s, f);}function _asyncStyles(u) {var d = document, f = d.getElementsByTagName(\"script\")[0], s = d.createElement(\"link\"); s.rel = \"stylesheet\"; s.href = u; f.parentNode.insertBefore(s, f); return s}(new Image()).src = \"/_/stat?event=pixel.load&origin=\" + encodeURIComponent(location.origin);</script><script>window.ga=window.ga||function(){(ga.q=ga.q||[]).push(arguments)};ga.l=+new Date; ga(\"create\", \"UA-24232453-2\", \"auto\", {\"allowLinker\": true, \"legacyCookieDomain\": window.location.hostname}); ga(\"send\", \"pageview\");</script><script async=\"\" src=\"https://www.google-analytics.com/analytics.js\"></script><!--[if lt IE 9]><script charset=\"UTF-8\" src=\"https://cdn-static-1.medium.com/_/fp/js/shiv.RI2ePTZ5gFmMgLzG5bEVAA.js\"></script><![endif]--><link class=\"js-favicon\" href=\"https://cdn-static-1.medium.com/_/fp/icons/favicon-rebrand-medium.3Y6xpZ-0FSdWDnPM3hSBIA.ico\" rel=\"icon\"/><link href=\"https://cdn-images-1.medium.com/fit/c/304/304/1*88Z0O0wD4KOrk6Y5EceZog.png\" rel=\"apple-touch-icon\" sizes=\"152x152\"/><link href=\"https://cdn-images-1.medium.com/fit/c/240/240/1*88Z0O0wD4KOrk6Y5EceZog.png\" rel=\"apple-touch-icon\" sizes=\"120x120\"/><link href=\"https://cdn-images-1.medium.com/fit/c/152/152/1*88Z0O0wD4KOrk6Y5EceZog.png\" rel=\"apple-touch-icon\" sizes=\"76x76\"/><link href=\"https://cdn-images-1.medium.com/fit/c/120/120/1*88Z0O0wD4KOrk6Y5EceZog.png\" rel=\"apple-touch-icon\" sizes=\"60x60\"/><link color=\"#171717\" href=\"https://cdn-static-1.medium.com/_/fp/icons/monogram-mask.KPLCSFEZviQN0jQ7veN2RQ.svg\" rel=\"mask-icon\"/></link></link></link></head><body class=\"postShowScreen browser-chrome os-windows is-withMagicUnderlines v-glyph v-glyph--m2 is-noJs\" itemscope=\"\"><script>document.body.className = document.body.className.replace(/(^|\\s)is-noJs(\\s|$)/, \"$1is-js$2\")</script><div class=\"site-main\" id=\"container\"><div class=\"butterBar butterBar--error\"></div><div class=\"surface\"><div class=\"screenContent\" id=\"prerendered\"><canvas class=\"canvas-renderer\"></canvas><div class=\"container u-maxWidth740 u-xs-margin0 notesPositionContainer js-notesPositionContainer\"></div><div class=\"metabar u-clearfix u-boxShadow4px12pxBlackLightest u-fixed u-backgroundTransparentWhiteDarkest u-xs-sizeFullViewportWidth js-metabar\"><div class=\"branch-journeys-top\"></div><div class=\"js-metabarMiddle metabar-inner u-marginAuto u-maxWidth1032 u-flexCenter u-justifyContentSpaceBetween u-height65 u-xs-height56 u-paddingHorizontal20\"><div class=\"metabar-block u-flex1 u-flexCenter\"><div class=\"u-xs-hide js-metabarLogoLeft\"><a class=\"siteNav-logo u-fillTransparentBlackDarker u-flex0 u-flexCenter u-paddingTop0\" data-log-event=\"home\" href=\"https://medium.com/\"><span class=\"svgIcon svgIcon--logoMonogram svgIcon--45px is-flushLeft u-flex0 u-flexCenter u-paddingTop0\"><svg class=\"svgIcon-use\" height=\"45\" width=\"45\"><path d=\"M5 40V5h35v35H5zm8.56-12.627c0 .555-.027.687-.318 1.03l-2.457 2.985v.396h6.974v-.396l-2.456-2.985c-.291-.343-.344-.502-.344-1.03V18.42l6.127 13.364h.714l5.256-13.364v10.644c0 .29 0 .342-.185.528l-1.848 1.796v.396h9.19v-.396l-1.822-1.796c-.184-.186-.21-.238-.21-.528V15.937c0-.291.026-.344.21-.528l1.823-1.797v-.396h-6.471l-4.622 11.542-5.203-11.542h-6.79v.396l2.14 2.64c.239.292.291.37.291.768v10.353z\"></path></svg></span><span class=\"u-textScreenReader\">Homepage</span></a></div><div class=\"u-xs-show js-metabarLogoLeft\"><a class=\"siteNav-logo u-fillTransparentBlackDarker u-flex0 u-flexCenter u-paddingTop0\" data-log-event=\"home\" href=\"https://medium.com/\"><span class=\"svgIcon svgIcon--logoMonogram svgIcon--45px is-flushLeft u-flex0 u-flexCenter u-paddingTop0\"><svg class=\"svgIcon-use\" height=\"45\" width=\"45\"><path d=\"M5 40V5h35v35H5zm8.56-12.627c0 .555-.027.687-.318 1.03l-2.457 2.985v.396h6.974v-.396l-2.456-2.985c-.291-.343-.344-.502-.344-1.03V18.42l6.127 13.364h.714l5.256-13.364v10.644c0 .29 0 .342-.185.528l-1.848 1.796v.396h9.19v-.396l-1.822-1.796c-.184-.186-.21-.238-.21-.528V15.937c0-.291.026-.344.21-.528l1.823-1.797v-.396h-6.471l-4.622 11.542-5.203-11.542h-6.79v.396l2.14 2.64c.239.292.291.37.291.768v10.353z\"></path></svg></span><span class=\"u-textScreenReader\">Homepage</span></a></div></div><div class=\"metabar-block u-flex0 u-flexCenter\"><div class=\"u-flexCenter u-height65 u-xs-height56\"><div class=\"buttonSet buttonSet--wide u-lineHeightInherit\"><a class=\"button button--primary button--chromeless u-accentColor--buttonNormal is-inSiteNavBar u-xs-hide js-signInButton\" data-action=\"sign-in-prompt\" data-action-source=\"--------------------------nav_reg\" data-redirect=\"https://onezero.medium.com/the-party-drug-that-could-help-stop-depression-2e57c195b294\" href=\"https://medium.com/m/signin?redirect=https%3A%2F%2Fonezero.medium.com%2Fthe-party-drug-that-could-help-stop-depression-2e57c195b294&amp;source=--------------------------nav_reg&amp;operation=login\">Sign in</a><a class=\"button button--primary button--withChrome u-accentColor--buttonNormal is-inSiteNavBar js-signUpButton\" data-action=\"sign-up-prompt\" data-action-source=\"--------------------------nav_reg\" data-redirect=\"https://onezero.medium.com/the-party-drug-that-could-help-stop-depression-2e57c195b294\" href=\"https://medium.com/m/signin?redirect=https%3A%2F%2Fonezero.medium.com%2Fthe-party-drug-that-could-help-stop-depression-2e57c195b294&amp;source=--------------------------nav_reg&amp;operation=register\">Get started</a></div></div></div></div><div class=\"u-borderTopLighter\"><div class=\"metabar-inner u-marginAuto u-maxWidth1032 u-paddingHorizontal20 js-metabarBottom\"><nav class=\"metabar-block metabar-block--below u-flexCenter u-overflowHidden u-height54\" role=\"navigation\"><div class=\"u-flexCenter u-overflowHidden\"><div class=\"u-marginRight40\"><a class=\"u-flexCenter js-collectionLogoOrName\" href=\"https://onezero.medium.com?source=logo-lo_kBEP9dfq2M2Z---444d13b52878\"><img alt=\"OneZero\" height=\"36\" src=\"https://cdn-images-1.medium.com/letterbox/280/72/50/50/1*RxCcqX5oOebo9NLExQ6rgw.png?source=logoAvatar-lo_kBEP9dfq2M2Z---444d13b52878\" width=\"140\"/></a></div><div class=\"u-overflowHidden u-xs-hide\"><ul class=\"u-textAlignLeft u-noWrap u-overflowX u-height80 u-marginTop40 js-collectionNavItems\"><li class=\"metabar-navItem js-collectionNavItem u-inlineBlock u-fontSize13 u-textUppercase u-letterSpacing1px u-textColorNormal u-xs-paddingRight12 u-xs-marginRight0 u-xs-paddingTop10\"><a class=\"link link--darken u-accentColor--textDarken link--noUnderline u-baseColor--link js-navItemLink\" href=\"https://onezero.medium.com/consumer-tech/home\">CONSUMER TECH</a></li><li class=\"metabar-navItem js-collectionNavItem u-inlineBlock u-fontSize13 u-textUppercase u-letterSpacing1px u-textColorNormal u-xs-paddingRight12 u-xs-marginRight0 u-xs-paddingTop10\"><a class=\"link link--darken u-accentColor--textDarken link--noUnderline u-baseColor--link js-navItemLink\" href=\"https://onezero.medium.com/digital-life/home\">DIGITAL LIFE</a></li><li class=\"metabar-navItem js-collectionNavItem u-inlineBlock u-fontSize13 u-textUppercase u-letterSpacing1px u-textColorNormal u-xs-paddingRight12 u-xs-marginRight0 u-xs-paddingTop10\"><a class=\"link link--darken u-accentColor--textDarken link--noUnderline u-baseColor--link js-navItemLink\" href=\"https://onezero.medium.com/industry/home\">INDUSTRY</a></li><li class=\"metabar-navItem js-collectionNavItem u-inlineBlock u-fontSize13 u-textUppercase u-letterSpacing1px u-textColorNormal u-xs-paddingRight12 u-xs-marginRight0 u-xs-paddingTop10\"><a class=\"link link--darken u-accentColor--textDarken link--noUnderline u-baseColor--link js-navItemLink\" href=\"https://onezero.medium.com/science-and-medicine/home\">SCIENCE &amp; MEDICINE</a></li></ul></div></div></nav></div></div></div><div class=\"metabar metabar--spacer js-metabarSpacer u-height119 u-xs-height110\"></div><main role=\"main\"><article class=\"u-minHeight100vhOffset65 u-overflowHidden postArticle postArticle--full is-withAccentColors u-marginBottom40\" lang=\"en\"><div class=\"postArticle-content js-postField js-notesSource js-trackPostScrolls\" data-collection-id=\"444d13b52878\" data-post-id=\"2e57c195b294\" data-source=\"post_page\" data-tracking-context=\"postPage\"><section class=\"section section--body section--first section--last\" name=\"7810\"><div class=\"section-divider\"><hr class=\"section-divider\"/></div><div class=\"section-content\"><div class=\"section-inner sectionLayout--insetColumn\"><h1 class=\"graf graf--h3 graf--leading graf--title\" id=\"9595\" name=\"9595\">The Party Drug That Could Help Stop Depression</h1><h2 class=\"graf graf--h4 graf-after--h3 graf--subtitle\" id=\"e127\" name=\"e127\">The anesthetic ketamine receives official FDA approval to treat depression. Is the tradeoff worth\u00a0it?</h2><div class=\"uiScale uiScale-ui--regular uiScale-caption--regular u-flexCenter u-marginVertical24 u-fontSize15 js-postMetaLockup\"><div class=\"u-flex0\"><a class=\"link u-baseColor--link avatar\" data-action=\"show-user-card\" data-action-source=\"post_header_lockup\" data-action-type=\"hover\" data-action-value=\"bf4c3c7dced5\" data-collection-slug=\"one-zero\" data-user-id=\"bf4c3c7dced5\" dir=\"auto\" href=\"https://onezero.medium.com/@smithdanag?source=post_header_lockup\"><div class=\"u-relative u-inlineBlock u-flex0\"><img alt=\"Go to the profile of Dana G Smith\" class=\"avatar-image u-size50x50\" src=\"https://cdn-images-1.medium.com/fit/c/100/100/1*uoseNvFQihxFrrGwRBUpxw.jpeg\"/><div class=\"avatar-halo u-absolute u-textColorGreenNormal svgIcon\" style=\"width: calc(100% + 10px); height: calc(100% + 10px); top:-5px; left:-5px\"><svg viewbox=\"0 0 70 70\" xmlns=\"http://www.w3.org/2000/svg\"><path d=\"M5.53538374,19.9430227 C11.180401,8.78497536 22.6271155,1.6 35.3571429,1.6 C48.0871702,1.6 59.5338847,8.78497536 65.178902,19.9430227 L66.2496695,19.401306 C60.4023065,7.84329843 48.5440457,0.4 35.3571429,0.4 C22.17024,0.4 10.3119792,7.84329843 4.46461626,19.401306 L5.53538374,19.9430227 Z\"></path><path d=\"M65.178902,49.9077131 C59.5338847,61.0657604 48.0871702,68.2507358 35.3571429,68.2507358 C22.6271155,68.2507358 11.180401,61.0657604 5.53538374,49.9077131 L4.46461626,50.4494298 C10.3119792,62.0074373 22.17024,69.4507358 35.3571429,69.4507358 C48.5440457,69.4507358 60.4023065,62.0074373 66.2496695,50.4494298 L65.178902,49.9077131 Z\"></path></svg></div></div></a></div><div class=\"u-flex1 u-paddingLeft15 u-overflowHidden\"><div class=\"u-paddingBottom3\"><a class=\"ds-link ds-link--styleSubtle ui-captionStrong u-inlineBlock link link--darken link--darker\" data-action=\"show-user-card\" data-action-type=\"hover\" data-action-value=\"bf4c3c7dced5\" data-collection-slug=\"one-zero\" data-user-id=\"bf4c3c7dced5\" dir=\"auto\" href=\"https://onezero.medium.com/@smithdanag\">Dana G Smith</a><span class=\"followState js-followState\" data-user-id=\"bf4c3c7dced5\"><button class=\"button button--smallest u-noUserSelect button--withChrome u-baseColor--buttonNormal button--withHover button--unblock js-unblockButton u-marginLeft10 u-xs-hide\" data-action=\"sign-up-prompt\" data-action-source=\"post_header_lockup\" data-redirect=\"https://onezero.medium.com/the-party-drug-that-could-help-stop-depression-2e57c195b294\" data-requires-token=\"true\" data-sign-in-action=\"toggle-block-user\"><span class=\"button-label button-defaultState\">Blocked</span><span class=\"button-label button-hoverState\">Unblock</span></button><button class=\"button button--primary button--smallest button--dark u-noUserSelect button--withChrome u-accentColor--buttonDark button--follow js-followButton u-marginLeft10 u-xs-hide\" data-action=\"sign-up-prompt\" data-action-source=\"post_header_lockup-bf4c3c7dced5-------------------------follow_byline\" data-redirect=\"https://medium.com/_/subscribe/user/bf4c3c7dced5\" data-requires-token=\"true\" data-sign-in-action=\"toggle-subscribe-user\"><span class=\"button-label button-defaultState js-buttonLabel\">Follow</span><span class=\"button-label button-activeState\">Following</span></button></span></div><div class=\"ui-caption u-noWrapWithEllipsis js-testPostMetaInlineSupplemental\"><time datetime=\"2019-03-06T00:36:47.707Z\">Mar 5</time><span class=\"middotDivider u-fontSize12\"></span><span class=\"readingTime\" title=\"5 min read\"></span><span class=\"u-paddingLeft4\"><span class=\"svgIcon svgIcon--star svgIcon--15px\"><svg class=\"svgIcon-use\" height=\"15\" width=\"15\"><path d=\"M7.438 2.324c.034-.099.09-.099.123 0l1.2 3.53a.29.29 0 0 0 .26.19h3.884c.11 0 .127.049.038.111L9.8 8.327a.271.271 0 0 0-.099.291l1.2 3.53c.034.1-.011.131-.098.069l-3.142-2.18a.303.303 0 0 0-.32 0l-3.145 2.182c-.087.06-.132.03-.099-.068l1.2-3.53a.271.271 0 0 0-.098-.292L2.056 6.146c-.087-.06-.071-.112.038-.112h3.884a.29.29 0 0 0 .26-.19l1.2-3.52z\"></path></svg></span></span></div></div></div></div><div class=\"section-inner sectionLayout--outsetColumn\"><figure class=\"graf graf--figure graf--layoutOutsetCenter graf-after--h4\" id=\"dc28\" name=\"dc28\"><div class=\"aspectRatioPlaceholder is-locked\" style=\"max-width: 1032px; max-height: 688px;\"><div class=\"aspectRatioPlaceholder-fill\" style=\"padding-bottom: 66.7%;\"></div><div class=\"progressiveMedia js-progressiveMedia graf-image\" data-action=\"zoom\" data-action-value=\"1*fIp9beyYlYnV-0ubLCBIGQ.jpeg\" data-focus-x=\"65\" data-focus-y=\"20\" data-height=\"2667\" data-image-id=\"1*fIp9beyYlYnV-0ubLCBIGQ.jpeg\" data-is-featured=\"true\" data-width=\"4000\"><img class=\"progressiveMedia-thumbnail js-progressiveMedia-thumbnail\" crossorigin=\"anonymous\" src=\"https://cdn-images-1.medium.com/freeze/max/60/1*fIp9beyYlYnV-0ubLCBIGQ.jpeg?q=20\"/><canvas class=\"progressiveMedia-canvas js-progressiveMedia-canvas\"></canvas><img class=\"progressiveMedia-image js-progressiveMedia-image\" data-src=\"https://cdn-images-1.medium.com/max/2400/1*fIp9beyYlYnV-0ubLCBIGQ.jpeg\"/><noscript class=\"js-progressiveMedia-inner\"><img class=\"progressiveMedia-noscript js-progressiveMedia-inner\" src=\"https://cdn-images-1.medium.com/max/2400/1*fIp9beyYlYnV-0ubLCBIGQ.jpeg\"/></noscript></div></div><figcaption class=\"imageCaption\">Credit: Florian Gaertner/Getty Images\u00a0Plus</figcaption></figure></div><div class=\"section-inner sectionLayout--insetColumn\"><p class=\"graf graf--p graf--hasDropCapModel graf--hasDropCap graf--hasDropCapImage graf-after--figure\" id=\"ff6b\" name=\"ff6b\"><span class=\"graf-dropCap\"><span class=\"aspectRatioPlaceholder is-locked\" style=\"width: 111px; height: 111px;\"><span class=\"aspectRatioPlaceholder-fill\" style=\"padding-bottom: 100%;\"></span><img class=\"graf-dropCapImage\" data-height=\"500\" data-image-id=\"1*x3MLNrKVby4_GZ1VCCYktA.png\" data-width=\"500\" src=\"https://cdn-images-1.medium.com/max/800/1*x3MLNrKVby4_GZ1VCCYktA.png\"/></span><span class=\"graf-dropCapText\">T</span></span>he U.S. Food and Drug Administration (FDA) on March 5 approved a form of ketamine to be prescribed for treatment-resistant depression. The drug, called esketamine, is administered as a nasal spray and is the first version of ketamine to be cleared to treat depression. It\u2019s also the <a class=\"markup--anchor markup--p-anchor\" data-href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428540/\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428540/\" rel=\"noopener\" target=\"_blank\">first new type of antidepressant drug</a> since Prozac was released over 30 years ago. Many psychiatrists and pharmacists see the ruling as a win for desperate patients with few options, but others have raised concerns about the drug\u2019s possibly serious side effects and have questioned its efficacy.</p><p class=\"graf graf--p graf--startsWithDoubleQuote graf-after--p\" id=\"1ef3\" name=\"1ef3\">\u201cOn the whole, I think they made the right choice,\u201d says Richard Friedman, a professor of psychiatry at Weill Cornell Medical College who was not involved in the decision. \u201cThis is a group of people who are really ill and for whom there are limited therapeutics. There\u2019s no question ketamine has antidepressant efficacy, and it\u2019s a new target.\u201d</p><p class=\"graf graf--p graf-after--p\" id=\"862d\" name=\"862d\">Esketamine will be sold under the brand name Spravato and is made by Janssen Pharmaceutical Company, a subsidiary of Johnson &amp; Johnson. \u201cBecause of safety concerns, the drug will only be available through a restricted distribution system and it must be administered in a certified medical office where the health care provider can monitor the patient,\u201d said Dr. Tiffany Farchione, acting director of the Division of Psychiatry Products in the FDA\u2019s Center for Drug Evaluation and Research <a class=\"markup--anchor markup--p-anchor\" data-href=\"https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm632761.htm\" href=\"https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm632761.htm\" rel=\"noopener\" target=\"_blank\">in a statement</a>.</p><p class=\"graf graf--p graf-after--p\" id=\"794e\" name=\"794e\">The FDA said that people who take the drug must be monitored by a health care provider for at least two hours after receiving it. Patients cannot take the spray home.</p><p class=\"graf graf--p graf-after--p\" id=\"46ea\" name=\"46ea\">An estimated 30 to 40 percent of people with depression fail to respond to traditional antidepressant drugs like Prozac (a selective serotonin reuptake inhibitor or SSRI) and Cymbalta (a serotonin-norepinephrine reuptake inhibitor or SNRI), classifying them as \u201ctreatment resistant.\u201d These patients have few alternative options, as all current antidepressants act on the same three neurochemicals: serotonin, dopamine, and norepinephrine. Ketamine, by contrast, acts on an entirely different pathway: the glutamate system, which is the brain\u2019s primary excitatory neurochemical and is involved in learning.</p><p class=\"graf graf--p graf-after--p\" id=\"3b3f\" name=\"3b3f\">Scientists aren\u2019t exactly sure how ketamine acts as an antidepressant, but it may do so by increasing the number of connections, or synapses, between cells in the brain, particularly in the prefrontal cortex. Stress and depression degrade these connections, and ketamine could reverse the damage, regrowing the lost synapses. \u201cIt\u2019s like fertilizer in the brain,\u201d says Friedman.</p><p class=\"graf graf--p graf--startsWithDoubleQuote graf-after--p\" id=\"0e3a\" name=\"0e3a\"><strong class=\"markup--strong markup--p-strong\">\u201c</strong>There\u2019s no question ketamine has antidepressant efficacy, and it\u2019s a new target.\u201d</p><p class=\"graf graf--p graf-after--p\" id=\"b40b\" name=\"b40b\">The <a class=\"markup--anchor markup--p-anchor\" data-href=\"https://www.ncbi.nlm.nih.gov/pubmed/10686270\" href=\"https://www.ncbi.nlm.nih.gov/pubmed/10686270\" rel=\"noopener\" target=\"_blank\">first study of ketamine as an antidepressant</a> was published in 2000, with a single dose of the drug dramatically improving depression symptoms in a majority of people. A rush of clinical trials followed, in addition to the opening of ketamine clinics where doctors provide people with the drug off-label. <a class=\"markup--anchor markup--p-anchor\" data-href=\"https://www.vox.com/first-person/2018/7/24/17603616/depression-treatment-severe-ketamine-special-k\" href=\"https://www.vox.com/first-person/2018/7/24/17603616/depression-treatment-severe-ketamine-special-k\" rel=\"noopener\" target=\"_blank\">On an anecdotal basis</a>, the drug has proven remarkable, with suicidal people reporting that the drug saved their lives.</p><p class=\"graf graf--p graf-after--p\" id=\"d11b\" name=\"d11b\">Researchers, though, are much more measured. \u201cI think any hope that this is a new wonder drug should be tamped down,\u201d says Steven Meisel, director of medication safety at Fairview Health Services and a member of the FDA advisory committee that initially recommended ketamine. \u201cThis is a drug that will benefit a minority of people greatly, and a majority of people not at all. For those it does help, it could be dramatic, but it\u2019s going to be a minority.\u201d</p><p class=\"graf graf--p graf-after--p\" id=\"ee2c\" name=\"ee2c\">In its review, the FDA evaluated esketamine based on five clinical trials presented by Janssen. However, only two of the studies showed significant positive results compared to a placebo. In one, roughly 53 percent of people who used esketamine twice a week for a month had a significant improvement in their depression scores, compared with 39 percent of people who took a placebo. The other study showed that people who initially responded to esketamine relapsed when they were switched to a placebo, whereas people who remained on the drug did not.</p><p class=\"graf graf--p graf-after--p\" id=\"afe8\" name=\"afe8\">Many health professionals are concerned about ketamine\u2019s notable side effects, particularly the ones that gained it notoriety as a party drug. Ketamine was first developed as an <a class=\"markup--anchor markup--p-anchor\" data-href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126726/\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126726/\" rel=\"noopener\" target=\"_blank\">anesthetic in the 1960s</a>. By the 1990s, ketamine had become a popular club drug for its dissociative qualities. At high doses, people are so sedated they become out of touch with their surroundings, feel unable to speak or move, and can start to hallucinate\u200a\u2014\u200aan experience often referred to as a \u201ck-hole.\u201d But if you\u2019re not looking to get high, these psychoactive effects might be off-putting.</p><p class=\"graf graf--p graf--startsWithDoubleQuote graf-after--p\" id=\"beab\" name=\"beab\">\u201cThis drug is known as a pretty nasty drug,\u201d says Meisel. \u201cOne of the well-known side effects is what\u2019s called dissociation, which means that you don\u2019t feel a part of your body anymore, you feel like you\u2019re in a different place. And that could be very troublesome for some folks.\u201d</p><p class=\"graf graf--p graf-after--p\" id=\"e6ba\" name=\"e6ba\">Other side effects include long-term changes in blood pressure and bladder problems. Ketamine also activates the opioid system in the brain, which has led many researchers and clinicians to worry about the drug\u2019s potential for abuse.</p><p class=\"graf graf--p graf-after--p\" id=\"d84b\" name=\"d84b\">Because of these concerns, as well as its side effects, the FDA committee recommended a strict risk mitigation plan for the drug. Ketamine will only be available at specialty pharmacies, clinics, and doctor\u2019s offices, and it has to be administered on-site. The patient must wait for a minimum of two hours for the drug\u2019s psychoactive effects to wear off before they can go home.</p><p class=\"graf graf--p graf-after--p\" id=\"a559\" name=\"a559\">The FDA hopes the plan will help prevent ketamine from being abused by patients or diverted into the community for recreational use on the black market. But the need to visit a clinic for several hours every week will likely be a burden for many people and could limit access for people who live in more rural areas.</p><p class=\"graf graf--p graf-after--p graf--trailing\" id=\"49e6\" name=\"49e6\">While the risk for side effects and abuse is not insubstantial, Meisel, Friedman, and the FDA believe the benefits outweigh them. People with treatment-resistant depression are 15 times more likely to attempt suicide than people without depression, so a new effective form of treatment could be a literal lifesaver. \u201cThe risk is there. On the other hand, the risk of untreated treatment-resistant depression is far greater. I mean, the risk of suicide is orders of magnitude higher in those people,\u201d says Friedman. \u201cSo you\u2019re balancing the risk and the benefit. The risk of the drug is real, but the risk of the untreated disease is far greater.\u201d</p></div></div></section></div><footer class=\"u-paddingTop10\"><div class=\"container u-maxWidth740\"><div class=\"row\"><div class=\"col u-size12of12\"><div class=\"postMetaInline postMetaInline--acknowledgments u-paddingTop5 u-paddingBottom20 js-postMetaAcknowledgments\"></div></div></div><div class=\"row\"><div class=\"col u-size12of12 js-postTags\"><div class=\"u-paddingBottom10\"><ul class=\"tags tags--postTags tags--borderless\"><li><a class=\"link u-baseColor--link\" data-action-source=\"post\" data-collection-slug=\"one-zero\" href=\"https://onezero.medium.com/tagged/depression?source=post\">Depression</a></li><li><a class=\"link u-baseColor--link\" data-action-source=\"post\" data-collection-slug=\"one-zero\" href=\"https://onezero.medium.com/tagged/treatment?source=post\">Treatment</a></li><li><a class=\"link u-baseColor--link\" data-action-source=\"post\" data-collection-slug=\"one-zero\" href=\"https://onezero.medium.com/tagged/antidepressants?source=post\">Antidepressants</a></li><li><a class=\"link u-baseColor--link\" data-action-source=\"post\" data-collection-slug=\"one-zero\" href=\"https://onezero.medium.com/tagged/fda?source=post\">FDA</a></li><li><a class=\"link u-baseColor--link\" data-action-source=\"post\" data-collection-slug=\"one-zero\" href=\"https://onezero.medium.com/tagged/science-and-medicine?source=post\">Science And Medicine</a></li></ul></div></div></div><div class=\"postActions js-postActionsFooter\"><div class=\"u-flexCenter\"><div class=\"u-flex1\"><div class=\"multirecommend js-actionMultirecommend u-flexCenter\" data-clap-string-plural=\"claps\" data-clap-string-singular=\"clap\" data-has-recommend-list=\"true\" data-is-circle=\"true\" data-is-icon-29px=\"true\" data-post-id=\"2e57c195b294\" data-source=\"post_actions_footer-----2e57c195b294---------------------clap_footer\"><div class=\"u-relative u-foreground\"><button aria-label=\"Clap\" class=\"button button--large button--circle button--withChrome u-baseColor--buttonNormal button--withIcon button--withSvgIcon clapButton js-actionMultirecommendButton clapButton--darker clapButton--largePill u-relative u-foreground u-xs-paddingLeft13 u-width60 u-height60 u-accentColor--textNormal u-accentColor--buttonNormal clap-onboardingcollection\" data-action=\"sign-up-prompt\" data-action-source=\"post_actions_footer-----2e57c195b294---------------------clap_footer\" data-redirect=\"https://medium.com/_/vote/p/2e57c195b294\" data-requires-token=\"true\" data-sign-in-action=\"multivote\"><span class=\"button-defaultState\"><span class=\"svgIcon svgIcon--clap svgIcon--33px u-relative u-topNegative2 u-xs-top0\"><svg class=\"svgIcon-use\" height=\"33\" width=\"33\"><path d=\"M28.86 17.342l-3.64-6.402c-.292-.433-.712-.729-1.163-.8a1.124 1.124 0 0 0-.889.213c-.63.488-.742 1.181-.33 2.061l1.222 2.587 1.4 2.46c2.234 4.085 1.511 8.007-2.145 11.663-.26.26-.526.49-.797.707 1.42-.084 2.881-.683 4.292-2.094 3.822-3.823 3.565-7.876 2.05-10.395zm-6.252 11.075c3.352-3.35 3.998-6.775 1.978-10.469l-3.378-5.945c-.292-.432-.712-.728-1.163-.8a1.122 1.122 0 0 0-.89.213c-.63.49-.742 1.182-.33 2.061l1.72 3.638a.502.502 0 0 1-.806.568l-8.91-8.91a1.335 1.335 0 0 0-1.887 1.886l5.292 5.292a.5.5 0 0 1-.707.707l-5.292-5.292-1.492-1.492c-.503-.503-1.382-.505-1.887 0a1.337 1.337 0 0 0 0 1.886l1.493 1.492 5.292 5.292a.499.499 0 0 1-.353.854.5.5 0 0 1-.354-.147L5.642 13.96a1.338 1.338 0 0 0-1.887 0 1.338 1.338 0 0 0 0 1.887l2.23 2.228 3.322 3.324a.499.499 0 0 1-.353.853.502.502 0 0 1-.354-.146l-3.323-3.324a1.333 1.333 0 0 0-1.886 0 1.325 1.325 0 0 0-.39.943c0 .356.138.691.39.943l6.396 6.397c3.528 3.53 8.86 5.313 12.821 1.353zM12.73 9.26l5.68 5.68-.49-1.037c-.518-1.107-.426-2.13.224-2.89l-3.303-3.304a1.337 1.337 0 0 0-1.886 0 1.326 1.326 0 0 0-.39.944c0 .217.067.42.165.607zm14.787 19.184c-1.599 1.6-3.417 2.392-5.353 2.392-.349 0-.7-.03-1.058-.082a7.922 7.922 0 0 1-3.667.887c-3.049 0-6.115-1.626-8.359-3.87l-6.396-6.397A2.315 2.315 0 0 1 2 19.724a2.327 2.327 0 0 1 1.923-2.296l-.875-.875a2.339 2.339 0 0 1 0-3.3 2.33 2.33 0 0 1 1.24-.647l-.139-.139c-.91-.91-.91-2.39 0-3.3.884-.884 2.421-.882 3.301 0l.138.14a2.335 2.335 0 0 1 3.948-1.24l.093.092c.091-.423.291-.828.62-1.157a2.336 2.336 0 0 1 3.3 0l3.384 3.386a2.167 2.167 0 0 1 1.271-.173c.534.086 1.03.354 1.441.765.11-.549.415-1.034.911-1.418a2.12 2.12 0 0 1 1.661-.41c.727.117 1.385.565 1.853 1.262l3.652 6.423c1.704 2.832 2.025 7.377-2.205 11.607zM13.217.484l-1.917.882 2.37 2.837-.454-3.719zm8.487.877l-1.928-.86-.44 3.697 2.368-2.837zM16.5 3.293L15.478-.005h2.044L16.5 3.293z\" fill-rule=\"evenodd\"></path></svg></span></span><span class=\"button-activeState\"><span class=\"svgIcon svgIcon--clapFilled svgIcon--33px u-relative u-topNegative2 u-xs-top0\"><svg class=\"svgIcon-use\" height=\"33\" width=\"33\"><g fill-rule=\"evenodd\"><path d=\"M29.58 17.1l-3.854-6.78c-.365-.543-.876-.899-1.431-.989a1.491 1.491 0 0 0-1.16.281c-.42.327-.65.736-.7 1.207v.001l3.623 6.367c2.46 4.498 1.67 8.802-2.333 12.807-.265.265-.536.505-.81.728 1.973-.222 3.474-1.286 4.45-2.263 4.166-4.165 3.875-8.6 2.215-11.36zm-4.831.82l-3.581-6.3c-.296-.439-.725-.742-1.183-.815a1.105 1.105 0 0 0-.89.213c-.647.502-.755 1.188-.33 2.098l1.825 3.858a.601.601 0 0 1-.197.747.596.596 0 0 1-.77-.067L10.178 8.21c-.508-.506-1.393-.506-1.901 0a1.335 1.335 0 0 0-.393.95c0 .36.139.698.393.95v.001l5.61 5.61a.599.599 0 1 1-.848.847l-5.606-5.606c-.001 0-.002 0-.003-.002L5.848 9.375a1.349 1.349 0 0 0-1.902 0 1.348 1.348 0 0 0 0 1.901l1.582 1.582 5.61 5.61a.6.6 0 0 1-.848.848l-5.61-5.61c-.51-.508-1.393-.508-1.9 0a1.332 1.332 0 0 0-.394.95c0 .36.139.697.393.952l2.363 2.362c.002.001.002.002.002.003l3.52 3.52a.6.6 0 0 1-.848.847l-3.522-3.523h-.001a1.336 1.336 0 0 0-.95-.393 1.345 1.345 0 0 0-.949 2.295l6.779 6.78c3.715 3.713 9.327 5.598 13.49 1.434 3.527-3.528 4.21-7.13 2.086-11.015zM11.817 7.727c.06-.328.213-.64.466-.893.64-.64 1.755-.64 2.396 0l3.232 3.232c-.82.783-1.09 1.833-.764 2.992l-5.33-5.33z\"></path><path d=\"M13.285.48l-1.916.881 2.37 2.837z\"></path><path d=\"M21.719 1.361L19.79.501l-.44 3.697z\"></path><path d=\"M16.502 3.298L15.481 0h2.043z\"></path></g></svg></span></span></button><div class=\"clapUndo u-width60 u-round u-height32 u-absolute u-borderBox u-paddingRight5 u-transition--transform200Springu-backgroundGrayLighter js-clapUndo\" style=\"top: 14px; padding: 2px;\"><button class=\"button button--chromeless u-baseColor--buttonNormal button--withIcon button--withSvgIcon u-floatRight\" data-action=\"multivote-undo\" data-action-value=\"2e57c195b294\"><span class=\"svgIcon svgIcon--removeThin svgIcon--29px\"><svg class=\"svgIcon-use\" height=\"29\" width=\"29\"><path d=\"M20.13 8.11l-5.61 5.61-5.609-5.61-.801.801 5.61 5.61-5.61 5.61.801.8 5.61-5.609 5.61 5.61.8-.801-5.609-5.61 5.61-5.61\" fill-rule=\"evenodd\"></path></svg></span></button></div></div><span class=\"u-relative u-background js-actionMultirecommendCount u-marginLeft16\"><button class=\"button button--chromeless u-baseColor--buttonNormal js-multirecommendCountButton u-textColorDarker\" data-action=\"show-recommends\" data-action-value=\"2e57c195b294\">2.7K claps</button><span class=\"u-xs-hide\"></span></span></div></div><div class=\"buttonSet u-flex0\"><a aria-label=\"Share on Twitter\" class=\"button button--dark button--chromeless u-baseColor--buttonDark button--withIcon button--withSvgIcon button--dark button--chromeless u-xs-hide u-marginRight12\" data-action-source=\"post_actions_footer\" href=\"https://medium.com/p/2e57c195b294/share/twitter\" target=\"_blank\" title=\"Share on Twitter\"><span class=\"button-defaultState\"><span class=\"svgIcon svgIcon--twitterFilled svgIcon--29px\"><svg class=\"svgIcon-use\" height=\"29\" width=\"29\"><path d=\"M22.053 7.54a4.474 4.474 0 0 0-3.31-1.455 4.526 4.526 0 0 0-4.526 4.524c0 .35.04.7.082 1.05a12.9 12.9 0 0 1-9.3-4.77c-.39.69-.61 1.46-.65 2.26.03 1.6.83 2.99 2.02 3.79-.72-.02-1.41-.22-2.02-.57-.01.02-.01.04 0 .08-.01 2.17 1.55 4 3.63 4.44-.39.08-.79.13-1.21.16-.28-.03-.57-.05-.81-.08.54 1.77 2.21 3.08 4.2 3.15a9.564 9.564 0 0 1-5.66 1.94c-.34-.03-.7-.06-1.05-.08 2 1.27 4.38 2.02 6.94 2.02 8.31 0 12.86-6.9 12.84-12.85.02-.24.01-.43 0-.65.89-.62 1.65-1.42 2.26-2.34-.82.38-1.69.62-2.59.72a4.37 4.37 0 0 0 1.94-2.51c-.84.53-1.81.9-2.83 1.13z\"></path></svg></span></span></a><a aria-label=\"Share on Facebook\" class=\"button button--dark button--chromeless u-baseColor--buttonDark button--withIcon button--withSvgIcon button--dark button--chromeless u-xs-hide u-marginRight12\" data-action-source=\"post_actions_footer\" href=\"https://medium.com/p/2e57c195b294/share/facebook\" target=\"_blank\" title=\"Share on Facebook\"><span class=\"button-defaultState\"><span class=\"svgIcon svgIcon--facebookSquare svgIcon--29px\"><svg class=\"svgIcon-use\" height=\"29\" width=\"29\"><path d=\"M23.209 5H5.792A.792.792 0 0 0 5 5.791V23.21c0 .437.354.791.792.791h9.303v-7.125H12.72v-2.968h2.375v-2.375c0-2.455 1.553-3.662 3.741-3.662 1.049 0 1.95.078 2.213.112v2.565h-1.517c-1.192 0-1.469.567-1.469 1.397v1.963h2.969l-.594 2.968h-2.375L18.11 24h5.099a.791.791 0 0 0 .791-.791V5.79a.791.791 0 0 0-.791-.79\"></path></svg></span></span></a><button aria-label=\"Share this story on Twitter or Facebook\" class=\"button button--large button--dark button--chromeless u-baseColor--buttonDark button--withIcon button--withSvgIcon u-xs-show u-marginRight10\" data-action=\"show-share-popover\" data-action-source=\"post_actions_footer\" title=\"Share this story on Twitter or Facebook\"><span class=\"svgIcon svgIcon--share svgIcon--29px\"><svg class=\"svgIcon-use\" height=\"29\" width=\"29\"><path d=\"M20.385 8H19a.5.5 0 1 0 .011 1h1.39c.43 0 .84.168 1.14.473.31.305.48.71.48 1.142v10.77c0 .43-.17.837-.47 1.142-.3.305-.71.473-1.14.473H8.62c-.43 0-.84-.168-1.144-.473a1.603 1.603 0 0 1-.473-1.142v-10.77c0-.43.17-.837.48-1.142A1.599 1.599 0 0 1 8.62 9H10a.502.502 0 0 0 0-1H8.615c-.67 0-1.338.255-1.85.766-.51.51-.765 1.18-.765 1.85v10.77c0 .668.255 1.337.766 1.848.51.51 1.18.766 1.85.766h11.77c.668 0 1.337-.255 1.848-.766.51-.51.766-1.18.766-1.85v-10.77c0-.668-.255-1.337-.766-1.848A2.61 2.61 0 0 0 20.384 8zm-8.67-2.508L14 3.207v8.362c0 .27.224.5.5.5s.5-.23.5-.5V3.2l2.285 2.285a.49.49 0 0 0 .704-.001.511.511 0 0 0 0-.708l-3.14-3.14a.504.504 0 0 0-.71 0L11 4.776a.501.501 0 0 0 .71.706\" fill-rule=\"evenodd\"></path></svg></span></button><button class=\"button button--large button--dark button--chromeless is-touchIconBlackPulse u-baseColor--buttonDark button--withIcon button--withSvgIcon\" data-action=\"show-membership-respond-warning\" data-action-source=\"post_actions_footer\"><span class=\"svgIcon svgIcon--response svgIcon--29px\"><svg class=\"svgIcon-use\" height=\"29\" width=\"29\"><path d=\"M21.27 20.058c1.89-1.826 2.754-4.17 2.754-6.674C24.024 8.21 19.67 4 14.1 4 8.53 4 4 8.21 4 13.384c0 5.175 4.53 9.385 10.1 9.385 1.007 0 2-.14 2.95-.41.285.25.592.49.918.7 1.306.87 2.716 1.31 4.19 1.31.276-.01.494-.14.6-.36a.625.625 0 0 0-.052-.65c-.61-.84-1.042-1.71-1.282-2.58a5.417 5.417 0 0 1-.154-.75zm-3.85 1.324l-.083-.28-.388.12a9.72 9.72 0 0 1-2.85.424c-4.96 0-8.99-3.706-8.99-8.262 0-4.556 4.03-8.263 8.99-8.263 4.95 0 8.77 3.71 8.77 8.27 0 2.25-.75 4.35-2.5 5.92l-.24.21v.32c0 .07 0 .19.02.37.03.29.1.6.19.92.19.7.49 1.4.89 2.08-.93-.14-1.83-.49-2.67-1.06-.34-.22-.88-.48-1.16-.74z\"></path></svg></span></button><button class=\"button button--chromeless u-baseColor--buttonNormal u-marginRight12\" data-action=\"scroll-to-responses\">37</button><button aria-label=\"Bookmark this story to read later\" class=\"button button--large button--dark button--chromeless is-touchIconFadeInPulse u-baseColor--buttonDark button--withIcon button--withSvgIcon button--bookmark js-bookmarkButton\" data-action=\"sign-up-prompt\" data-action-source=\"post_actions_footer\" data-redirect=\"https://medium.com/_/bookmark/p/2e57c195b294\" data-requires-token=\"true\" data-sign-in-action=\"add-to-bookmarks\" title=\"Bookmark this story to read later\"><span class=\"button-defaultState\"><span class=\"svgIcon svgIcon--bookmark svgIcon--29px u-marginRight4\"><svg class=\"svgIcon-use\" height=\"29\" width=\"29\"><path d=\"M19.385 4h-9.77A2.623 2.623 0 0 0 7 6.615V23.01a1.022 1.022 0 0 0 1.595.847l5.905-4.004 5.905 4.004A1.022 1.022 0 0 0 22 23.011V6.62A2.625 2.625 0 0 0 19.385 4zM21 23l-5.91-3.955-.148-.107a.751.751 0 0 0-.884 0l-.147.107L8 23V6.615C8 5.725 8.725 5 9.615 5h9.77C20.275 5 21 5.725 21 6.615V23z\" fill-rule=\"evenodd\"></path></svg></span></span><span class=\"button-activeState\"><span class=\"svgIcon svgIcon--bookmarkFilled svgIcon--29px u-marginRight4\"><svg class=\"svgIcon-use\" height=\"29\" width=\"29\"><path d=\"M19.385 4h-9.77A2.623 2.623 0 0 0 7 6.615V23.01a1.022 1.022 0 0 0 1.595.847l5.905-4.004 5.905 4.004A1.022 1.022 0 0 0 22 23.011V6.62A2.625 2.625 0 0 0 19.385 4z\" fill-rule=\"evenodd\"></path></svg></span></span></button><button aria-label=\"More actions\" class=\"button button--large button--dark button--chromeless is-touchIconBlackPulse u-baseColor--buttonDark button--withIcon button--withSvgIcon js-moreActionsButton\" data-action=\"more-actions\" title=\"More actions\"><span class=\"svgIcon svgIcon--more svgIcon--25px\"><svg class=\"svgIcon-use\" height=\"25\" viewbox=\"-480.5 272.5 21 21\" width=\"25\"><path d=\"M-463 284.6c.9 0 1.6-.7 1.6-1.6s-.7-1.6-1.6-1.6-1.6.7-1.6 1.6.7 1.6 1.6 1.6zm0 .9c-1.4 0-2.5-1.1-2.5-2.5s1.1-2.5 2.5-2.5 2.5 1.1 2.5 2.5-1.1 2.5-2.5 2.5zm-7-.9c.9 0 1.6-.7 1.6-1.6s-.7-1.6-1.6-1.6-1.6.7-1.6 1.6.7 1.6 1.6 1.6zm0 .9c-1.4 0-2.5-1.1-2.5-2.5s1.1-2.5 2.5-2.5 2.5 1.1 2.5 2.5-1.1 2.5-2.5 2.5zm-7-.9c.9 0 1.6-.7 1.6-1.6s-.7-1.6-1.6-1.6-1.6.7-1.6 1.6.7 1.6 1.6 1.6zm0 .9c-1.4 0-2.5-1.1-2.5-2.5s1.1-2.5 2.5-2.5 2.5 1.1 2.5 2.5-1.1 2.5-2.5 2.5z\"></path></svg></span></button></div></div></div></div><div class=\"u-maxWidth740 u-paddingTop20 u-marginTop20 u-borderTopLightest container u-paddingBottom20 u-xs-paddingBottom10 js-postAttributionFooterContainer\"><div class=\"row js-postFooterInfo\"><div class=\"col u-size6of12 u-xs-size12of12\"><li class=\"uiScale uiScale-ui--small uiScale-caption--regular u-block u-paddingBottom18 js-cardUser\"><div class=\"u-marginLeft20 u-floatRight\"><span class=\"followState js-followState\" data-user-id=\"bf4c3c7dced5\"><button class=\"button button--small u-noUserSelect button--withChrome u-baseColor--buttonNormal button--withHover button--unblock js-unblockButton\" data-action=\"sign-up-prompt\" data-action-source=\"footer_card\" data-redirect=\"https://onezero.medium.com/the-party-drug-that-could-help-stop-depression-2e57c195b294\" data-requires-token=\"true\" data-sign-in-action=\"toggle-block-user\"><span class=\"button-label button-defaultState\">Blocked</span><span class=\"button-label button-hoverState\">Unblock</span></button><button class=\"button button--primary button--small u-noUserSelect button--withChrome u-accentColor--buttonNormal button--follow js-followButton\" data-action=\"sign-up-prompt\" data-action-source=\"footer_card-bf4c3c7dced5-------------------------follow_footer\" data-redirect=\"https://medium.com/_/subscribe/user/bf4c3c7dced5\" data-requires-token=\"true\" data-sign-in-action=\"toggle-subscribe-user\"><span class=\"button-label button-defaultState js-buttonLabel\">Follow</span><span class=\"button-label button-activeState\">Following</span></button></span></div><div class=\"u-tableCell\"><a aria-label=\"Go to the profile of Dana G Smith\" class=\"link u-baseColor--link avatar\" data-action-source=\"footer_card\" data-collection-slug=\"one-zero\" data-user-id=\"bf4c3c7dced5\" dir=\"auto\" href=\"https://onezero.medium.com/@smithdanag?source=footer_card\" title=\"Go to the profile of Dana G Smith\"><div class=\"u-relative u-inlineBlock u-flex0\"><img alt=\"Go to the profile of Dana G Smith\" class=\"avatar-image avatar-image--small\" src=\"https://cdn-images-1.medium.com/fit/c/120/120/1*uoseNvFQihxFrrGwRBUpxw.jpeg\"/><div class=\"avatar-halo u-absolute u-textColorGreenNormal svgIcon\" style=\"width: calc(100% + 12px); height: calc(100% + 12px); top:-6px; left:-6px\"><svg viewbox=\"0 0 114 114\" xmlns=\"http://www.w3.org/2000/svg\"><path d=\"M7.66922967,32.092726 C17.0070768,13.6353618 35.9421928,1.75 57,1.75 C78.0578072,1.75 96.9929232,13.6353618 106.33077,32.092726 L107.66923,31.4155801 C98.0784505,12.4582656 78.6289015,0.25 57,0.25 C35.3710985,0.25 15.9215495,12.4582656 6.33077033,31.4155801 L7.66922967,32.092726 Z\"></path><path d=\"M106.33077,81.661427 C96.9929232,100.118791 78.0578072,112.004153 57,112.004153 C35.9421928,112.004153 17.0070768,100.118791 7.66922967,81.661427 L6.33077033,82.338573 C15.9215495,101.295887 35.3710985,113.504153 57,113.504153 C78.6289015,113.504153 98.0784505,101.295887 107.66923,82.338573 L106.33077,81.661427 Z\"></path></svg></div></div></a></div><div class=\"u-tableCell u-verticalAlignMiddle u-breakWord u-paddingLeft15\"><h3 class=\"ui-h3 u-fontSize18 u-lineHeightTighter\"><a aria-label=\"Go to the profile of Dana G Smith\" class=\"link link--primary u-accentColor--hoverTextNormal\" data-collection-slug=\"one-zero\" data-user-id=\"bf4c3c7dced5\" dir=\"auto\" href=\"https://onezero.medium.com/@smithdanag\" property=\"cc:attributionName\" rel=\"author cc:attributionUrl\" title=\"Go to the profile of Dana G Smith\">Dana G Smith</a></h3><div class=\"ui-caption u-textColorGreenNormal u-fontSize13 u-tintSpectrum u-accentColor--textNormal u-marginBottom7\">Medium member since Oct 2018</div><p class=\"ui-body u-fontSize14 u-lineHeightBaseSans u-textColorDark u-marginBottom4\">Freelance science writer specializing in brains and bodies. Website: danagsmith.com; Twitter: <a href=\"http://twitter.com/smithdanag\" target=\"_blank\" title=\"Twitter profile for @smithdanag\">@smithdanag</a></p></div></li></div><div class=\"col u-size6of12 u-xs-size12of12 u-xs-marginTop30\"><li class=\"uiScale uiScale-ui--small uiScale-caption--regular u-block u-paddingBottom18 js-cardCollection\"><div class=\"u-marginLeft20 u-floatRight\"><button class=\"button button--primary button--small u-noUserSelect button--withChrome u-accentColor--buttonNormal js-relationshipButton\" data-action=\"sign-up-prompt\" data-action-source=\"footer_card----444d13b52878----------------------follow_footer\" data-collection-id=\"444d13b52878\" data-redirect=\"https://medium.com/_/subscribe/collection/one-zero\" data-requires-token=\"true\" data-sign-in-action=\"toggle-follow-collection\"><span class=\"button-label js-buttonLabel\">Follow</span></button></div><div class=\"u-tableCell\"><a aria-label=\"Go to OneZero\" class=\"link u-baseColor--link avatar avatar--roundedRectangle\" data-action-source=\"footer_card\" data-collection-slug=\"one-zero\" href=\"https://onezero.medium.com?source=footer_card\" title=\"Go to OneZero\"><img alt=\"OneZero\" class=\"avatar-image u-size60x60\" src=\"https://cdn-images-1.medium.com/fit/c/120/120/1*88Z0O0wD4KOrk6Y5EceZog.png\"/></a></div><div class=\"u-tableCell u-verticalAlignMiddle u-breakWord u-paddingLeft15\"><h3 class=\"ui-h3 u-fontSize18 u-lineHeightTighter u-marginBottom4\"><a class=\"link link--primary u-accentColor--hoverTextNormal\" data-action-source=\"footer_card\" data-collection-slug=\"one-zero\" href=\"https://onezero.medium.com?source=footer_card\" rel=\"collection\">OneZero</a></h3><p class=\"ui-body u-fontSize14 u-lineHeightBaseSans u-textColorDark u-marginBottom4\">Medium\u2019s technology and science publication</p><div class=\"buttonSet\"></div></div></li></div></div></div><div class=\"js-postFooterPlacements\" data-collection-id=\"444d13b52878\" data-post-id=\"2e57c195b294\"></div><div class=\"u-padding0 u-clearfix u-backgroundGrayLightest u-print-hide supplementalPostContent js-responsesWrapper\"></div><div class=\"supplementalPostContent js-heroPromo\"></div></footer></article></main><aside class=\"u-marginAuto u-maxWidth1032 js-postLeftSidebar\"><div class=\"u-foreground u-top0 u-transition--fadeOut300 u-fixed u-sm-hide js-postShareWidget\"><ul><li class=\"u-marginVertical10\"><div class=\"multirecommend js-actionMultirecommend u-flexCenter\" data-has-recommend-list=\"true\" data-is-icon-29px=\"true\" data-post-id=\"2e57c195b294\" data-source=\"post_share_widget-----2e57c195b294---------------------clap_sidebar\"><div class=\"u-relative u-foreground\"><button aria-label=\"Clap\" class=\"button button--primary button--large button--chromeless u-accentColor--buttonNormal button--withIcon button--withSvgIcon clapButton js-actionMultirecommendButton clapButton--darker\" data-action=\"sign-up-prompt\" data-action-source=\"post_share_widget-----2e57c195b294---------------------clap_sidebar\" data-redirect=\"https://medium.com/_/vote/p/2e57c195b294\" data-requires-token=\"true\" data-sign-in-action=\"multivote\"><span class=\"button-defaultState\"><span class=\"svgIcon svgIcon--clap svgIcon--29px\"><svg class=\"svgIcon-use\" height=\"29\" width=\"29\"><g fill-rule=\"evenodd\"><path d=\"M13.739 1l.761 2.966L15.261 1z\"></path><path d=\"M16.815 4.776l1.84-2.551-1.43-.471z\"></path><path d=\"M10.378 2.224l1.84 2.551-.408-3.022z\"></path><path d=\"M22.382 22.622c-1.04 1.04-2.115 1.507-3.166 1.608.168-.14.332-.29.492-.45 2.885-2.886 3.456-5.982 1.69-9.211l-1.101-1.937-.955-2.02c-.315-.676-.235-1.185.245-1.556a.836.836 0 0 1 .66-.16c.342.056.66.28.879.605l2.856 5.023c1.179 1.962 1.379 5.119-1.6 8.098m-13.29-.528l-5.02-5.02a1 1 0 0 1 .707-1.701c.255 0 .512.098.707.292l2.607 2.607a.442.442 0 0 0 .624-.624L6.11 15.04l-1.75-1.75a.998.998 0 1 1 1.41-1.413l4.154 4.156a.44.44 0 0 0 .624 0 .44.44 0 0 0 0-.624l-4.152-4.153-1.172-1.171a.998.998 0 0 1 0-1.41 1.018 1.018 0 0 1 1.41 0l1.172 1.17 4.153 4.152a.437.437 0 0 0 .624 0 .442.442 0 0 0 0-.624L8.43 9.222a.988.988 0 0 1-.291-.705.99.99 0 0 1 .29-.706 1 1 0 0 1 1.412 0l6.992 6.993a.443.443 0 0 0 .71-.501l-1.35-2.856c-.315-.676-.235-1.185.246-1.557a.85.85 0 0 1 .66-.16c.342.056.659.28.879.606L20.628 15c1.573 2.876 1.067 5.545-1.544 8.156-1.396 1.397-3.144 1.966-5.063 1.652-1.713-.286-3.463-1.248-4.928-2.714zM12.99 6.976l2.562 2.562c-.497.607-.563 1.414-.155 2.284l.265.562-4.257-4.257a.98.98 0 0 1-.117-.445c0-.267.104-.517.292-.706a1.023 1.023 0 0 1 1.41 0zm8.887 2.06c-.375-.557-.902-.916-1.486-1.011a1.738 1.738 0 0 0-1.342.332c-.376.29-.61.656-.712 1.065a2.1 2.1 0 0 0-1.095-.562 1.776 1.776 0 0 0-.992.128l-2.636-2.636a1.883 1.883 0 0 0-2.658 0 1.862 1.862 0 0 0-.478.847 1.886 1.886 0 0 0-2.671-.012 1.867 1.867 0 0 0-.503.909c-.754-.754-1.992-.754-2.703-.044a1.881 1.881 0 0 0 0 2.658c-.288.12-.605.288-.864.547a1.884 1.884 0 0 0 0 2.659l.624.622a1.879 1.879 0 0 0-.91 3.16l5.019 5.02c1.595 1.594 3.515 2.645 5.408 2.959a7.16 7.16 0 0 0 1.173.098c1.026 0 1.997-.24 2.892-.7.279.04.555.065.828.065 1.53 0 2.969-.628 4.236-1.894 3.338-3.338 3.083-6.928 1.738-9.166l-2.868-5.043z\"></path></g></svg></span></span><span class=\"button-activeState\"><span class=\"svgIcon svgIcon--clapFilled svgIcon--29px\"><svg class=\"svgIcon-use\" height=\"29\" width=\"29\"><g fill-rule=\"evenodd\"><path d=\"M13.738 1l.762 2.966L15.262 1z\"></path><path d=\"M18.634 2.224l-1.432-.47-.408 3.022z\"></path><path d=\"M11.79 1.754l-1.431.47 1.84 2.552z\"></path><path d=\"M24.472 14.307l-3.023-5.32c-.287-.426-.689-.705-1.123-.776a1.16 1.16 0 0 0-.911.221c-.297.231-.474.515-.535.84.017.022.036.04.053.063l2.843 5.001c1.95 3.564 1.328 6.973-1.843 10.144a8.46 8.46 0 0 1-.549.501c1.205-.156 2.328-.737 3.351-1.76 3.268-3.268 3.041-6.749 1.737-8.914\"></path><path d=\"M14.58 10.887c-.156-.83.096-1.569.692-2.142L12.78 6.252c-.5-.504-1.378-.504-1.879 0-.178.18-.273.4-.329.63l4.008 4.005z\"></path><path d=\"M17.812 10.04c-.218-.323-.539-.55-.88-.606a.814.814 0 0 0-.644.153c-.176.137-.713.553-.24 1.566l1.43 3.025a.539.539 0 1 1-.868.612L9.2 7.378a.986.986 0 1 0-1.395 1.395l4.401 4.403a.538.538 0 1 1-.762.762L7.046 9.54 5.802 8.295a.99.99 0 0 0-1.396 0 .981.981 0 0 0 0 1.394l1.241 1.241 4.402 4.403a.537.537 0 0 1 0 .761.535.535 0 0 1-.762 0L4.89 11.696a.992.992 0 0 0-1.399-.003.983.983 0 0 0 0 1.395l1.855 1.854 2.763 2.765a.538.538 0 0 1-.76.761l-2.765-2.764a.982.982 0 0 0-1.395 0 .989.989 0 0 0 0 1.395l5.32 5.32c3.371 3.372 6.64 4.977 10.49 1.126C21.74 20.8 22.271 18 20.62 14.982l-2.809-4.942z\"></path></g></svg></span></span></button></div><span class=\"u-relative u-background js-actionMultirecommendCount u-marginLeft5\"><button class=\"button button--chromeless u-baseColor--buttonNormal js-multirecommendCountButton\" data-action=\"show-recommends\" data-action-value=\"2e57c195b294\">2.7K</button></span></div></li><li class=\"u-marginVertical10 u-marginLeft3\"><button aria-label=\"Bookmark this story to read later\" class=\"button button--large button--dark button--chromeless is-touchIconFadeInPulse u-baseColor--buttonDark button--withIcon button--withSvgIcon button--bookmark js-bookmarkButton\" data-action=\"sign-up-prompt\" data-action-source=\"post_share_widget-----2e57c195b294---------------------bookmark_sidebar\" data-redirect=\"https://medium.com/_/bookmark/p/2e57c195b294\" data-requires-token=\"true\" data-sign-in-action=\"add-to-bookmarks\" title=\"Bookmark this story to read later\"><span class=\"button-defaultState\"><span class=\"svgIcon svgIcon--bookmark svgIcon--29px\"><svg class=\"svgIcon-use\" height=\"29\" width=\"29\"><path d=\"M19.385 4h-9.77A2.623 2.623 0 0 0 7 6.615V23.01a1.022 1.022 0 0 0 1.595.847l5.905-4.004 5.905 4.004A1.022 1.022 0 0 0 22 23.011V6.62A2.625 2.625 0 0 0 19.385 4zM21 23l-5.91-3.955-.148-.107a.751.751 0 0 0-.884 0l-.147.107L8 23V6.615C8 5.725 8.725 5 9.615 5h9.77C20.275 5 21 5.725 21 6.615V23z\" fill-rule=\"evenodd\"></path></svg></span></span><span class=\"button-activeState\"><span class=\"svgIcon svgIcon--bookmarkFilled svgIcon--29px\"><svg class=\"svgIcon-use\" height=\"29\" width=\"29\"><path d=\"M19.385 4h-9.77A2.623 2.623 0 0 0 7 6.615V23.01a1.022 1.022 0 0 0 1.595.847l5.905-4.004 5.905 4.004A1.022 1.022 0 0 0 22 23.011V6.62A2.625 2.625 0 0 0 19.385 4z\" fill-rule=\"evenodd\"></path></svg></span></span></button></li><li class=\"u-marginVertical10 u-marginLeft3\"><a aria-label=\"Share on Twitter\" class=\"button button--dark button--chromeless u-baseColor--buttonDark button--withIcon button--withSvgIcon button--dark button--chromeless\" data-action-source=\"post_share_widget\" href=\"https://medium.com/p/2e57c195b294/share/twitter\" target=\"_blank\" title=\"Share on Twitter\"><span class=\"button-defaultState\"><span class=\"svgIcon svgIcon--twitterFilled svgIcon--29px\"><svg class=\"svgIcon-use\" height=\"29\" width=\"29\"><path d=\"M22.053 7.54a4.474 4.474 0 0 0-3.31-1.455 4.526 4.526 0 0 0-4.526 4.524c0 .35.04.7.082 1.05a12.9 12.9 0 0 1-9.3-4.77c-.39.69-.61 1.46-.65 2.26.03 1.6.83 2.99 2.02 3.79-.72-.02-1.41-.22-2.02-.57-.01.02-.01.04 0 .08-.01 2.17 1.55 4 3.63 4.44-.39.08-.79.13-1.21.16-.28-.03-.57-.05-.81-.08.54 1.77 2.21 3.08 4.2 3.15a9.564 9.564 0 0 1-5.66 1.94c-.34-.03-.7-.06-1.05-.08 2 1.27 4.38 2.02 6.94 2.02 8.31 0 12.86-6.9 12.84-12.85.02-.24.01-.43 0-.65.89-.62 1.65-1.42 2.26-2.34-.82.38-1.69.62-2.59.72a4.37 4.37 0 0 0 1.94-2.51c-.84.53-1.81.9-2.83 1.13z\"></path></svg></span></span></a></li><li class=\"u-marginVertical10 u-marginLeft3\"><a aria-label=\"Share on Facebook\" class=\"button button--dark button--chromeless u-baseColor--buttonDark button--withIcon button--withSvgIcon button--dark button--chromeless\" data-action-source=\"post_share_widget\" href=\"https://medium.com/p/2e57c195b294/share/facebook\" target=\"_blank\" title=\"Share on Facebook\"><span class=\"button-defaultState\"><span class=\"svgIcon svgIcon--facebookSquare svgIcon--29px\"><svg class=\"svgIcon-use\" height=\"29\" width=\"29\"><path d=\"M23.209 5H5.792A.792.792 0 0 0 5 5.791V23.21c0 .437.354.791.792.791h9.303v-7.125H12.72v-2.968h2.375v-2.375c0-2.455 1.553-3.662 3.741-3.662 1.049 0 1.95.078 2.213.112v2.565h-1.517c-1.192 0-1.469.567-1.469 1.397v1.963h2.969l-.594 2.968h-2.375L18.11 24h5.099a.791.791 0 0 0 .791-.791V5.79a.791.791 0 0 0-.791-.79\"></path></svg></span></span></a></li></ul></div></aside><style class=\"js-collectionStyle\">\n.u-accentColor--borderLight {border-color: #8C5DFF !important;}\n.u-accentColor--borderNormal {border-color: #8C5DFF !important;}\n.u-accentColor--borderDark {border-color: #7656F2 !important;}\n.u-accentColor--iconLight .svgIcon,.u-accentColor--iconLight.svgIcon {fill: #8C5DFF !important;}\n.u-accentColor--iconNormal .svgIcon,.u-accentColor--iconNormal.svgIcon {fill: #8C5DFF !important;}\n.u-accentColor--iconDark .svgIcon,.u-accentColor--iconDark.svgIcon {fill: #7656F2 !important;}\n.u-accentColor--textNormal {color: #7656F2 !important;}\n.u-accentColor--hoverTextNormal:hover {color: #7656F2 !important;}\n.u-accentColor--textNormal.u-accentColor--textDarken:hover {color: #6B51D8 !important;}\n.u-accentColor--textDark {color: #6B51D8 !important;}\n.u-accentColor--backgroundLight {background-color: #8C5DFF !important;}\n.u-accentColor--backgroundNormal {background-color: #8C5DFF !important;}\n.u-accentColor--backgroundDark {background-color: #7656F2 !important;}\n.u-accentColor--buttonDark {border-color: #7656F2 !important; color: #6B51D8 !important;}\n.u-accentColor--buttonDark:hover {border-color: #6B51D8 !important;}\n.u-accentColor--buttonDark .icon:before,.u-accentColor--buttonDark .svgIcon{color: #7656F2 !important; fill: #7656F2 !important;}\n.u-accentColor--buttonNormal:not(.clapButton--largePill) {border-color: #8C5DFF !important; color: #7656F2 !important;}\n.u-accentColor--buttonNormal:hover {border-color: #7656F2 !important;}\n.u-accentColor--buttonNormal .icon:before,.u-accentColor--buttonNormal .svgIcon{color: #8C5DFF !important; fill: #8C5DFF !important;}\n.u-accentColor--buttonNormal.button--filled .icon:before,.u-accentColor--buttonNormal.button--filled .svgIcon{color: rgba(255, 255, 255, 1) !important; fill: rgba(255, 255, 255, 1) !important;}\n.u-accentColor--buttonDark.button--filled,.u-accentColor--buttonDark.button--withChrome.is-active,.u-accentColor--fillWhenActive.is-active {background-color: #7656F2 !important; border-color: #7656F2 !important; color: rgba(255, 255, 255, 1) !important; fill: rgba(255, 255, 255, 1) !important;}\n.u-accentColor--buttonNormal.button--filled:not(.clapButton--largePill),.u-accentColor--buttonNormal.button--withChrome.is-active:not(.clapButton--largePill) {background-color: #8C5DFF !important; border-color: #8C5DFF !important; color: rgba(255, 255, 255, 1) !important; fill: rgba(255, 255, 255, 1) !important;}\n.postArticle.is-withAccentColors .markup--user,.postArticle.is-withAccentColors .markup--query {color: #7656F2 !important;}.u-tintBgColor {background-color: rgba(106, 11, 255, 1) !important;}.u-tintBgColor .u-fadeLeft:before {background-image: linear-gradient(to right, rgba(106, 11, 255, 1) 0%, rgba(106, 11, 255, 0) 100%) !important;}.u-tintBgColor .u-fadeRight:after {background-image: linear-gradient(to right, rgba(106, 11, 255, 0) 0%, rgba(106, 11, 255, 1) 100%) !important;}\n.u-tintSpectrum .u-baseColor--borderLight {border-color: #B1A6FF !important;}\n.u-tintSpectrum .u-baseColor--borderNormal {border-color: #D0CAFF !important;}\n.u-tintSpectrum .u-baseColor--borderDark {border-color: #F0EBFF !important;}\n.u-tintSpectrum .u-baseColor--iconLight .svgIcon,.u-tintSpectrum .u-baseColor--iconLight.svgIcon {fill: #B1A6FF !important;}\n.u-tintSpectrum .u-baseColor--iconNormal .svgIcon,.u-tintSpectrum .u-baseColor--iconNormal.svgIcon {fill: #D0CAFF !important;}\n.u-tintSpectrum .u-baseColor--iconDark .svgIcon,.u-tintSpectrum .u-baseColor--iconDark.svgIcon {fill: #F0EBFF !important;}\n.u-tintSpectrum .u-baseColor--textNormal {color: #D0CAFF !important;}\n.u-tintSpectrum .u-baseColor--textNormal.u-baseColor--textDarken:hover {color: #FFFBFF !important;}\n.u-tintSpectrum .u-baseColor--textDark {color: #FFFBFF !important;}\n.u-tintSpectrum .u-baseColor--textDarker {color: #FFFBFF !important;}\n.u-tintSpectrum .u-baseColor--backgroundLight {background-color: #B1A6FF !important;}\n.u-tintSpectrum .u-baseColor--backgroundNormal {background-color: #D0CAFF !important;}\n.u-tintSpectrum .u-baseColor--backgroundDark {background-color: #F0EBFF !important;}\n.u-tintSpectrum .u-baseColor--buttonLight {border-color: #B1A6FF !important; color: #B1A6FF !important;}\n.u-tintSpectrum .u-baseColor--buttonLight:hover {border-color: #B1A6FF !important;}\n.u-tintSpectrum .u-baseColor--buttonLight .icon:before,.u-tintSpectrum .u-baseColor--buttonLight .svgIcon {color: #B1A6FF !important; fill: #B1A6FF !important;}\n.u-tintSpectrum .u-baseColor--buttonDark {border-color: #F0EBFF !important; color: #FFFBFF !important;}\n.u-tintSpectrum .u-baseColor--buttonDark:hover {border-color: #FFFBFF !important;}\n.u-tintSpectrum .u-baseColor--buttonDark .icon:before,.u-tintSpectrum .u-baseColor--buttonDark .svgIcon {color: #F0EBFF !important; fill: #F0EBFF !important;}\n.u-tintSpectrum .u-baseColor--buttonNormal {border-color: #D0CAFF !important; color: #D0CAFF !important;}\n.u-tintSpectrum .u-baseColor--buttonNormal:hover {border-color: #F0EBFF !important;}\n.u-tintSpectrum .u-baseColor--buttonNormal .icon:before,.u-tintSpectrum .u-baseColor--buttonNormal .svgIcon {color: #D0CAFF !important; fill: #D0CAFF !important;}\n.u-tintSpectrum .u-baseColor--buttonDark.button--filled,.u-tintSpectrum .u-baseColor--buttonDark.button--withChrome.is-active {background-color: #F0EBFF !important; border-color: #F0EBFF !important; color: rgba(106, 11, 255, 1) !important; fill: rgba(106, 11, 255, 1) !important;}\n.u-tintSpectrum .u-baseColor--buttonNormal.button--filled,.u-tintSpectrum .u-baseColor--buttonNormal.button--withChrome.is-active {background-color: #D0CAFF !important; border-color: #D0CAFF !important; color: rgba(106, 11, 255, 1) !important; fill: rgba(106, 11, 255, 1) !important;}\n.u-tintSpectrum .u-baseColor--link {color: #D0CAFF !important;}\n.u-tintSpectrum .u-baseColor--link.link--darkenOnHover:hover {color: #FFFBFF !important;}\n.u-tintSpectrum .u-baseColor--link.link--darken:hover,.u-tintSpectrum .u-baseColor--link.link--darken:focus,.u-tintSpectrum .u-baseColor--link.link--darken:active {color: #FFFBFF !important;}\n.u-tintSpectrum .u-baseColor--link.link--dark {color: #FFFBFF !important;}\n.u-tintSpectrum .u-baseColor--link.link--dark.link--darken:hover,.u-tintSpectrum .u-baseColor--link.link--dark.link--darken:focus,.u-tintSpectrum .u-baseColor--link.link--dark.link--darken:active {color: #FFFBFF !important;}\n.u-tintSpectrum .u-baseColor--link.link--darker {color: #FFFBFF !important;}\n.u-tintSpectrum .u-baseColor--placeholderNormal ::-webkit-input-placeholder {color: #B1A6FF;}\n.u-tintSpectrum .u-baseColor--placeholderNormal ::-moz-placeholder {color: #B1A6FF;}\n.u-tintSpectrum .u-baseColor--placeholderNormal :-ms-input-placeholder {color: #B1A6FF;}\n.u-tintSpectrum .svgIcon--logoWordmark {stroke: none !important; fill: #FFFBFF !important;}\n.u-tintSpectrum .svgIcon--logoMonogram {stroke: none !important; fill: #FFFBFF !important;}\n.u-tintSpectrum  .ui-h1,.u-tintSpectrum  .ui-h2,.u-tintSpectrum  .ui-h3,.u-tintSpectrum  .ui-h4,.u-tintSpectrum  .ui-brand1,.u-tintSpectrum  .ui-brand2,.u-tintSpectrum  .ui-captionStrong {color: #FFFBFF !important; fill: #FFFBFF !important;}\n.u-tintSpectrum  .ui-body,.u-tintSpectrum  .ui-caps {color: #FFFBFF !important; fill: #FFFBFF !important;}\n.u-tintSpectrum  .ui-summary,.u-tintSpectrum  .ui-caption {color: #B1A6FF !important; fill: #B1A6FF !important;}\n.u-tintSpectrum .u-accentColor--borderLight {border-color: #B1A6FF !important;}\n.u-tintSpectrum .u-accentColor--borderNormal {border-color: #D0CAFF !important;}\n.u-tintSpectrum .u-accentColor--borderDark {border-color: #F0EBFF !important;}\n.u-tintSpectrum .u-accentColor--iconLight .svgIcon,.u-tintSpectrum .u-accentColor--iconLight.svgIcon {fill: #B1A6FF !important;}\n.u-tintSpectrum .u-accentColor--iconNormal .svgIcon,.u-tintSpectrum .u-accentColor--iconNormal.svgIcon {fill: #D0CAFF !important;}\n.u-tintSpectrum .u-accentColor--iconDark .svgIcon,.u-tintSpectrum .u-accentColor--iconDark.svgIcon {fill: #F0EBFF !important;}\n.u-tintSpectrum .u-accentColor--textNormal {color: #D0CAFF !important;}\n.u-tintSpectrum .u-accentColor--hoverTextNormal:hover {color: #D0CAFF !important;}\n.u-tintSpectrum .u-accentColor--textNormal.u-accentColor--textDarken:hover {color: #FFFBFF !important;}\n.u-tintSpectrum .u-accentColor--textDark {color: #FFFBFF !important;}\n.u-tintSpectrum .u-accentColor--backgroundLight {background-color: #B1A6FF !important;}\n.u-tintSpectrum .u-accentColor--backgroundNormal {background-color: #D0CAFF !important;}\n.u-tintSpectrum .u-accentColor--backgroundDark {background-color: #F0EBFF !important;}\n.u-tintSpectrum .u-accentColor--buttonDark {border-color: #F0EBFF !important; color: #FFFBFF !important;}\n.u-tintSpectrum .u-accentColor--buttonDark:hover {border-color: #FFFBFF !important;}\n.u-tintSpectrum .u-accentColor--buttonDark .icon:before,.u-tintSpectrum .u-accentColor--buttonDark .svgIcon{color: #F0EBFF !important; fill: #F0EBFF !important;}\n.u-tintSpectrum .u-accentColor--buttonNormal:not(.clapButton--largePill) {border-color: #D0CAFF !important; color: #D0CAFF !important;}\n.u-tintSpectrum .u-accentColor--buttonNormal:hover {border-color: #F0EBFF !important;}\n.u-tintSpectrum .u-accentColor--buttonNormal .icon:before,.u-tintSpectrum .u-accentColor--buttonNormal .svgIcon{color: #D0CAFF !important; fill: #D0CAFF !important;}\n.u-tintSpectrum .u-accentColor--buttonNormal.button--filled .icon:before,.u-tintSpectrum .u-accentColor--buttonNormal.button--filled .svgIcon{color: rgba(106, 11, 255, 1) !important; fill: rgba(106, 11, 255, 1) !important;}\n.u-tintSpectrum .u-accentColor--buttonDark.button--filled,.u-tintSpectrum .u-accentColor--buttonDark.button--withChrome.is-active,.u-tintSpectrum .u-accentColor--fillWhenActive.is-active {background-color: #F0EBFF !important; border-color: #F0EBFF !important; color: rgba(106, 11, 255, 1) !important; fill: rgba(106, 11, 255, 1) !important;}\n.u-tintSpectrum .u-accentColor--buttonNormal.button--filled:not(.clapButton--largePill),.u-tintSpectrum .u-accentColor--buttonNormal.button--withChrome.is-active:not(.clapButton--largePill) {background-color: #D0CAFF !important; border-color: #D0CAFF !important; color: rgba(106, 11, 255, 1) !important; fill: rgba(106, 11, 255, 1) !important;}\n.u-tintSpectrum .postArticle.is-withAccentColors .markup--user,.u-tintSpectrum .postArticle.is-withAccentColors .markup--query {color: #D0CAFF !important;}\n.u-accentColor--highlightFaint {background-color: rgba(240, 235, 255, 1) !important;}\n.u-accentColor--highlightStrong.is-active .svgIcon {fill: rgba(222, 205, 255, 1) !important;}\n.postArticle.is-withAccentColors .markup--quote.is-other {background-color: rgba(240, 235, 255, 1) !important;}\nbody.is-withMagicUnderlines .postArticle.is-withAccentColors .markup--quote.is-other {background-color: transparent !important; background-image: linear-gradient(to bottom, rgba(240, 235, 255, 1), rgba(240, 235, 255, 1));}\n.postArticle.is-withAccentColors .markup--quote.is-me {background-color: rgba(229, 220, 255, 1) !important;}\nbody.is-withMagicUnderlines .postArticle.is-withAccentColors .markup--quote.is-me {background-color: transparent !important; background-image: linear-gradient(to bottom, rgba(229, 220, 255, 1), rgba(229, 220, 255, 1));}\n.postArticle.is-withAccentColors .markup--quote.is-targeted {background-color: rgba(222, 205, 255, 1) !important;}\nbody.is-withMagicUnderlines .postArticle.is-withAccentColors .markup--quote.is-targeted {background-color: transparent !important; background-image: linear-gradient(to bottom, rgba(222, 205, 255, 1), rgba(222, 205, 255, 1));}\n.postArticle.is-withAccentColors .markup--quote.is-selected {background-color: rgba(222, 205, 255, 1) !important;}\nbody.is-withMagicUnderlines .postArticle.is-withAccentColors .markup--quote.is-selected {background-color: transparent !important; background-image: linear-gradient(to bottom, rgba(222, 205, 255, 1), rgba(222, 205, 255, 1));}\n.postArticle.is-withAccentColors .markup--highlight {background-color: rgba(222, 205, 255, 1) !important;}\nbody.is-withMagicUnderlines .postArticle.is-withAccentColors .markup--highlight {background-color: transparent !important; background-image: linear-gradient(to bottom, rgba(222, 205, 255, 1), rgba(222, 205, 255, 1));}.u-baseColor--iconNormal.avatar-halo {fill: rgba(0, 0, 0, 0.4980392156862745) !important;}</style><style class=\"js-collectionStyleConstant\">.u-imageBgColor {background-color: rgba(0, 0, 0, 0.24705882352941178);}\n.u-imageSpectrum .u-baseColor--borderLight {border-color: rgba(255, 255, 255, 0.6980392156862745) !important;}\n.u-imageSpectrum .u-baseColor--borderNormal {border-color: rgba(255, 255, 255, 0.8980392156862745) !important;}\n.u-imageSpectrum .u-baseColor--borderDark {border-color: rgba(255, 255, 255, 0.9490196078431372) !important;}\n.u-imageSpectrum .u-baseColor--iconLight .svgIcon,.u-imageSpectrum .u-baseColor--iconLight.svgIcon {fill: rgba(255, 255, 255, 0.8) !important;}\n.u-imageSpectrum .u-baseColor--iconNormal .svgIcon,.u-imageSpectrum .u-baseColor--iconNormal.svgIcon {fill: rgba(255, 255, 255, 0.9490196078431372) !important;}\n.u-imageSpectrum .u-baseColor--iconDark .svgIcon,.u-imageSpectrum .u-baseColor--iconDark.svgIcon {fill: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum .u-baseColor--textNormal {color: rgba(255, 255, 255, 0.9490196078431372) !important;}\n.u-imageSpectrum .u-baseColor--textNormal.u-baseColor--textDarken:hover {color: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum .u-baseColor--textDark {color: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum .u-baseColor--textDarker {color: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum .u-baseColor--backgroundLight {background-color: rgba(255, 255, 255, 0.8980392156862745) !important;}\n.u-imageSpectrum .u-baseColor--backgroundNormal {background-color: rgba(255, 255, 255, 0.9490196078431372) !important;}\n.u-imageSpectrum .u-baseColor--backgroundDark {background-color: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum .u-baseColor--buttonLight {border-color: rgba(255, 255, 255, 0.6980392156862745) !important; color: rgba(255, 255, 255, 0.8) !important;}\n.u-imageSpectrum .u-baseColor--buttonLight:hover {border-color: rgba(255, 255, 255, 0.6980392156862745) !important;}\n.u-imageSpectrum .u-baseColor--buttonLight .icon:before,.u-imageSpectrum .u-baseColor--buttonLight .svgIcon {color: rgba(255, 255, 255, 0.8) !important; fill: rgba(255, 255, 255, 0.8) !important;}\n.u-imageSpectrum .u-baseColor--buttonDark {border-color: rgba(255, 255, 255, 0.9490196078431372) !important; color: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum .u-baseColor--buttonDark:hover {border-color: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum .u-baseColor--buttonDark .icon:before,.u-imageSpectrum .u-baseColor--buttonDark .svgIcon {color: rgba(255, 255, 255, 1) !important; fill: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum .u-baseColor--buttonNormal {border-color: rgba(255, 255, 255, 0.8980392156862745) !important; color: rgba(255, 255, 255, 0.9490196078431372) !important;}\n.u-imageSpectrum .u-baseColor--buttonNormal:hover {border-color: rgba(255, 255, 255, 0.9490196078431372) !important;}\n.u-imageSpectrum .u-baseColor--buttonNormal .icon:before,.u-imageSpectrum .u-baseColor--buttonNormal .svgIcon {color: rgba(255, 255, 255, 0.9490196078431372) !important; fill: rgba(255, 255, 255, 0.9490196078431372) !important;}\n.u-imageSpectrum .u-baseColor--buttonDark.button--filled,.u-imageSpectrum .u-baseColor--buttonDark.button--withChrome.is-active {background-color: rgba(255, 255, 255, 1) !important; border-color: rgba(255, 255, 255, 1) !important; color: rgba(0, 0, 0, 0.24705882352941178) !important; fill: rgba(0, 0, 0, 0.24705882352941178) !important;}\n.u-imageSpectrum .u-baseColor--buttonNormal.button--filled,.u-imageSpectrum .u-baseColor--buttonNormal.button--withChrome.is-active {background-color: rgba(255, 255, 255, 0.9490196078431372) !important; border-color: rgba(255, 255, 255, 0.9490196078431372) !important; color: rgba(0, 0, 0, 0.24705882352941178) !important; fill: rgba(0, 0, 0, 0.24705882352941178) !important;}\n.u-imageSpectrum .u-baseColor--link {color: rgba(255, 255, 255, 0.9490196078431372) !important;}\n.u-imageSpectrum .u-baseColor--link.link--darkenOnHover:hover {color: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum .u-baseColor--link.link--darken:hover,.u-imageSpectrum .u-baseColor--link.link--darken:focus,.u-imageSpectrum .u-baseColor--link.link--darken:active {color: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum .u-baseColor--link.link--dark {color: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum .u-baseColor--link.link--dark.link--darken:hover,.u-imageSpectrum .u-baseColor--link.link--dark.link--darken:focus,.u-imageSpectrum .u-baseColor--link.link--dark.link--darken:active {color: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum .u-baseColor--link.link--darker {color: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum .u-baseColor--placeholderNormal ::-webkit-input-placeholder {color: rgba(255, 255, 255, 0.8);}\n.u-imageSpectrum .u-baseColor--placeholderNormal ::-moz-placeholder {color: rgba(255, 255, 255, 0.8);}\n.u-imageSpectrum .u-baseColor--placeholderNormal :-ms-input-placeholder {color: rgba(255, 255, 255, 0.8);}\n.u-imageSpectrum .svgIcon--logoWordmark {stroke: none !important; fill: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum .svgIcon--logoMonogram {stroke: none !important; fill: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum  .ui-h1,.u-imageSpectrum  .ui-h2,.u-imageSpectrum  .ui-h3,.u-imageSpectrum  .ui-h4,.u-imageSpectrum  .ui-brand1,.u-imageSpectrum  .ui-brand2,.u-imageSpectrum  .ui-captionStrong {color: rgba(255, 255, 255, 1) !important; fill: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum  .ui-body,.u-imageSpectrum  .ui-caps {color: rgba(255, 255, 255, 1) !important; fill: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum  .ui-summary,.u-imageSpectrum  .ui-caption {color: rgba(255, 255, 255, 0.8) !important; fill: rgba(255, 255, 255, 0.8) !important;}\n.u-imageSpectrum .u-accentColor--borderLight {border-color: rgba(255, 255, 255, 0.6980392156862745) !important;}\n.u-imageSpectrum .u-accentColor--borderNormal {border-color: rgba(255, 255, 255, 0.8980392156862745) !important;}\n.u-imageSpectrum .u-accentColor--borderDark {border-color: rgba(255, 255, 255, 0.9490196078431372) !important;}\n.u-imageSpectrum .u-accentColor--iconLight .svgIcon,.u-imageSpectrum .u-accentColor--iconLight.svgIcon {fill: rgba(255, 255, 255, 0.8) !important;}\n.u-imageSpectrum .u-accentColor--iconNormal .svgIcon,.u-imageSpectrum .u-accentColor--iconNormal.svgIcon {fill: rgba(255, 255, 255, 0.9490196078431372) !important;}\n.u-imageSpectrum .u-accentColor--iconDark .svgIcon,.u-imageSpectrum .u-accentColor--iconDark.svgIcon {fill: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum .u-accentColor--textNormal {color: rgba(255, 255, 255, 0.9490196078431372) !important;}\n.u-imageSpectrum .u-accentColor--hoverTextNormal:hover {color: rgba(255, 255, 255, 0.9490196078431372) !important;}\n.u-imageSpectrum .u-accentColor--textNormal.u-accentColor--textDarken:hover {color: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum .u-accentColor--textDark {color: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum .u-accentColor--backgroundLight {background-color: rgba(255, 255, 255, 0.8980392156862745) !important;}\n.u-imageSpectrum .u-accentColor--backgroundNormal {background-color: rgba(255, 255, 255, 0.9490196078431372) !important;}\n.u-imageSpectrum .u-accentColor--backgroundDark {background-color: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum .u-accentColor--buttonDark {border-color: rgba(255, 255, 255, 0.9490196078431372) !important; color: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum .u-accentColor--buttonDark:hover {border-color: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum .u-accentColor--buttonDark .icon:before,.u-imageSpectrum .u-accentColor--buttonDark .svgIcon{color: rgba(255, 255, 255, 1) !important; fill: rgba(255, 255, 255, 1) !important;}\n.u-imageSpectrum .u-accentColor--buttonNormal:not(.clapButton--largePill) {border-color: rgba(255, 255, 255, 0.8980392156862745) !important; color: rgba(255, 255, 255, 0.9490196078431372) !important;}\n.u-imageSpectrum .u-accentColor--buttonNormal:hover {border-color: rgba(255, 255, 255, 0.9490196078431372) !important;}\n.u-imageSpectrum .u-accentColor--buttonNormal .icon:before,.u-imageSpectrum .u-accentColor--buttonNormal .svgIcon{color: rgba(255, 255, 255, 0.9490196078431372) !important; fill: rgba(255, 255, 255, 0.9490196078431372) !important;}\n.u-imageSpectrum .u-accentColor--buttonNormal.button--filled .icon:before,.u-imageSpectrum .u-accentColor--buttonNormal.button--filled .svgIcon{color: rgba(0, 0, 0, 0.24705882352941178) !important; fill: rgba(0, 0, 0, 0.24705882352941178) !important;}\n.u-imageSpectrum .u-accentColor--buttonDark.button--filled,.u-imageSpectrum .u-accentColor--buttonDark.button--withChrome.is-active,.u-imageSpectrum .u-accentColor--fillWhenActive.is-active {background-color: rgba(255, 255, 255, 1) !important; border-color: rgba(255, 255, 255, 1) !important; color: rgba(0, 0, 0, 0.24705882352941178) !important; fill: rgba(0, 0, 0, 0.24705882352941178) !important;}\n.u-imageSpectrum .u-accentColor--buttonNormal.button--filled:not(.clapButton--largePill),.u-imageSpectrum .u-accentColor--buttonNormal.button--withChrome.is-active:not(.clapButton--largePill) {background-color: rgba(255, 255, 255, 0.9490196078431372) !important; border-color: rgba(255, 255, 255, 0.9490196078431372) !important; color: rgba(0, 0, 0, 0.24705882352941178) !important; fill: rgba(0, 0, 0, 0.24705882352941178) !important;}\n.u-imageSpectrum .postArticle.is-withAccentColors .markup--user,.u-imageSpectrum .postArticle.is-withAccentColors .markup--query {color: rgba(255, 255, 255, 0.9490196078431372) !important;}\n.u-imageSpectrum .u-accentColor--highlightFaint {background-color: rgba(255, 255, 255, 0.2) !important;}\n.u-imageSpectrum .u-accentColor--highlightStrong.is-active .svgIcon {fill: rgba(255, 255, 255, 0.6) !important;}\n.postArticle.is-withAccentColors .u-imageSpectrum .markup--quote.is-other {background-color: rgba(255, 255, 255, 0.2) !important;}\nbody.is-withMagicUnderlines .postArticle.is-withAccentColors .u-imageSpectrum .markup--quote.is-other {background-color: transparent !important; background-image: linear-gradient(to bottom, rgba(255, 255, 255, 0.2), rgba(255, 255, 255, 0.2));}\n.postArticle.is-withAccentColors .u-imageSpectrum .markup--quote.is-me {background-color: rgba(255, 255, 255, 0.4) !important;}\nbody.is-withMagicUnderlines .postArticle.is-withAccentColors .u-imageSpectrum .markup--quote.is-me {background-color: transparent !important; background-image: linear-gradient(to bottom, rgba(255, 255, 255, 0.4), rgba(255, 255, 255, 0.4));}\n.postArticle.is-withAccentColors .u-imageSpectrum .markup--quote.is-targeted {background-color: rgba(255, 255, 255, 0.6) !important;}\nbody.is-withMagicUnderlines .postArticle.is-withAccentColors .u-imageSpectrum .markup--quote.is-targeted {background-color: transparent !important; background-image: linear-gradient(to bottom, rgba(255, 255, 255, 0.6), rgba(255, 255, 255, 0.6));}\n.postArticle.is-withAccentColors .u-imageSpectrum .markup--quote.is-selected {background-color: rgba(255, 255, 255, 0.6) !important;}\nbody.is-withMagicUnderlines .postArticle.is-withAccentColors .u-imageSpectrum .markup--quote.is-selected {background-color: transparent !important; background-image: linear-gradient(to bottom, rgba(255, 255, 255, 0.6), rgba(255, 255, 255, 0.6));}\n.postArticle.is-withAccentColors .u-imageSpectrum .markup--highlight {background-color: rgba(255, 255, 255, 0.6) !important;}\nbody.is-withMagicUnderlines .postArticle.is-withAccentColors .u-imageSpectrum .markup--highlight {background-color: transparent !important; background-image: linear-gradient(to bottom, rgba(255, 255, 255, 0.6), rgba(255, 255, 255, 0.6));}.u-resetSpectrum .u-tintBgColor {background-color: rgba(255, 255, 255, 1) !important;}.u-resetSpectrum .u-tintBgColor .u-fadeLeft:before {background-image: linear-gradient(to right, rgba(255, 255, 255, 1) 0%, rgba(255, 255, 255, 0) 100%) !important;}.u-resetSpectrum .u-tintBgColor .u-fadeRight:after {background-image: linear-gradient(to right, rgba(255, 255, 255, 0) 0%, rgba(255, 255, 255, 1) 100%) !important;}\n.u-resetSpectrum .u-baseColor--borderLight {border-color: rgba(0, 0, 0, 0.2980392156862745) !important;}\n.u-resetSpectrum .u-baseColor--borderNormal {border-color: rgba(0, 0, 0, 0.4980392156862745) !important;}\n.u-resetSpectrum .u-baseColor--borderDark {border-color: rgba(0, 0, 0, 0.6) !important;}\n.u-resetSpectrum .u-baseColor--iconLight .svgIcon,.u-resetSpectrum .u-baseColor--iconLight.svgIcon {fill: rgba(0, 0, 0, 0.2980392156862745) !important;}\n.u-resetSpectrum .u-baseColor--iconNormal .svgIcon,.u-resetSpectrum .u-baseColor--iconNormal.svgIcon {fill: rgba(0, 0, 0, 0.4980392156862745) !important;}\n.u-resetSpectrum .u-baseColor--iconDark .svgIcon,.u-resetSpectrum .u-baseColor--iconDark.svgIcon {fill: rgba(0, 0, 0, 0.6) !important;}\n.u-resetSpectrum .u-baseColor--textNormal {color: rgba(0, 0, 0, 0.4980392156862745) !important;}\n.u-resetSpectrum .u-baseColor--textNormal.u-baseColor--textDarken:hover {color: rgba(0, 0, 0, 0.6) !important;}\n.u-resetSpectrum .u-baseColor--textDark {color: rgba(0, 0, 0, 0.6) !important;}\n.u-resetSpectrum .u-baseColor--textDarker {color: rgba(0, 0, 0, 0.8) !important;}\n.u-resetSpectrum .u-baseColor--backgroundLight {background-color: rgba(0, 0, 0, 0.09803921568627451) !important;}\n.u-resetSpectrum .u-baseColor--backgroundNormal {background-color: rgba(0, 0, 0, 0.2) !important;}\n.u-resetSpectrum .u-baseColor--backgroundDark {background-color: rgba(0, 0, 0, 0.2980392156862745) !important;}\n.u-resetSpectrum .u-baseColor--buttonLight {border-color: rgba(0, 0, 0, 0.2980392156862745) !important; color: rgba(0, 0, 0, 0.2980392156862745) !important;}\n.u-resetSpectrum .u-baseColor--buttonLight:hover {border-color: rgba(0, 0, 0, 0.2980392156862745) !important;}\n.u-resetSpectrum .u-baseColor--buttonLight .icon:before,.u-resetSpectrum .u-baseColor--buttonLight .svgIcon {color: rgba(0, 0, 0, 0.2980392156862745) !important; fill: rgba(0, 0, 0, 0.2980392156862745) !important;}\n.u-resetSpectrum .u-baseColor--buttonDark {border-color: rgba(0, 0, 0, 0.6) !important; color: rgba(0, 0, 0, 0.6) !important;}\n.u-resetSpectrum .u-baseColor--buttonDark:hover {border-color: rgba(0, 0, 0, 0.8) !important;}\n.u-resetSpectrum .u-baseColor--buttonDark .icon:before,.u-resetSpectrum .u-baseColor--buttonDark .svgIcon {color: rgba(0, 0, 0, 0.6) !important; fill: rgba(0, 0, 0, 0.6) !important;}\n.u-resetSpectrum .u-baseColor--buttonNormal {border-color: rgba(0, 0, 0, 0.4980392156862745) !important; color: rgba(0, 0, 0, 0.4980392156862745) !important;}\n.u-resetSpectrum .u-baseColor--buttonNormal:hover {border-color: rgba(0, 0, 0, 0.6) !important;}\n.u-resetSpectrum .u-baseColor--buttonNormal .icon:before,.u-resetSpectrum .u-baseColor--buttonNormal .svgIcon {color: rgba(0, 0, 0, 0.4980392156862745) !important; fill: rgba(0, 0, 0, 0.4980392156862745) !important;}\n.u-resetSpectrum .u-baseColor--buttonDark.button--filled,.u-resetSpectrum .u-baseColor--buttonDark.button--withChrome.is-active {background-color: rgba(0, 0, 0, 0.2980392156862745) !important; border-color: rgba(0, 0, 0, 0.2980392156862745) !important; color: rgba(255, 255, 255, 1) !important; fill: rgba(255, 255, 255, 1) !important;}\n.u-resetSpectrum .u-baseColor--buttonNormal.button--filled,.u-resetSpectrum .u-baseColor--buttonNormal.button--withChrome.is-active {background-color: rgba(0, 0, 0, 0.2) !important; border-color: rgba(0, 0, 0, 0.2) !important; color: rgba(255, 255, 255, 1) !important; fill: rgba(255, 255, 255, 1) !important;}\n.u-resetSpectrum .u-baseColor--link {color: rgba(0, 0, 0, 0.4980392156862745) !important;}\n.u-resetSpectrum .u-baseColor--link.link--darkenOnHover:hover {color: rgba(0, 0, 0, 0.6) !important;}\n.u-resetSpectrum .u-baseColor--link.link--darken:hover,.u-resetSpectrum .u-baseColor--link.link--darken:focus,.u-resetSpectrum .u-baseColor--link.link--darken:active {color: rgba(0, 0, 0, 0.6) !important;}\n.u-resetSpectrum .u-baseColor--link.link--dark {color: rgba(0, 0, 0, 0.6) !important;}\n.u-resetSpectrum .u-baseColor--link.link--dark.link--darken:hover,.u-resetSpectrum .u-baseColor--link.link--dark.link--darken:focus,.u-resetSpectrum .u-baseColor--link.link--dark.link--darken:active {color: rgba(0, 0, 0, 0.8) !important;}\n.u-resetSpectrum .u-baseColor--link.link--darker {color: rgba(0, 0, 0, 0.8) !important;}\n.u-resetSpectrum .u-baseColor--placeholderNormal ::-webkit-input-placeholder {color: rgba(0, 0, 0, 0.2980392156862745);}\n.u-resetSpectrum .u-baseColor--placeholderNormal ::-moz-placeholder {color: rgba(0, 0, 0, 0.2980392156862745);}\n.u-resetSpectrum .u-baseColor--placeholderNormal :-ms-input-placeholder {color: rgba(0, 0, 0, 0.2980392156862745);}\n.u-resetSpectrum .svgIcon--logoWordmark {stroke: none !important; fill: rgba(0, 0, 0, 0.6) !important;}\n.u-resetSpectrum .svgIcon--logoMonogram {stroke: none !important; fill: rgba(0, 0, 0, 0.6) !important;}\n.u-resetSpectrum  .ui-h1,.u-resetSpectrum  .ui-h2,.u-resetSpectrum  .ui-h3,.u-resetSpectrum  .ui-h4,.u-resetSpectrum  .ui-brand1,.u-resetSpectrum  .ui-brand2,.u-resetSpectrum  .ui-captionStrong {color: rgba(0, 0, 0, 0.8) !important; fill: rgba(0, 0, 0, 0.8) !important;}\n.u-resetSpectrum  .ui-body,.u-resetSpectrum  .ui-caps {color: rgba(0, 0, 0, 0.6) !important; fill: rgba(0, 0, 0, 0.6) !important;}\n.u-resetSpectrum  .ui-summary,.u-resetSpectrum  .ui-caption {color: rgba(0, 0, 0, 0.2980392156862745) !important; fill: rgba(0, 0, 0, 0.2980392156862745) !important;}\n.u-resetSpectrum .u-accentColor--borderLight {border-color: rgba(2, 184, 117, 1) !important;}\n.u-resetSpectrum .u-accentColor--borderNormal {border-color: rgba(2, 184, 117, 1) !important;}\n.u-resetSpectrum .u-accentColor--borderDark {border-color: rgba(0, 171, 107, 1) !important;}\n.u-resetSpectrum .u-accentColor--iconLight .svgIcon,.u-resetSpectrum .u-accentColor--iconLight.svgIcon {fill: rgba(2, 184, 117, 1) !important;}\n.u-resetSpectrum .u-accentColor--iconNormal .svgIcon,.u-resetSpectrum .u-accentColor--iconNormal.svgIcon {fill: rgba(0, 171, 107, 1) !important;}\n.u-resetSpectrum .u-accentColor--iconDark .svgIcon,.u-resetSpectrum .u-accentColor--iconDark.svgIcon {fill: rgba(28, 153, 99, 1) !important;}\n.u-resetSpectrum .u-accentColor--textNormal {color: rgba(0, 171, 107, 1) !important;}\n.u-resetSpectrum .u-accentColor--hoverTextNormal:hover {color: rgba(0, 171, 107, 1) !important;}\n.u-resetSpectrum .u-accentColor--textNormal.u-accentColor--textDarken:hover {color: rgba(28, 153, 99, 1) !important;}\n.u-resetSpectrum .u-accentColor--textDark {color: rgba(28, 153, 99, 1) !important;}\n.u-resetSpectrum .u-accentColor--backgroundLight {background-color: rgba(2, 184, 117, 1) !important;}\n.u-resetSpectrum .u-accentColor--backgroundNormal {background-color: rgba(0, 171, 107, 1) !important;}\n.u-resetSpectrum .u-accentColor--backgroundDark {background-color: rgba(28, 153, 99, 1) !important;}\n.u-resetSpectrum .u-accentColor--buttonDark {border-color: rgba(0, 171, 107, 1) !important; color: rgba(28, 153, 99, 1) !important;}\n.u-resetSpectrum .u-accentColor--buttonDark:hover {border-color: rgba(28, 153, 99, 1) !important;}\n.u-resetSpectrum .u-accentColor--buttonDark .icon:before,.u-resetSpectrum .u-accentColor--buttonDark .svgIcon{color: rgba(28, 153, 99, 1) !important; fill: rgba(28, 153, 99, 1) !important;}\n.u-resetSpectrum .u-accentColor--buttonNormal:not(.clapButton--largePill) {border-color: rgba(2, 184, 117, 1) !important; color: rgba(0, 171, 107, 1) !important;}\n.u-resetSpectrum .u-accentColor--buttonNormal:hover {border-color: rgba(0, 171, 107, 1) !important;}\n.u-resetSpectrum .u-accentColor--buttonNormal .icon:before,.u-resetSpectrum .u-accentColor--buttonNormal .svgIcon{color: rgba(0, 171, 107, 1) !important; fill: rgba(0, 171, 107, 1) !important;}\n.u-resetSpectrum .u-accentColor--buttonNormal.button--filled .icon:before,.u-resetSpectrum .u-accentColor--buttonNormal.button--filled .svgIcon{color: rgba(255, 255, 255, 1) !important; fill: rgba(255, 255, 255, 1) !important;}\n.u-resetSpectrum .u-accentColor--buttonDark.button--filled,.u-resetSpectrum .u-accentColor--buttonDark.button--withChrome.is-active,.u-resetSpectrum .u-accentColor--fillWhenActive.is-active {background-color: rgba(28, 153, 99, 1) !important; border-color: rgba(28, 153, 99, 1) !important; color: rgba(255, 255, 255, 1) !important; fill: rgba(255, 255, 255, 1) !important;}\n.u-resetSpectrum .u-accentColor--buttonNormal.button--filled:not(.clapButton--largePill),.u-resetSpectrum .u-accentColor--buttonNormal.button--withChrome.is-active:not(.clapButton--largePill) {background-color: rgba(0, 171, 107, 1) !important; border-color: rgba(0, 171, 107, 1) !important; color: rgba(255, 255, 255, 1) !important; fill: rgba(255, 255, 255, 1) !important;}\n.u-resetSpectrum .postArticle.is-withAccentColors .markup--user,.u-resetSpectrum .postArticle.is-withAccentColors .markup--query {color: rgba(0, 171, 107, 1) !important;}</style></div></div></div><div class=\"loadingBar\"></div><script>// <![CDATA[\nwindow[\"obvInit\"] = function (opt_embedded) {window[\"obvInit\"][\"embedded\"] = opt_embedded; window[\"obvInit\"][\"ready\"] = true;}\n// ]]></script><script>// <![CDATA[\nvar GLOBALS = {\"audioUrl\":\"https://d1fcbxp97j4nb2.cloudfront.net\",\"baseUrl\":\"https://onezero.medium.com\",\"buildLabel\":\"37089-823c9b4\",\"currentUser\":{\"userId\":\"lo_kBEP9dfq2M2Z\",\"isVerified\":false,\"subscriberEmail\":\"\",\"hasPastMemberships\":false,\"isEnrolledInHightower\":false,\"isEligibleForHightower\":false,\"hightowerLastLockedAt\":0,\"isWriterProgramEnrolled\":false,\"isWriterProgramInvited\":false,\"isWriterProgramOptedOut\":false,\"writerProgramVersion\":0,\"writerProgramEnrolledAt\":0,\"friendLinkOnboarding\":0,\"hasAdditionalUnlocks\":false,\"hasApiAccess\":false,\"isQuarantined\":false,\"writerProgramDistributionSettingOptedIn\":false},\"currentUserHasUnverifiedEmail\":false,\"isAuthenticated\":false,\"isCurrentUserVerified\":false,\"miroUrl\":\"https://cdn-images-1.medium.com\",\"moduleUrls\":{\"base\":\"https://cdn-static-1.medium.com/_/fp/gen-js/main-base.bundle.IbkHvfLQzCD_wSB0aORB_Q.js\",\"common-async\":\"https://cdn-static-1.medium.com/_/fp/gen-js/main-common-async.bundle.htWnIUvdXGDiHIvvp2N7dw.js\",\"hightower\":\"https://cdn-static-1.medium.com/_/fp/gen-js/main-hightower.bundle.aT2OFc8Ccsu1VzDz-c0s8g.js\",\"home-screens\":\"https://cdn-static-1.medium.com/_/fp/gen-js/main-home-screens.bundle.U3bY-35_vFokhgpKDpmBVw.js\",\"misc-screens\":\"https://cdn-static-1.medium.com/_/fp/gen-js/main-misc-screens.bundle.ksRllN8YzkymFaj-CrvFLA.js\",\"notes\":\"https://cdn-static-1.medium.com/_/fp/gen-js/main-notes.bundle.3Lawe7ZU5a9e9z9jB-Uc9Q.js\",\"payments\":\"https://cdn-static-1.medium.com/_/fp/gen-js/main-payments.bundle.J5j1KGPzOC52detbkGRWYQ.js\",\"posters\":\"https://cdn-static-1.medium.com/_/fp/gen-js/main-posters.bundle.ph-GLSdgsAfDWIPCMPgLLg.js\",\"power-readers\":\"https://cdn-static-1.medium.com/_/fp/gen-js/main-power-readers.bundle.Ns-aXsnqdGPXVOPt0_AnsQ.js\",\"pubs\":\"https://cdn-static-1.medium.com/_/fp/gen-js/main-pubs.bundle.nHBfyugbb6I1JWtdPO600w.js\",\"stats\":\"https://cdn-static-1.medium.com/_/fp/gen-js/main-stats.bundle.7nKgIEvisRK11udIOQk93g.js\"},\"previewConfig\":{\"weightThreshold\":1,\"weightImageParagraph\":0.51,\"weightIframeParagraph\":0.8,\"weightTextParagraph\":0.08,\"weightEmptyParagraph\":0,\"weightP\":0.003,\"weightH\":0.005,\"weightBq\":0.003,\"minPTextLength\":60,\"truncateBoundaryChars\":20,\"detectTitle\":true,\"detectTitleLevThreshold\":0.15},\"productName\":\"Medium\",\"supportsEdit\":true,\"termsUrl\":\"//medium.com/policy/9db0094a1e0f\",\"textshotHost\":\"textshot.medium.com\",\"transactionId\":\"1554317370830:2924c764090a\",\"useragent\":{\"browser\":\"chrome\",\"family\":\"chrome\",\"os\":\"windows\",\"version\":60,\"supportsDesktopEdit\":true,\"supportsInteract\":true,\"supportsView\":true,\"isMobile\":false,\"isTablet\":false,\"isNative\":false,\"supportsFileAPI\":true,\"isTier1\":true,\"clientVersion\":\"\",\"unknownParagraphsBad\":false,\"clientChannel\":\"\",\"supportsRealScrollEvents\":true,\"supportsVhUnits\":true,\"ruinsViewportSections\":false,\"supportsHtml5Video\":true,\"supportsMagicUnderlines\":true,\"isWebView\":false,\"isFacebookWebView\":false,\"supportsProgressiveMedia\":true,\"supportsPromotedPosts\":true,\"isBot\":false,\"isNativeIphone\":false,\"supportsCssVariables\":true,\"supportsVideoSections\":true,\"emojiSupportLevel\":1,\"isSearchBot\":false,\"isSyndicationBot\":false,\"isNativeAndroid\":false,\"supportsScrollableMetabar\":true},\"variants\":{\"allow_access\":true,\"allow_signup\":true,\"allow_test_auth\":\"disallow\",\"signin_services\":\"twitter,facebook,google,email,google-fastidv,google-one-tap\",\"signup_services\":\"twitter,facebook,google,email,google-fastidv,google-one-tap\",\"google_sign_in_android\":true,\"reengagement_notification_duration\":3,\"browsable_stream_config_bucket\":\"curated-topics\",\"enable_dedicated_series_tab_api_ios\":true,\"enable_post_import\":true,\"available_monthly_plan\":\"60e220181034\",\"available_annual_plan\":\"2c754bcc2995\",\"disable_ios_resume_reading_toast\":true,\"is_not_medium_subscriber\":true,\"glyph_font_set\":\"m2\",\"enable_branding\":true,\"enable_branding_fonts\":true,\"max_premium_content_per_user_under_metering\":3,\"enable_automated_mission_control_triggers\":true,\"enable_lite_profile\":true,\"enable_marketing_emails\":true,\"enable_topic_lifecycle_email\":true,\"enable_parsely\":true,\"enable_branch_io\":true,\"enable_ios_post_stats\":true,\"enable_lite_topics\":true,\"enable_lite_stories\":true,\"redis_read_write_splitting\":true,\"enable_tipalti_onboarding\":true,\"enable_annual_renewal_reminder_email\":true,\"enable_janky_spam_rules\":\"users,posts\",\"enable_new_collaborative_filtering_data\":true,\"android_rating_prompt_stories_read_threshold\":2,\"enable_smart_meter_with_incentive\":true,\"stripe_v3\":true,\"enable_google_one_tap\":true,\"enable_email_sign_in_captcha\":true,\"enable_rito_sequence_post_recirc_query\":true,\"enable_primary_topic_for_mobile\":true,\"enable_rito_sequence_post_handler\":true,\"enable_todays_highlights_ios\":true,\"enable_todays_highlights_android\":true,\"enable_improved_stats_curation_status\":true,\"enable_story_onboarding\":true,\"enable_logged_out_homepage_signup\":true,\"enable_email_signup_nonmoc\":true,\"use_new_admin_topic_backend\":true,\"enable_full_name_screen_refresh\":true,\"enable_quarantine_rules\":true,\"enable_lite_privacy_banner\":true,\"enable_reduced_post_age_in_feed\":true,\"enable_follow_topics_directly_from_nonboarded_welcome_email\":true,\"enable_digest_inbox_education_promo\":true,\"posts_sharing_tags_without_hopper\":true,\"enable_april_meter_email_test\":true},\"xsrfToken\":\"\",\"iosAppId\":\"828256236\",\"supportEmail\":\"yourfriends@medium.com\",\"fp\":{\"/icons/monogram-mask.svg\":\"https://cdn-static-1.medium.com/_/fp/icons/monogram-mask.KPLCSFEZviQN0jQ7veN2RQ.svg\",\"/icons/favicon-dev-editor.ico\":\"https://cdn-static-1.medium.com/_/fp/icons/favicon-dev-editor.YKKRxBO8EMvIqhyCwIiJeQ.ico\",\"/icons/favicon-hatch-editor.ico\":\"https://cdn-static-1.medium.com/_/fp/icons/favicon-hatch-editor.BuEyHIqlyh2s_XEk4Rl32Q.ico\",\"/icons/favicon-medium-editor.ico\":\"https://cdn-static-1.medium.com/_/fp/icons/favicon-medium-editor.PiakrZWB7Yb80quUVQWM6g.ico\"},\"authBaseUrl\":\"https://medium.com\",\"imageUploadSizeMb\":25,\"isAuthDomainRequest\":false,\"domainCollectionSlug\":\"one-zero\",\"algoliaApiEndpoint\":\"https://MQ57UUUQZ2-dsn.algolia.net\",\"algoliaAppId\":\"MQ57UUUQZ2\",\"algoliaSearchOnlyApiKey\":\"394474ced050e3911ae2249ecc774921\",\"iosAppStoreUrl\":\"https://itunes.apple.com/app/medium-everyones-stories/id828256236?pt=698524&mt=8\",\"iosAppLinkBaseUrl\":\"medium:\",\"algoliaIndexPrefix\":\"medium_\",\"androidPlayStoreUrl\":\"https://play.google.com/store/apps/details?id=com.medium.reader\",\"googleClientId\":\"216296035834-k1k6qe060s2tp2a2jam4ljdcms00sttg.apps.googleusercontent.com\",\"androidPackage\":\"com.medium.reader\",\"androidPlayStoreMarketScheme\":\"market://details?id=com.medium.reader\",\"googleAuthUri\":\"https://accounts.google.com/o/oauth2/auth\",\"androidScheme\":\"medium\",\"layoutData\":{\"useDynamicScripts\":false,\"googleAnalyticsTrackingCode\":\"UA-24232453-2\",\"jsShivUrl\":\"https://cdn-static-1.medium.com/_/fp/js/shiv.RI2ePTZ5gFmMgLzG5bEVAA.js\",\"useDynamicCss\":false,\"faviconUrl\":\"https://cdn-static-1.medium.com/_/fp/icons/favicon-rebrand-medium.3Y6xpZ-0FSdWDnPM3hSBIA.ico\",\"faviconImageId\":\"1*8I-HPL0bfoIzGied-dzOvA.png\",\"fontSets\":[{\"id\":8,\"url\":\"https://glyph.medium.com/css/e/sr/latin/e/ssr/latin/e/ssb/latin/m2.css\"},{\"id\":11,\"url\":\"https://glyph.medium.com/css/m2.css\"},{\"id\":9,\"url\":\"https://glyph.medium.com/css/mkt.css\"}],\"editorFaviconUrl\":\"https://cdn-static-1.medium.com/_/fp/icons/favicon-rebrand-medium-editor.3Y6xpZ-0FSdWDnPM3hSBIA.ico\",\"glyphUrl\":\"https://glyph.medium.com\"},\"authBaseUrlRev\":\"moc.muidem//:sptth\",\"isDnt\":false,\"stripePublishableKey\":\"pk_live_7FReX44VnNIInZwrIIx6ghjl\",\"archiveUploadSizeMb\":100,\"paymentData\":{\"currencies\":{\"1\":{\"label\":\"US Dollar\",\"external\":\"usd\"}},\"countries\":{\"1\":{\"label\":\"United States of America\",\"external\":\"US\"}},\"accountTypes\":{\"1\":{\"label\":\"Individual\",\"external\":\"individual\"},\"2\":{\"label\":\"Company\",\"external\":\"company\"}}},\"previewConfig2\":{\"weightThreshold\":1,\"weightImageParagraph\":0.05,\"raiseImage\":true,\"enforceHeaderHierarchy\":true,\"isImageInsetRight\":true},\"isAmp\":false,\"iosScheme\":\"medium\",\"isSwBoot\":false,\"lightstep\":{\"accessToken\":\"ce5be895bef60919541332990ac9fef2\",\"carrier\":\"{\\\"ot-tracer-spanid\\\":\\\"7e72cfe321df047d\\\",\\\"ot-tracer-traceid\\\":\\\"3357b0d8200bc269\\\",\\\"ot-tracer-sampled\\\":\\\"true\\\"}\",\"host\":\"collector-medium.lightstep.com\"},\"facebook\":{\"key\":\"542599432471018\",\"namespace\":\"medium-com\",\"scope\":{\"default\":[\"public_profile\",\"email\"],\"connect\":[\"public_profile\",\"email\"],\"login\":[\"public_profile\",\"email\"],\"share\":[\"public_profile\",\"email\"]}},\"editorsPicksTopicId\":\"3985d2a191c5\",\"popularOnMediumTopicId\":\"9d34e48ecf94\",\"memberContentTopicId\":\"13d7efd82fb2\",\"audioContentTopicId\":\"3792abbd134\",\"brandedSequenceId\":\"7d337ddf1941\",\"isDoNotAuth\":false,\"goldfinchUrl\":\"https://goldfinch.medium.com\",\"buggle\":{\"url\":\"https://buggle.medium.com\",\"videoUrl\":\"https://cdn-videos-1.medium.com\",\"audioUrl\":\"https://cdn-audio-1.medium.com\"},\"referrerType\":5,\"isMeteredOut\":false,\"meterConfig\":{\"maxUnlockCount\":3,\"windowLength\":\"MONTHLY\"},\"partnerProgramEmail\":\"partnerprogram@medium.com\",\"userResearchPrompts\":[{\"promptId\":\"lo_post_page_4\",\"type\":0,\"url\":\"www.calendly.com\"},{\"promptId\":\"lo_home_page\",\"type\":1,\"url\":\"www.calendly.com\"},{\"promptId\":\"lo_profile_page\",\"type\":2,\"url\":\"www.calendly.com\"}],\"recaptchaKey\":\"6LdAokEUAAAAAC7seICd4vtC8chDb3jIXDQulyUJ\",\"signinWallCustomDomainCollectionIds\":[\"3a8144eabfe3\",\"336d898217ee\",\"61061eb0c96b\",\"138adf9c44c\",\"819cc2aaeee0\"],\"countryCode\":\"A1\",\"bypassMeter\":false,\"branchKey\":\"key_live_ofxXr2qTrrU9NqURK8ZwEhknBxiI6KBm\",\"paypal\":{\"clientMode\":\"production\",\"oneYearGift\":{\"name\":\"Medium Membership (1 Year, Digital Gift Code)\",\"description\":\"Unlimited access to the best and brightest stories on Medium. Gift codes can be redeemed at medium.com/redeem.\",\"price\":\"50.00\",\"currency\":\"USD\",\"sku\":\"membership-gift-1-yr\"}},\"collectionConfig\":{\"mediumOwnedAndOperatedCollectionIds\":[\"544c7006046e // Human Parts\",\"bcc38c8f6edf // Matter\",\"444d13b52878 // OneZero\"]}}\n// ]]></script><script async=\"\" charset=\"UTF-8\" src=\"https://cdn-static-1.medium.com/_/fp/gen-js/main-base.bundle.IbkHvfLQzCD_wSB0aORB_Q.js\"></script><script>// <![CDATA[\nwindow[\"obvInit\"]({\"value\":{\"id\":\"2e57c195b294\",\"versionId\":\"88e8595a9d26\",\"creatorId\":\"bf4c3c7dced5\",\"creator\":{\"userId\":\"bf4c3c7dced5\",\"name\":\"Dana G Smith\",\"username\":\"smithdanag\",\"createdAt\":1384382054778,\"imageId\":\"1*uoseNvFQihxFrrGwRBUpxw.jpeg\",\"backgroundImageId\":\"\",\"bio\":\"Freelance science writer specializing in brains and bodies. Website: danagsmith.com; Twitter: @smithdanag\",\"twitterScreenName\":\"SmithDanaG\",\"socialStats\":{\"userId\":\"bf4c3c7dced5\",\"usersFollowedCount\":387,\"usersFollowedByCount\":1154,\"type\":\"SocialStats\"},\"social\":{\"userId\":\"lo_kBEP9dfq2M2Z\",\"targetUserId\":\"bf4c3c7dced5\",\"type\":\"Social\"},\"facebookAccountId\":\"\",\"allowNotes\":1,\"mediumMemberAt\":1540314409000,\"isNsfw\":false,\"isWriterProgramEnrolled\":true,\"isQuarantined\":false,\"type\":\"User\"},\"homeCollection\":{\"id\":\"444d13b52878\",\"name\":\"OneZero\",\"slug\":\"one-zero\",\"tags\":[\"TECHNOLOGY\",\"SCIENCE\",\"FUTURE\"],\"creatorId\":\"c626e36ed20\",\"description\":\"Medium\u2019s technology and science publication\",\"shortDescription\":\"Medium\u2019s technology and science publication\",\"image\":{\"imageId\":\"1*88Z0O0wD4KOrk6Y5EceZog.png\",\"filter\":\"\",\"backgroundSize\":\"\",\"originalWidth\":750,\"originalHeight\":750,\"strategy\":\"resample\",\"height\":0,\"width\":0},\"metadata\":{\"followerCount\":13902,\"activeAt\":1554309902819},\"virtuals\":{\"permissions\":{\"canPublish\":false,\"canPublishAll\":false,\"canRepublish\":false,\"canRemove\":false,\"canManageAll\":false,\"canSubmit\":false,\"canEditPosts\":false,\"canAddWriters\":false,\"canViewStats\":false,\"canSendNewsletter\":false,\"canViewLockedPosts\":false,\"canViewCloaked\":false,\"canEditOwnPosts\":false,\"canBeAssignedAuthor\":false,\"canEnrollInHightower\":false,\"canLockPostsForMediumMembers\":false,\"canLockOwnPostsForMediumMembers\":false},\"isSubscribed\":false,\"isNewsletterSubscribed\":false,\"memberOfMembershipPlanId\":\"\",\"isEnrolledInHightower\":false,\"isEligibleForHightower\":false},\"logo\":{\"imageId\":\"1*RxCcqX5oOebo9NLExQ6rgw.png\",\"filter\":\"\",\"backgroundSize\":\"\",\"originalWidth\":394,\"originalHeight\":101,\"strategy\":\"resample\",\"height\":0,\"width\":0},\"collectionMastheadId\":\"118ea8ba7b68\",\"domain\":\"onezero.medium.com\",\"sections\":[{\"type\":2,\"collectionHeaderMetadata\":{\"title\":\"\",\"description\":\"by Medium\",\"backgroundImage\":{},\"logoImage\":{\"id\":\"1*zv9JXqaS9O8OcHTzOoGPUA@2x.png\",\"originalWidth\":1404,\"originalHeight\":319,\"alt\":\"OneZero\"},\"alignment\":2,\"layout\":5}},{\"type\":1,\"postListMetadata\":{\"source\":3,\"layout\":4,\"number\":1,\"postIds\":[\"1584ba041b74\"]}},{\"type\":1,\"postListMetadata\":{\"source\":3,\"layout\":4,\"number\":2,\"postIds\":[\"e2e521664cb9\",\"1c0fc4375ba9\"]}},{\"type\":1,\"postListMetadata\":{\"source\":3,\"layout\":4,\"number\":1,\"postIds\":[\"7503d0ada8e0\"]}},{\"type\":1,\"postListMetadata\":{\"source\":1,\"layout\":4,\"number\":3,\"postIds\":[]}},{\"type\":1,\"postListMetadata\":{\"source\":3,\"layout\":4,\"number\":4,\"postIds\":[\"85df2ee9045e\",\"307bc4e97120\",\"1d31d4b043ea\",\"69cbdf5bfc9c\"],\"sectionHeader\":\"THE AMAZON DIARIES\"}},{\"type\":1,\"postListMetadata\":{\"source\":1,\"layout\":4,\"number\":5,\"postIds\":[],\"sectionHeader\":\"RECENT\"}},{\"type\":1,\"postListMetadata\":{\"source\":4,\"layout\":4,\"number\":3,\"postIds\":[],\"tagSlug\":\"Microprocessing\",\"sectionHeader\":\"MICROPROCESSING\"}},{\"type\":1,\"postListMetadata\":{\"source\":4,\"layout\":4,\"number\":3,\"postIds\":[],\"tagSlug\":\"The Upgrade\",\"sectionHeader\":\"THE UPGRADE\"}},{\"type\":1,\"postListMetadata\":{\"source\":1,\"layout\":4,\"number\":25,\"postIds\":[],\"sectionHeader\":\"MORE\"}}],\"tintColor\":\"#FF6A0BFF\",\"lightText\":false,\"favicon\":{\"imageId\":\"1*88Z0O0wD4KOrk6Y5EceZog.png\",\"filter\":\"\",\"backgroundSize\":\"\",\"originalWidth\":750,\"originalHeight\":750,\"strategy\":\"resample\",\"height\":0,\"width\":0},\"colorPalette\":{\"defaultBackgroundSpectrum\":{\"colorPoints\":[{\"color\":\"#FF8C5DFF\",\"point\":0},{\"color\":\"#FF815AFF\",\"point\":0.1},{\"color\":\"#FF7656F2\",\"point\":0.2},{\"color\":\"#FF6B51D8\",\"point\":0.3},{\"color\":\"#FF614BBF\",\"point\":0.4},{\"color\":\"#FF5645A6\",\"point\":0.5},{\"color\":\"#FF4A3E8E\",\"point\":0.6},{\"color\":\"#FF3F3576\",\"point\":0.7},{\"color\":\"#FF332C5E\",\"point\":0.8},{\"color\":\"#FF272247\",\"point\":0.9},{\"color\":\"#FF1A1730\",\"point\":1}],\"backgroundColor\":\"#FFFFFFFF\"},\"tintBackgroundSpectrum\":{\"colorPoints\":[{\"color\":\"#FF6A0BFF\",\"point\":0},{\"color\":\"#FF7548FE\",\"point\":0.1},{\"color\":\"#FF8365FF\",\"point\":0.2},{\"color\":\"#FF927DFF\",\"point\":0.3},{\"color\":\"#FFA192FF\",\"point\":0.4},{\"color\":\"#FFB1A6FF\",\"point\":0.5},{\"color\":\"#FFC1B8FF\",\"point\":0.6},{\"color\":\"#FFD0CAFF\",\"point\":0.7},{\"color\":\"#FFE0DBFF\",\"point\":0.8},{\"color\":\"#FFF0EBFF\",\"point\":0.9},{\"color\":\"#FFFFFBFF\",\"point\":1}],\"backgroundColor\":\"#FF6A0BFF\"},\"highlightSpectrum\":{\"colorPoints\":[{\"color\":\"#FFF2EEFF\",\"point\":0},{\"color\":\"#FFF0EBFF\",\"point\":0.1},{\"color\":\"#FFEEE9FF\",\"point\":0.2},{\"color\":\"#FFECE6FF\",\"point\":0.3},{\"color\":\"#FFE9E3FF\",\"point\":0.4},{\"color\":\"#FFE7DFFF\",\"point\":0.5},{\"color\":\"#FFE5DCFF\",\"point\":0.6},{\"color\":\"#FFE4D9FF\",\"point\":0.7},{\"color\":\"#FFE2D5FF\",\"point\":0.8},{\"color\":\"#FFE0D1FF\",\"point\":0.9},{\"color\":\"#FFDECDFF\",\"point\":1}],\"backgroundColor\":\"#FFFFFFFF\"}},\"navItems\":[{\"type\":4,\"title\":\"CONSUMER TECH\",\"url\":\"https://onezero.medium.com/consumer-tech/home\",\"topicId\":\"bf4f982530da\",\"source\":\"topicId\"},{\"type\":4,\"title\":\"DIGITAL LIFE\",\"url\":\"https://onezero.medium.com/digital-life/home\",\"topicId\":\"e3a73cb442d6\",\"source\":\"topicId\"},{\"type\":4,\"title\":\"INDUSTRY\",\"url\":\"https://onezero.medium.com/industry/home\",\"topicId\":\"2ba052a12d20\",\"source\":\"topicId\"},{\"type\":4,\"title\":\"SCIENCE & MEDICINE\",\"url\":\"https://onezero.medium.com/science-and-medicine/home\",\"topicId\":\"12839895cc53\",\"source\":\"topicId\"}],\"colorBehavior\":1,\"instantArticlesState\":0,\"acceleratedMobilePagesState\":0,\"collectionFeatures\":[3],\"ampLogo\":{\"imageId\":\"\",\"filter\":\"\",\"backgroundSize\":\"\",\"originalWidth\":0,\"originalHeight\":0,\"strategy\":\"resample\",\"height\":0,\"width\":0},\"header\":{\"title\":\"\",\"description\":\"by Medium\",\"backgroundImage\":{},\"logoImage\":{\"id\":\"1*zv9JXqaS9O8OcHTzOoGPUA@2x.png\",\"originalWidth\":1404,\"originalHeight\":319,\"alt\":\"OneZero\"},\"alignment\":2,\"layout\":5},\"type\":\"Collection\"},\"homeCollectionId\":\"444d13b52878\",\"title\":\"The Party Drug That Could Help Stop Depression\",\"detectedLanguage\":\"en\",\"latestVersion\":\"88e8595a9d26\",\"latestPublishedVersion\":\"88e8595a9d26\",\"hasUnpublishedEdits\":false,\"latestRev\":131,\"createdAt\":1551489265138,\"updatedAt\":1551833428644,\"acceptedAt\":0,\"firstPublishedAt\":1551832607707,\"latestPublishedAt\":1551833428644,\"vote\":false,\"experimentalCss\":\"\",\"displayAuthor\":\"\",\"content\":{\"subtitle\":\"The anesthetic ketamine receives official FDA approval to treat depression. Is the tradeoff worth it?\",\"bodyModel\":{\"paragraphs\":[{\"name\":\"9595\",\"type\":3,\"text\":\"The Party Drug That Could Help Stop Depression\",\"markups\":[]},{\"name\":\"e127\",\"type\":13,\"text\":\"The anesthetic ketamine receives official FDA approval to treat depression. Is the tradeoff worth it?\",\"markups\":[]},{\"name\":\"dc28\",\"type\":4,\"text\":\"Credit: Florian Gaertner/Getty Images Plus\",\"markups\":[],\"layout\":3,\"metadata\":{\"id\":\"1*fIp9beyYlYnV-0ubLCBIGQ.jpeg\",\"originalWidth\":4000,\"originalHeight\":2667,\"isFeatured\":true,\"focusPercentX\":65,\"focusPercentY\":20}},{\"name\":\"ff6b\",\"type\":1,\"text\":\"The U.S. Food and Drug Administration (FDA) on March 5 approved a form of ketamine to be prescribed for treatment-resistant depression. The drug, called esketamine, is administered as a nasal spray and is the first version of ketamine to be cleared to treat depression. It\u2019s also the first new type of antidepressant drug since Prozac was released over 30 years ago. Many psychiatrists and pharmacists see the ruling as a win for desperate patients with few options, but others have raised concerns about the drug\u2019s possibly serious side effects and have questioned its efficacy.\",\"markups\":[{\"type\":3,\"start\":284,\"end\":321,\"href\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428540/\",\"title\":\"\",\"rel\":\"\",\"anchorType\":0}],\"hasDropCap\":true,\"dropCapImage\":{\"id\":\"1*x3MLNrKVby4_GZ1VCCYktA.png\",\"originalWidth\":500,\"originalHeight\":500}},{\"name\":\"1ef3\",\"type\":1,\"text\":\"\u201cOn the whole, I think they made the right choice,\u201d says Richard Friedman, a professor of psychiatry at Weill Cornell Medical College who was not involved in the decision. \u201cThis is a group of people who are really ill and for whom there are limited therapeutics. There\u2019s no question ketamine has antidepressant efficacy, and it\u2019s a new target.\u201d\",\"markups\":[]},{\"name\":\"862d\",\"type\":1,\"text\":\"Esketamine will be sold under the brand name Spravato and is made by Janssen Pharmaceutical Company, a subsidiary of Johnson & Johnson. \u201cBecause of safety concerns, the drug will only be available through a restricted distribution system and it must be administered in a certified medical office where the health care provider can monitor the patient,\u201d said Dr. Tiffany Farchione, acting director of the Division of Psychiatry Products in the FDA\u2019s Center for Drug Evaluation and Research in a statement.\",\"markups\":[{\"type\":3,\"start\":489,\"end\":503,\"href\":\"https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm632761.htm\",\"title\":\"\",\"rel\":\"\",\"anchorType\":0}]},{\"name\":\"794e\",\"type\":1,\"text\":\"The FDA said that people who take the drug must be monitored by a health care provider for at least two hours after receiving it. Patients cannot take the spray home.\",\"markups\":[]},{\"name\":\"46ea\",\"type\":1,\"text\":\"An estimated 30 to 40 percent of people with depression fail to respond to traditional antidepressant drugs like Prozac (a selective serotonin reuptake inhibitor or SSRI) and Cymbalta (a serotonin-norepinephrine reuptake inhibitor or SNRI), classifying them as \u201ctreatment resistant.\u201d These patients have few alternative options, as all current antidepressants act on the same three neurochemicals: serotonin, dopamine, and norepinephrine. Ketamine, by contrast, acts on an entirely different pathway: the glutamate system, which is the brain\u2019s primary excitatory neurochemical and is involved in learning.\",\"markups\":[]},{\"name\":\"3b3f\",\"type\":1,\"text\":\"Scientists aren\u2019t exactly sure how ketamine acts as an antidepressant, but it may do so by increasing the number of connections, or synapses, between cells in the brain, particularly in the prefrontal cortex. Stress and depression degrade these connections, and ketamine could reverse the damage, regrowing the lost synapses. \u201cIt\u2019s like fertilizer in the brain,\u201d says Friedman.\",\"markups\":[]},{\"name\":\"0e3a\",\"type\":1,\"text\":\"\u201cThere\u2019s no question ketamine has antidepressant efficacy, and it\u2019s a new target.\u201d\",\"markups\":[{\"type\":1,\"start\":0,\"end\":1}]},{\"name\":\"b40b\",\"type\":1,\"text\":\"The first study of ketamine as an antidepressant was published in 2000, with a single dose of the drug dramatically improving depression symptoms in a majority of people. A rush of clinical trials followed, in addition to the opening of ketamine clinics where doctors provide people with the drug off-label. On an anecdotal basis, the drug has proven remarkable, with suicidal people reporting that the drug saved their lives.\",\"markups\":[{\"type\":3,\"start\":4,\"end\":48,\"href\":\"https://www.ncbi.nlm.nih.gov/pubmed/10686270\",\"title\":\"\",\"rel\":\"\",\"anchorType\":0},{\"type\":3,\"start\":308,\"end\":329,\"href\":\"https://www.vox.com/first-person/2018/7/24/17603616/depression-treatment-severe-ketamine-special-k\",\"title\":\"\",\"rel\":\"\",\"anchorType\":0}]},{\"name\":\"d11b\",\"type\":1,\"text\":\"Researchers, though, are much more measured. \u201cI think any hope that this is a new wonder drug should be tamped down,\u201d says Steven Meisel, director of medication safety at Fairview Health Services and a member of the FDA advisory committee that initially recommended ketamine. \u201cThis is a drug that will benefit a minority of people greatly, and a majority of people not at all. For those it does help, it could be dramatic, but it\u2019s going to be a minority.\u201d\",\"markups\":[]},{\"name\":\"ee2c\",\"type\":1,\"text\":\"In its review, the FDA evaluated esketamine based on five clinical trials presented by Janssen. However, only two of the studies showed significant positive results compared to a placebo. In one, roughly 53 percent of people who used esketamine twice a week for a month had a significant improvement in their depression scores, compared with 39 percent of people who took a placebo. The other study showed that people who initially responded to esketamine relapsed when they were switched to a placebo, whereas people who remained on the drug did not.\",\"markups\":[]},{\"name\":\"afe8\",\"type\":1,\"text\":\"Many health professionals are concerned about ketamine\u2019s notable side effects, particularly the ones that gained it notoriety as a party drug. Ketamine was first developed as an anesthetic in the 1960s. By the 1990s, ketamine had become a popular club drug for its dissociative qualities. At high doses, people are so sedated they become out of touch with their surroundings, feel unable to speak or move, and can start to hallucinate \u2014 an experience often referred to as a \u201ck-hole.\u201d But if you\u2019re not looking to get high, these psychoactive effects might be off-putting.\",\"markups\":[{\"type\":3,\"start\":178,\"end\":201,\"href\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126726/\",\"title\":\"\",\"rel\":\"\",\"anchorType\":0}]},{\"name\":\"beab\",\"type\":1,\"text\":\"\u201cThis drug is known as a pretty nasty drug,\u201d says Meisel. \u201cOne of the well-known side effects is what\u2019s called dissociation, which means that you don\u2019t feel a part of your body anymore, you feel like you\u2019re in a different place. And that could be very troublesome for some folks.\u201d\",\"markups\":[]},{\"name\":\"e6ba\",\"type\":1,\"text\":\"Other side effects include long-term changes in blood pressure and bladder problems. Ketamine also activates the opioid system in the brain, which has led many researchers and clinicians to worry about the drug\u2019s potential for abuse.\",\"markups\":[]},{\"name\":\"d84b\",\"type\":1,\"text\":\"Because of these concerns, as well as its side effects, the FDA committee recommended a strict risk mitigation plan for the drug. Ketamine will only be available at specialty pharmacies, clinics, and doctor\u2019s offices, and it has to be administered on-site. The patient must wait for a minimum of two hours for the drug\u2019s psychoactive effects to wear off before they can go home.\",\"markups\":[]},{\"name\":\"a559\",\"type\":1,\"text\":\"The FDA hopes the plan will help prevent ketamine from being abused by patients or diverted into the community for recreational use on the black market. But the need to visit a clinic for several hours every week will likely be a burden for many people and could limit access for people who live in more rural areas.\",\"markups\":[]},{\"name\":\"49e6\",\"type\":1,\"text\":\"While the risk for side effects and abuse is not insubstantial, Meisel, Friedman, and the FDA believe the benefits outweigh them. People with treatment-resistant depression are 15 times more likely to attempt suicide than people without depression, so a new effective form of treatment could be a literal lifesaver. \u201cThe risk is there. On the other hand, the risk of untreated treatment-resistant depression is far greater. I mean, the risk of suicide is orders of magnitude higher in those people,\u201d says Friedman. \u201cSo you\u2019re balancing the risk and the benefit. The risk of the drug is real, but the risk of the untreated disease is far greater.\u201d\",\"markups\":[]}],\"sections\":[{\"name\":\"7810\",\"startIndex\":0}]},\"postDisplay\":{\"coverless\":true}},\"virtuals\":{\"statusForCollection\":\"APPROVED\",\"allowNotes\":true,\"previewImage\":{\"imageId\":\"1*fIp9beyYlYnV-0ubLCBIGQ.jpeg\",\"filter\":\"\",\"backgroundSize\":\"\",\"originalWidth\":4000,\"originalHeight\":2667,\"strategy\":\"resample\",\"height\":0,\"width\":0,\"focusPercentX\":65,\"focusPercentY\":20},\"wordCount\":1097,\"imageCount\":1,\"readingTime\":4.339622641509434,\"subtitle\":\"The anesthetic ketamine receives official FDA approval to treat depression. Is the tradeoff worth it?\",\"publishedInCount\":1,\"usersBySocialRecommends\":[],\"noIndex\":false,\"recommends\":437,\"socialRecommends\":[],\"isBookmarked\":false,\"tags\":[{\"slug\":\"depression\",\"name\":\"Depression\",\"postCount\":37078,\"metadata\":{\"postCount\":37078,\"coverImage\":{\"id\":\"1*4eoDVHG9Bs23Xl_2Qt1Leg.jpeg\",\"originalWidth\":950,\"originalHeight\":633,\"focusPercentX\":50,\"focusPercentY\":20}},\"type\":\"Tag\"},{\"slug\":\"treatment\",\"name\":\"Treatment\",\"postCount\":1759,\"metadata\":{\"postCount\":1759,\"coverImage\":{\"id\":\"1*ZJH4sfRqdwbu4NSHf-Us-w.png\",\"originalWidth\":2400,\"originalHeight\":1200,\"isFeatured\":true,\"focusPercentX\":50,\"focusPercentY\":53}},\"type\":\"Tag\"},{\"slug\":\"antidepressants\",\"name\":\"Antidepressants\",\"postCount\":327,\"metadata\":{\"postCount\":327,\"coverImage\":{\"id\":\"1*fIp9beyYlYnV-0ubLCBIGQ.jpeg\",\"originalWidth\":4000,\"originalHeight\":2667,\"isFeatured\":true,\"focusPercentX\":65,\"focusPercentY\":20}},\"type\":\"Tag\"},{\"slug\":\"fda\",\"name\":\"FDA\",\"postCount\":892,\"metadata\":{\"postCount\":892,\"coverImage\":{\"id\":\"1*fIp9beyYlYnV-0ubLCBIGQ.jpeg\",\"originalWidth\":4000,\"originalHeight\":2667,\"isFeatured\":true,\"focusPercentX\":65,\"focusPercentY\":20}},\"type\":\"Tag\"},{\"slug\":\"science-and-medicine\",\"name\":\"Science And Medicine\",\"postCount\":29,\"metadata\":{\"postCount\":29,\"coverImage\":{\"id\":\"1*xuCBlYMvr-3rL1pB6ZY5Yw.jpeg\",\"originalWidth\":5000,\"originalHeight\":3750,\"isFeatured\":true,\"focusPercentX\":49,\"focusPercentY\":50}},\"type\":\"Tag\"}],\"socialRecommendsCount\":0,\"responsesCreatedCount\":37,\"links\":{\"entries\":[{\"url\":\"https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm632761.htm\",\"alts\":[],\"httpStatus\":200},{\"url\":\"https://www.vox.com/first-person/2018/7/24/17603616/depression-treatment-severe-ketamine-special-k\",\"alts\":[{\"type\":1,\"url\":\"https://cdn.ampproject.org/c/s/www.vox.com/platform/amp/first-person/2018/7/24/17603616/depression-treatment-severe-ketamine-special-k\"}],\"httpStatus\":200},{\"url\":\"https://www.ncbi.nlm.nih.gov/pubmed/10686270\",\"alts\":[],\"httpStatus\":200},{\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126726/\",\"alts\":[],\"httpStatus\":200},{\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428540/\",\"alts\":[],\"httpStatus\":200}],\"version\":\"0.3\",\"generatedAt\":1551833429768},\"isLockedPreviewOnly\":false,\"takeoverId\":\"\",\"metaDescription\":\"\",\"totalClapCount\":2730,\"sectionCount\":1,\"readingList\":0,\"topics\":[{\"topicId\":\"80e54e691fc9\",\"slug\":\"mental-health\",\"createdAt\":1493932391083,\"deletedAt\":0,\"image\":{\"id\":\"1*-5taj6lnLnCjq6bGuIV0MA@2x.jpeg\",\"originalWidth\":2624,\"originalHeight\":3936},\"name\":\"Mental Health\",\"description\":\"A little more conversation, a little less stigma.\",\"relatedTopics\":[],\"visibility\":1,\"relatedTags\":[],\"type\":\"Topic\"},{\"topicId\":\"9ff4c9770e22\",\"slug\":\"science\",\"createdAt\":1490119357713,\"deletedAt\":0,\"image\":{\"id\":\"1*A6TotBcTdB2v0-WzLx6nOQ@2x.jpeg\",\"originalWidth\":5184,\"originalHeight\":3456},\"name\":\"Science\",\"description\":\"Of rocks and rockets.\",\"relatedTopics\":[],\"visibility\":1,\"relatedTags\":[],\"type\":\"Topic\"},{\"topicId\":\"d61cf867d93f\",\"slug\":\"health\",\"createdAt\":1493930296516,\"deletedAt\":0,\"image\":{\"id\":\"1*sDLqtash5p_3dq8wlztLaQ@2x.jpeg\",\"originalWidth\":1997,\"originalHeight\":3000},\"name\":\"Health\",\"description\":\"Body talk.\",\"relatedTopics\":[],\"visibility\":1,\"relatedTags\":[],\"type\":\"Topic\"}]},\"coverless\":true,\"slug\":\"the-party-drug-that-could-help-stop-depression\",\"translationSourcePostId\":\"\",\"translationSourceCreatorId\":\"\",\"isApprovedTranslation\":false,\"inResponseToPostId\":\"\",\"inResponseToRemovedAt\":0,\"isTitleSynthesized\":false,\"allowResponses\":true,\"importedUrl\":\"\",\"importedPublishedAt\":0,\"visibility\":2,\"uniqueSlug\":\"the-party-drug-that-could-help-stop-depression-2e57c195b294\",\"previewContent\":{\"bodyModel\":{\"paragraphs\":[{\"name\":\"previewImage\",\"type\":4,\"text\":\"\",\"layout\":10,\"metadata\":{\"id\":\"1*fIp9beyYlYnV-0ubLCBIGQ.jpeg\",\"originalWidth\":4000,\"originalHeight\":2667,\"isFeatured\":true,\"focusPercentX\":65,\"focusPercentY\":20}},{\"name\":\"9595\",\"type\":3,\"text\":\"The Party Drug That Could Help Stop Depression\",\"markups\":[],\"alignment\":1},{\"name\":\"e127\",\"type\":13,\"text\":\"The anesthetic ketamine receives official FDA approval\u2026\",\"markups\":[],\"alignment\":1}],\"sections\":[{\"startIndex\":0}]},\"isFullContent\":false,\"subtitle\":\"The anesthetic ketamine receives official FDA approval to treat depression. Is the tradeoff worth it?\"},\"license\":0,\"inResponseToMediaResourceId\":\"\",\"canonicalUrl\":\"https://onezero.medium.com/the-party-drug-that-could-help-stop-depression-2e57c195b294\",\"approvedHomeCollectionId\":\"444d13b52878\",\"approvedHomeCollection\":{\"id\":\"444d13b52878\",\"name\":\"OneZero\",\"slug\":\"one-zero\",\"tags\":[\"TECHNOLOGY\",\"SCIENCE\",\"FUTURE\"],\"creatorId\":\"c626e36ed20\",\"description\":\"Medium\u2019s technology and science publication\",\"shortDescription\":\"Medium\u2019s technology and science publication\",\"image\":{\"imageId\":\"1*88Z0O0wD4KOrk6Y5EceZog.png\",\"filter\":\"\",\"backgroundSize\":\"\",\"originalWidth\":750,\"originalHeight\":750,\"strategy\":\"resample\",\"height\":0,\"width\":0},\"metadata\":{\"followerCount\":13902,\"activeAt\":1554309902819},\"virtuals\":{\"permissions\":{\"canPublish\":false,\"canPublishAll\":false,\"canRepublish\":false,\"canRemove\":false,\"canManageAll\":false,\"canSubmit\":false,\"canEditPosts\":false,\"canAddWriters\":false,\"canViewStats\":false,\"canSendNewsletter\":false,\"canViewLockedPosts\":false,\"canViewCloaked\":false,\"canEditOwnPosts\":false,\"canBeAssignedAuthor\":false,\"canEnrollInHightower\":false,\"canLockPostsForMediumMembers\":false,\"canLockOwnPostsForMediumMembers\":false},\"isSubscribed\":false,\"isNewsletterSubscribed\":false,\"memberOfMembershipPlanId\":\"\",\"isEnrolledInHightower\":false,\"isEligibleForHightower\":false},\"logo\":{\"imageId\":\"1*RxCcqX5oOebo9NLExQ6rgw.png\",\"filter\":\"\",\"backgroundSize\":\"\",\"originalWidth\":394,\"originalHeight\":101,\"strategy\":\"resample\",\"height\":0,\"width\":0},\"collectionMastheadId\":\"118ea8ba7b68\",\"domain\":\"onezero.medium.com\",\"sections\":[{\"type\":2,\"collectionHeaderMetadata\":{\"title\":\"\",\"description\":\"by Medium\",\"backgroundImage\":{},\"logoImage\":{\"id\":\"1*zv9JXqaS9O8OcHTzOoGPUA@2x.png\",\"originalWidth\":1404,\"originalHeight\":319,\"alt\":\"OneZero\"},\"alignment\":2,\"layout\":5}},{\"type\":1,\"postListMetadata\":{\"source\":3,\"layout\":4,\"number\":1,\"postIds\":[\"1584ba041b74\"]}},{\"type\":1,\"postListMetadata\":{\"source\":3,\"layout\":4,\"number\":2,\"postIds\":[\"e2e521664cb9\",\"1c0fc4375ba9\"]}},{\"type\":1,\"postListMetadata\":{\"source\":3,\"layout\":4,\"number\":1,\"postIds\":[\"7503d0ada8e0\"]}},{\"type\":1,\"postListMetadata\":{\"source\":1,\"layout\":4,\"number\":3,\"postIds\":[]}},{\"type\":1,\"postListMetadata\":{\"source\":3,\"layout\":4,\"number\":4,\"postIds\":[\"85df2ee9045e\",\"307bc4e97120\",\"1d31d4b043ea\",\"69cbdf5bfc9c\"],\"sectionHeader\":\"THE AMAZON DIARIES\"}},{\"type\":1,\"postListMetadata\":{\"source\":1,\"layout\":4,\"number\":5,\"postIds\":[],\"sectionHeader\":\"RECENT\"}},{\"type\":1,\"postListMetadata\":{\"source\":4,\"layout\":4,\"number\":3,\"postIds\":[],\"tagSlug\":\"Microprocessing\",\"sectionHeader\":\"MICROPROCESSING\"}},{\"type\":1,\"postListMetadata\":{\"source\":4,\"layout\":4,\"number\":3,\"postIds\":[],\"tagSlug\":\"The Upgrade\",\"sectionHeader\":\"THE UPGRADE\"}},{\"type\":1,\"postListMetadata\":{\"source\":1,\"layout\":4,\"number\":25,\"postIds\":[],\"sectionHeader\":\"MORE\"}}],\"tintColor\":\"#FF6A0BFF\",\"lightText\":false,\"favicon\":{\"imageId\":\"1*88Z0O0wD4KOrk6Y5EceZog.png\",\"filter\":\"\",\"backgroundSize\":\"\",\"originalWidth\":750,\"originalHeight\":750,\"strategy\":\"resample\",\"height\":0,\"width\":0},\"colorPalette\":{\"defaultBackgroundSpectrum\":{\"colorPoints\":[{\"color\":\"#FF8C5DFF\",\"point\":0},{\"color\":\"#FF815AFF\",\"point\":0.1},{\"color\":\"#FF7656F2\",\"point\":0.2},{\"color\":\"#FF6B51D8\",\"point\":0.3},{\"color\":\"#FF614BBF\",\"point\":0.4},{\"color\":\"#FF5645A6\",\"point\":0.5},{\"color\":\"#FF4A3E8E\",\"point\":0.6},{\"color\":\"#FF3F3576\",\"point\":0.7},{\"color\":\"#FF332C5E\",\"point\":0.8},{\"color\":\"#FF272247\",\"point\":0.9},{\"color\":\"#FF1A1730\",\"point\":1}],\"backgroundColor\":\"#FFFFFFFF\"},\"tintBackgroundSpectrum\":{\"colorPoints\":[{\"color\":\"#FF6A0BFF\",\"point\":0},{\"color\":\"#FF7548FE\",\"point\":0.1},{\"color\":\"#FF8365FF\",\"point\":0.2},{\"color\":\"#FF927DFF\",\"point\":0.3},{\"color\":\"#FFA192FF\",\"point\":0.4},{\"color\":\"#FFB1A6FF\",\"point\":0.5},{\"color\":\"#FFC1B8FF\",\"point\":0.6},{\"color\":\"#FFD0CAFF\",\"point\":0.7},{\"color\":\"#FFE0DBFF\",\"point\":0.8},{\"color\":\"#FFF0EBFF\",\"point\":0.9},{\"color\":\"#FFFFFBFF\",\"point\":1}],\"backgroundColor\":\"#FF6A0BFF\"},\"highlightSpectrum\":{\"colorPoints\":[{\"color\":\"#FFF2EEFF\",\"point\":0},{\"color\":\"#FFF0EBFF\",\"point\":0.1},{\"color\":\"#FFEEE9FF\",\"point\":0.2},{\"color\":\"#FFECE6FF\",\"point\":0.3},{\"color\":\"#FFE9E3FF\",\"point\":0.4},{\"color\":\"#FFE7DFFF\",\"point\":0.5},{\"color\":\"#FFE5DCFF\",\"point\":0.6},{\"color\":\"#FFE4D9FF\",\"point\":0.7},{\"color\":\"#FFE2D5FF\",\"point\":0.8},{\"color\":\"#FFE0D1FF\",\"point\":0.9},{\"color\":\"#FFDECDFF\",\"point\":1}],\"backgroundColor\":\"#FFFFFFFF\"}},\"navItems\":[{\"type\":4,\"title\":\"CONSUMER TECH\",\"url\":\"https://onezero.medium.com/consumer-tech/home\",\"topicId\":\"bf4f982530da\",\"source\":\"topicId\"},{\"type\":4,\"title\":\"DIGITAL LIFE\",\"url\":\"https://onezero.medium.com/digital-life/home\",\"topicId\":\"e3a73cb442d6\",\"source\":\"topicId\"},{\"type\":4,\"title\":\"INDUSTRY\",\"url\":\"https://onezero.medium.com/industry/home\",\"topicId\":\"2ba052a12d20\",\"source\":\"topicId\"},{\"type\":4,\"title\":\"SCIENCE & MEDICINE\",\"url\":\"https://onezero.medium.com/science-and-medicine/home\",\"topicId\":\"12839895cc53\",\"source\":\"topicId\"}],\"colorBehavior\":1,\"instantArticlesState\":0,\"acceleratedMobilePagesState\":0,\"collectionFeatures\":[3],\"ampLogo\":{\"imageId\":\"\",\"filter\":\"\",\"backgroundSize\":\"\",\"originalWidth\":0,\"originalHeight\":0,\"strategy\":\"resample\",\"height\":0,\"width\":0},\"header\":{\"title\":\"\",\"description\":\"by Medium\",\"backgroundImage\":{},\"logoImage\":{\"id\":\"1*zv9JXqaS9O8OcHTzOoGPUA@2x.png\",\"originalWidth\":1404,\"originalHeight\":319,\"alt\":\"OneZero\"},\"alignment\":2,\"layout\":5},\"type\":\"Collection\"},\"newsletterId\":\"\",\"webCanonicalUrl\":\"https://onezero.medium.com/the-party-drug-that-could-help-stop-depression-2e57c195b294\",\"mediumUrl\":\"https://onezero.medium.com/the-party-drug-that-could-help-stop-depression-2e57c195b294\",\"migrationId\":\"\",\"notifyFollowers\":true,\"notifyTwitter\":false,\"notifyFacebook\":false,\"responseHiddenOnParentPostAt\":0,\"isSeries\":false,\"isSubscriptionLocked\":true,\"seriesLastAppendedAt\":0,\"audioVersionDurationSec\":0,\"sequenceId\":\"\",\"isNsfw\":false,\"isEligibleForRevenue\":false,\"isBlockedFromHightower\":false,\"deletedAt\":0,\"lockedPostSource\":2,\"hightowerMinimumGuaranteeStartsAt\":0,\"hightowerMinimumGuaranteeEndsAt\":0,\"featureLockRequestAcceptedAt\":0,\"mongerRequestType\":1,\"layerCake\":1,\"socialTitle\":\"\",\"socialDek\":\"\",\"editorialPreviewTitle\":\"\",\"editorialPreviewDek\":\"\",\"curationEligibleAt\":1551832606749,\"primaryTopic\":{\"topicId\":\"d61cf867d93f\",\"slug\":\"health\",\"createdAt\":1493930296516,\"deletedAt\":0,\"image\":{\"id\":\"1*sDLqtash5p_3dq8wlztLaQ@2x.jpeg\",\"originalWidth\":1997,\"originalHeight\":3000},\"name\":\"Health\",\"description\":\"Body talk.\",\"relatedTopics\":[],\"visibility\":1,\"relatedTags\":[],\"type\":\"Topic\"},\"type\":\"Post\"},\"mentionedUsers\":[],\"collaborators\":[],\"collectionUserRelations\":[],\"mode\":null,\"references\":{\"User\":{\"bf4c3c7dced5\":{\"userId\":\"bf4c3c7dced5\",\"name\":\"Dana G Smith\",\"username\":\"smithdanag\",\"createdAt\":1384382054778,\"imageId\":\"1*uoseNvFQihxFrrGwRBUpxw.jpeg\",\"backgroundImageId\":\"\",\"bio\":\"Freelance science writer specializing in brains and bodies. Website: danagsmith.com; Twitter: @smithdanag\",\"twitterScreenName\":\"SmithDanaG\",\"socialStats\":{\"userId\":\"bf4c3c7dced5\",\"usersFollowedCount\":387,\"usersFollowedByCount\":1154,\"type\":\"SocialStats\"},\"social\":{\"userId\":\"lo_kBEP9dfq2M2Z\",\"targetUserId\":\"bf4c3c7dced5\",\"type\":\"Social\"},\"facebookAccountId\":\"\",\"allowNotes\":1,\"mediumMemberAt\":1540314409000,\"isNsfw\":false,\"isWriterProgramEnrolled\":true,\"isQuarantined\":false,\"type\":\"User\"}},\"Collection\":{\"444d13b52878\":{\"id\":\"444d13b52878\",\"name\":\"OneZero\",\"slug\":\"one-zero\",\"tags\":[\"TECHNOLOGY\",\"SCIENCE\",\"FUTURE\"],\"creatorId\":\"c626e36ed20\",\"description\":\"Medium\u2019s technology and science publication\",\"shortDescription\":\"Medium\u2019s technology and science publication\",\"image\":{\"imageId\":\"1*88Z0O0wD4KOrk6Y5EceZog.png\",\"filter\":\"\",\"backgroundSize\":\"\",\"originalWidth\":750,\"originalHeight\":750,\"strategy\":\"resample\",\"height\":0,\"width\":0},\"metadata\":{\"followerCount\":13902,\"activeAt\":1554309902819},\"virtuals\":{\"permissions\":{\"canPublish\":false,\"canPublishAll\":false,\"canRepublish\":false,\"canRemove\":false,\"canManageAll\":false,\"canSubmit\":false,\"canEditPosts\":false,\"canAddWriters\":false,\"canViewStats\":false,\"canSendNewsletter\":false,\"canViewLockedPosts\":false,\"canViewCloaked\":false,\"canEditOwnPosts\":false,\"canBeAssignedAuthor\":false,\"canEnrollInHightower\":false,\"canLockPostsForMediumMembers\":false,\"canLockOwnPostsForMediumMembers\":false},\"isSubscribed\":false,\"isNewsletterSubscribed\":false,\"memberOfMembershipPlanId\":\"\",\"isEnrolledInHightower\":false,\"isEligibleForHightower\":false},\"logo\":{\"imageId\":\"1*RxCcqX5oOebo9NLExQ6rgw.png\",\"filter\":\"\",\"backgroundSize\":\"\",\"originalWidth\":394,\"originalHeight\":101,\"strategy\":\"resample\",\"height\":0,\"width\":0},\"collectionMastheadId\":\"118ea8ba7b68\",\"domain\":\"onezero.medium.com\",\"sections\":[{\"type\":2,\"collectionHeaderMetadata\":{\"title\":\"\",\"description\":\"by Medium\",\"backgroundImage\":{},\"logoImage\":{\"id\":\"1*zv9JXqaS9O8OcHTzOoGPUA@2x.png\",\"originalWidth\":1404,\"originalHeight\":319,\"alt\":\"OneZero\"},\"alignment\":2,\"layout\":5}},{\"type\":1,\"postListMetadata\":{\"source\":3,\"layout\":4,\"number\":1,\"postIds\":[\"1584ba041b74\"]}},{\"type\":1,\"postListMetadata\":{\"source\":3,\"layout\":4,\"number\":2,\"postIds\":[\"e2e521664cb9\",\"1c0fc4375ba9\"]}},{\"type\":1,\"postListMetadata\":{\"source\":3,\"layout\":4,\"number\":1,\"postIds\":[\"7503d0ada8e0\"]}},{\"type\":1,\"postListMetadata\":{\"source\":1,\"layout\":4,\"number\":3,\"postIds\":[]}},{\"type\":1,\"postListMetadata\":{\"source\":3,\"layout\":4,\"number\":4,\"postIds\":[\"85df2ee9045e\",\"307bc4e97120\",\"1d31d4b043ea\",\"69cbdf5bfc9c\"],\"sectionHeader\":\"THE AMAZON DIARIES\"}},{\"type\":1,\"postListMetadata\":{\"source\":1,\"layout\":4,\"number\":5,\"postIds\":[],\"sectionHeader\":\"RECENT\"}},{\"type\":1,\"postListMetadata\":{\"source\":4,\"layout\":4,\"number\":3,\"postIds\":[],\"tagSlug\":\"Microprocessing\",\"sectionHeader\":\"MICROPROCESSING\"}},{\"type\":1,\"postListMetadata\":{\"source\":4,\"layout\":4,\"number\":3,\"postIds\":[],\"tagSlug\":\"The Upgrade\",\"sectionHeader\":\"THE UPGRADE\"}},{\"type\":1,\"postListMetadata\":{\"source\":1,\"layout\":4,\"number\":25,\"postIds\":[],\"sectionHeader\":\"MORE\"}}],\"tintColor\":\"#FF6A0BFF\",\"lightText\":false,\"favicon\":{\"imageId\":\"1*88Z0O0wD4KOrk6Y5EceZog.png\",\"filter\":\"\",\"backgroundSize\":\"\",\"originalWidth\":750,\"originalHeight\":750,\"strategy\":\"resample\",\"height\":0,\"width\":0},\"colorPalette\":{\"defaultBackgroundSpectrum\":{\"colorPoints\":[{\"color\":\"#FF8C5DFF\",\"point\":0},{\"color\":\"#FF815AFF\",\"point\":0.1},{\"color\":\"#FF7656F2\",\"point\":0.2},{\"color\":\"#FF6B51D8\",\"point\":0.3},{\"color\":\"#FF614BBF\",\"point\":0.4},{\"color\":\"#FF5645A6\",\"point\":0.5},{\"color\":\"#FF4A3E8E\",\"point\":0.6},{\"color\":\"#FF3F3576\",\"point\":0.7},{\"color\":\"#FF332C5E\",\"point\":0.8},{\"color\":\"#FF272247\",\"point\":0.9},{\"color\":\"#FF1A1730\",\"point\":1}],\"backgroundColor\":\"#FFFFFFFF\"},\"tintBackgroundSpectrum\":{\"colorPoints\":[{\"color\":\"#FF6A0BFF\",\"point\":0},{\"color\":\"#FF7548FE\",\"point\":0.1},{\"color\":\"#FF8365FF\",\"point\":0.2},{\"color\":\"#FF927DFF\",\"point\":0.3},{\"color\":\"#FFA192FF\",\"point\":0.4},{\"color\":\"#FFB1A6FF\",\"point\":0.5},{\"color\":\"#FFC1B8FF\",\"point\":0.6},{\"color\":\"#FFD0CAFF\",\"point\":0.7},{\"color\":\"#FFE0DBFF\",\"point\":0.8},{\"color\":\"#FFF0EBFF\",\"point\":0.9},{\"color\":\"#FFFFFBFF\",\"point\":1}],\"backgroundColor\":\"#FF6A0BFF\"},\"highlightSpectrum\":{\"colorPoints\":[{\"color\":\"#FFF2EEFF\",\"point\":0},{\"color\":\"#FFF0EBFF\",\"point\":0.1},{\"color\":\"#FFEEE9FF\",\"point\":0.2},{\"color\":\"#FFECE6FF\",\"point\":0.3},{\"color\":\"#FFE9E3FF\",\"point\":0.4},{\"color\":\"#FFE7DFFF\",\"point\":0.5},{\"color\":\"#FFE5DCFF\",\"point\":0.6},{\"color\":\"#FFE4D9FF\",\"point\":0.7},{\"color\":\"#FFE2D5FF\",\"point\":0.8},{\"color\":\"#FFE0D1FF\",\"point\":0.9},{\"color\":\"#FFDECDFF\",\"point\":1}],\"backgroundColor\":\"#FFFFFFFF\"}},\"navItems\":[{\"type\":4,\"title\":\"CONSUMER TECH\",\"url\":\"https://onezero.medium.com/consumer-tech/home\",\"topicId\":\"bf4f982530da\",\"source\":\"topicId\"},{\"type\":4,\"title\":\"DIGITAL LIFE\",\"url\":\"https://onezero.medium.com/digital-life/home\",\"topicId\":\"e3a73cb442d6\",\"source\":\"topicId\"},{\"type\":4,\"title\":\"INDUSTRY\",\"url\":\"https://onezero.medium.com/industry/home\",\"topicId\":\"2ba052a12d20\",\"source\":\"topicId\"},{\"type\":4,\"title\":\"SCIENCE & MEDICINE\",\"url\":\"https://onezero.medium.com/science-and-medicine/home\",\"topicId\":\"12839895cc53\",\"source\":\"topicId\"}],\"colorBehavior\":1,\"instantArticlesState\":0,\"acceleratedMobilePagesState\":0,\"collectionFeatures\":[3],\"ampLogo\":{\"imageId\":\"\",\"filter\":\"\",\"backgroundSize\":\"\",\"originalWidth\":0,\"originalHeight\":0,\"strategy\":\"resample\",\"height\":0,\"width\":0},\"header\":{\"title\":\"\",\"description\":\"by Medium\",\"backgroundImage\":{},\"logoImage\":{\"id\":\"1*zv9JXqaS9O8OcHTzOoGPUA@2x.png\",\"originalWidth\":1404,\"originalHeight\":319,\"alt\":\"OneZero\"},\"alignment\":2,\"layout\":5},\"type\":\"Collection\"}},\"Social\":{\"bf4c3c7dced5\":{\"userId\":\"lo_kBEP9dfq2M2Z\",\"targetUserId\":\"bf4c3c7dced5\",\"type\":\"Social\"}},\"SocialStats\":{\"bf4c3c7dced5\":{\"userId\":\"bf4c3c7dced5\",\"usersFollowedCount\":387,\"usersFollowedByCount\":1154,\"type\":\"SocialStats\"}}}})\n// ]]></script><script id=\"parsely-cfg\" src=\"//d1z2jf7jlzjs58.cloudfront.net/keys/medium.com/p.js\"></script><script type=\"text/javascript\">(function(b,r,a,n,c,h,_,s,d,k){if(!b[n]||!b[n]._q){for(;s<_.length;)c(h,_[s++]);d=r.createElement(a);d.async=1;d.src=\"https://cdn.branch.io/branch-latest.min.js\";k=r.getElementsByTagName(a)[0];k.parentNode.insertBefore(d,k);b[n]=h}})(window,document,\"script\",\"branch\",function(b,r){b[r]=function(){b._q.push([r,arguments])}},{_q:[],_v:1},\"addListener applyCode autoAppIndex banner closeBanner closeJourney creditHistory credits data deepview deepviewCta first getCode init link logout redeem referrals removeListener sendSMS setBranchViewData setIdentity track validateCode trackCommerceEvent logEvent\".split(\" \"), 0); branch.init('key_live_ofxXr2qTrrU9NqURK8ZwEhknBxiI6KBm', {'no_journeys': true, 'disable_exit_animation': true, 'disable_entry_animation': true, 'tracking_disabled':  false }, function(err, data) {});</script></body></html>", "content_html": "<div class=\"section-content\"><div class=\"section-inner sectionLayout--insetColumn\"><h1 class=\"graf graf--h3 graf--leading graf--title\" id=\"9595\" name=\"9595\">The Party Drug That Could Help Stop Depression</h1><h2 class=\"graf graf--h4 graf-after--h3 graf--subtitle\" id=\"e127\" name=\"e127\">The anesthetic ketamine receives official FDA approval to treat depression. Is the tradeoff worth\u00a0it?</h2><div class=\"uiScale uiScale-ui--regular uiScale-caption--regular u-flexCenter u-marginVertical24 u-fontSize15 js-postMetaLockup\"><div class=\"u-flex0\"><a class=\"link u-baseColor--link avatar\" data-action=\"show-user-card\" data-action-source=\"post_header_lockup\" data-action-type=\"hover\" data-action-value=\"bf4c3c7dced5\" data-collection-slug=\"one-zero\" data-user-id=\"bf4c3c7dced5\" dir=\"auto\" href=\"https://onezero.medium.com/@smithdanag?source=post_header_lockup\"><div class=\"u-relative u-inlineBlock u-flex0\"><img alt=\"Go to the profile of Dana G Smith\" class=\"avatar-image u-size50x50\" src=\"https://cdn-images-1.medium.com/fit/c/100/100/1*uoseNvFQihxFrrGwRBUpxw.jpeg\"/><div class=\"avatar-halo u-absolute u-textColorGreenNormal svgIcon\" style=\"width: calc(100% + 10px); height: calc(100% + 10px); top:-5px; left:-5px\"><svg viewbox=\"0 0 70 70\" xmlns=\"http://www.w3.org/2000/svg\"><path d=\"M5.53538374,19.9430227 C11.180401,8.78497536 22.6271155,1.6 35.3571429,1.6 C48.0871702,1.6 59.5338847,8.78497536 65.178902,19.9430227 L66.2496695,19.401306 C60.4023065,7.84329843 48.5440457,0.4 35.3571429,0.4 C22.17024,0.4 10.3119792,7.84329843 4.46461626,19.401306 L5.53538374,19.9430227 Z\"></path><path d=\"M65.178902,49.9077131 C59.5338847,61.0657604 48.0871702,68.2507358 35.3571429,68.2507358 C22.6271155,68.2507358 11.180401,61.0657604 5.53538374,49.9077131 L4.46461626,50.4494298 C10.3119792,62.0074373 22.17024,69.4507358 35.3571429,69.4507358 C48.5440457,69.4507358 60.4023065,62.0074373 66.2496695,50.4494298 L65.178902,49.9077131 Z\"></path></svg></div></div></a></div><div class=\"u-flex1 u-paddingLeft15 u-overflowHidden\"><div class=\"u-paddingBottom3\"><a class=\"ds-link ds-link--styleSubtle ui-captionStrong u-inlineBlock link link--darken link--darker\" data-action=\"show-user-card\" data-action-type=\"hover\" data-action-value=\"bf4c3c7dced5\" data-collection-slug=\"one-zero\" data-user-id=\"bf4c3c7dced5\" dir=\"auto\" href=\"https://onezero.medium.com/@smithdanag\">Dana G Smith</a><span class=\"followState js-followState\" data-user-id=\"bf4c3c7dced5\"><button class=\"button button--smallest u-noUserSelect button--withChrome u-baseColor--buttonNormal button--withHover button--unblock js-unblockButton u-marginLeft10 u-xs-hide\" data-action=\"sign-up-prompt\" data-action-source=\"post_header_lockup\" data-redirect=\"https://onezero.medium.com/the-party-drug-that-could-help-stop-depression-2e57c195b294\" data-requires-token=\"true\" data-sign-in-action=\"toggle-block-user\"><span class=\"button-label button-defaultState\">Blocked</span><span class=\"button-label button-hoverState\">Unblock</span></button><button class=\"button button--primary button--smallest button--dark u-noUserSelect button--withChrome u-accentColor--buttonDark button--follow js-followButton u-marginLeft10 u-xs-hide\" data-action=\"sign-up-prompt\" data-action-source=\"post_header_lockup-bf4c3c7dced5-------------------------follow_byline\" data-redirect=\"https://medium.com/_/subscribe/user/bf4c3c7dced5\" data-requires-token=\"true\" data-sign-in-action=\"toggle-subscribe-user\"><span class=\"button-label button-defaultState js-buttonLabel\">Follow</span><span class=\"button-label button-activeState\">Following</span></button></span></div><div class=\"ui-caption u-noWrapWithEllipsis js-testPostMetaInlineSupplemental\"><time datetime=\"2019-03-06T00:36:47.707Z\">Mar 5</time><span class=\"middotDivider u-fontSize12\"></span><span class=\"readingTime\" title=\"5 min read\"></span><span class=\"u-paddingLeft4\"><span class=\"svgIcon svgIcon--star svgIcon--15px\"><svg class=\"svgIcon-use\" height=\"15\" width=\"15\"><path d=\"M7.438 2.324c.034-.099.09-.099.123 0l1.2 3.53a.29.29 0 0 0 .26.19h3.884c.11 0 .127.049.038.111L9.8 8.327a.271.271 0 0 0-.099.291l1.2 3.53c.034.1-.011.131-.098.069l-3.142-2.18a.303.303 0 0 0-.32 0l-3.145 2.182c-.087.06-.132.03-.099-.068l1.2-3.53a.271.271 0 0 0-.098-.292L2.056 6.146c-.087-.06-.071-.112.038-.112h3.884a.29.29 0 0 0 .26-.19l1.2-3.52z\"></path></svg></span></span></div></div></div></div><div class=\"section-inner sectionLayout--outsetColumn\"><figure class=\"graf graf--figure graf--layoutOutsetCenter graf-after--h4\" id=\"dc28\" name=\"dc28\"><div class=\"aspectRatioPlaceholder is-locked\" style=\"max-width: 1032px; max-height: 688px;\"><div class=\"aspectRatioPlaceholder-fill\" style=\"padding-bottom: 66.7%;\"></div><div class=\"progressiveMedia js-progressiveMedia graf-image\" data-action=\"zoom\" data-action-value=\"1*fIp9beyYlYnV-0ubLCBIGQ.jpeg\" data-focus-x=\"65\" data-focus-y=\"20\" data-height=\"2667\" data-image-id=\"1*fIp9beyYlYnV-0ubLCBIGQ.jpeg\" data-is-featured=\"true\" data-width=\"4000\"><img class=\"progressiveMedia-thumbnail js-progressiveMedia-thumbnail\" crossorigin=\"anonymous\" src=\"https://cdn-images-1.medium.com/freeze/max/60/1*fIp9beyYlYnV-0ubLCBIGQ.jpeg?q=20\"/><canvas class=\"progressiveMedia-canvas js-progressiveMedia-canvas\"></canvas><img class=\"progressiveMedia-image js-progressiveMedia-image\" data-src=\"https://cdn-images-1.medium.com/max/2400/1*fIp9beyYlYnV-0ubLCBIGQ.jpeg\"/><noscript class=\"js-progressiveMedia-inner\"><img class=\"progressiveMedia-noscript js-progressiveMedia-inner\" src=\"https://cdn-images-1.medium.com/max/2400/1*fIp9beyYlYnV-0ubLCBIGQ.jpeg\"/></noscript></div></div><figcaption class=\"imageCaption\">Credit: Florian Gaertner/Getty Images\u00a0Plus</figcaption></figure></div><div class=\"section-inner sectionLayout--insetColumn\"><p class=\"graf graf--p graf--hasDropCapModel graf--hasDropCap graf--hasDropCapImage graf-after--figure\" id=\"ff6b\" name=\"ff6b\"><span class=\"graf-dropCap\"><span class=\"aspectRatioPlaceholder is-locked\" style=\"width: 111px; height: 111px;\"><span class=\"aspectRatioPlaceholder-fill\" style=\"padding-bottom: 100%;\"></span><img class=\"graf-dropCapImage\" data-height=\"500\" data-image-id=\"1*x3MLNrKVby4_GZ1VCCYktA.png\" data-width=\"500\" src=\"https://cdn-images-1.medium.com/max/800/1*x3MLNrKVby4_GZ1VCCYktA.png\"/></span><span class=\"graf-dropCapText\">T</span></span>he U.S. Food and Drug Administration (FDA) on March 5 approved a form of ketamine to be prescribed for treatment-resistant depression. The drug, called esketamine, is administered as a nasal spray and is the first version of ketamine to be cleared to treat depression. It\u2019s also the <a class=\"markup--anchor markup--p-anchor\" data-href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428540/\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428540/\" rel=\"noopener\" target=\"_blank\">first new type of antidepressant drug</a> since Prozac was released over 30 years ago. Many psychiatrists and pharmacists see the ruling as a win for desperate patients with few options, but others have raised concerns about the drug\u2019s possibly serious side effects and have questioned its efficacy.</p><p class=\"graf graf--p graf--startsWithDoubleQuote graf-after--p\" id=\"1ef3\" name=\"1ef3\">\u201cOn the whole, I think they made the right choice,\u201d says Richard Friedman, a professor of psychiatry at Weill Cornell Medical College who was not involved in the decision. \u201cThis is a group of people who are really ill and for whom there are limited therapeutics. There\u2019s no question ketamine has antidepressant efficacy, and it\u2019s a new target.\u201d</p><p class=\"graf graf--p graf-after--p\" id=\"862d\" name=\"862d\">Esketamine will be sold under the brand name Spravato and is made by Janssen Pharmaceutical Company, a subsidiary of Johnson &amp; Johnson. \u201cBecause of safety concerns, the drug will only be available through a restricted distribution system and it must be administered in a certified medical office where the health care provider can monitor the patient,\u201d said Dr. Tiffany Farchione, acting director of the Division of Psychiatry Products in the FDA\u2019s Center for Drug Evaluation and Research <a class=\"markup--anchor markup--p-anchor\" data-href=\"https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm632761.htm\" href=\"https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm632761.htm\" rel=\"noopener\" target=\"_blank\">in a statement</a>.</p><p class=\"graf graf--p graf-after--p\" id=\"794e\" name=\"794e\">The FDA said that people who take the drug must be monitored by a health care provider for at least two hours after receiving it. Patients cannot take the spray home.</p><p class=\"graf graf--p graf-after--p\" id=\"46ea\" name=\"46ea\">An estimated 30 to 40 percent of people with depression fail to respond to traditional antidepressant drugs like Prozac (a selective serotonin reuptake inhibitor or SSRI) and Cymbalta (a serotonin-norepinephrine reuptake inhibitor or SNRI), classifying them as \u201ctreatment resistant.\u201d These patients have few alternative options, as all current antidepressants act on the same three neurochemicals: serotonin, dopamine, and norepinephrine. Ketamine, by contrast, acts on an entirely different pathway: the glutamate system, which is the brain\u2019s primary excitatory neurochemical and is involved in learning.</p><p class=\"graf graf--p graf-after--p\" id=\"3b3f\" name=\"3b3f\">Scientists aren\u2019t exactly sure how ketamine acts as an antidepressant, but it may do so by increasing the number of connections, or synapses, between cells in the brain, particularly in the prefrontal cortex. Stress and depression degrade these connections, and ketamine could reverse the damage, regrowing the lost synapses. \u201cIt\u2019s like fertilizer in the brain,\u201d says Friedman.</p><p class=\"graf graf--p graf--startsWithDoubleQuote graf-after--p\" id=\"0e3a\" name=\"0e3a\"><strong class=\"markup--strong markup--p-strong\">\u201c</strong>There\u2019s no question ketamine has antidepressant efficacy, and it\u2019s a new target.\u201d</p><p class=\"graf graf--p graf-after--p\" id=\"b40b\" name=\"b40b\">The <a class=\"markup--anchor markup--p-anchor\" data-href=\"https://www.ncbi.nlm.nih.gov/pubmed/10686270\" href=\"https://www.ncbi.nlm.nih.gov/pubmed/10686270\" rel=\"noopener\" target=\"_blank\">first study of ketamine as an antidepressant</a> was published in 2000, with a single dose of the drug dramatically improving depression symptoms in a majority of people. A rush of clinical trials followed, in addition to the opening of ketamine clinics where doctors provide people with the drug off-label. <a class=\"markup--anchor markup--p-anchor\" data-href=\"https://www.vox.com/first-person/2018/7/24/17603616/depression-treatment-severe-ketamine-special-k\" href=\"https://www.vox.com/first-person/2018/7/24/17603616/depression-treatment-severe-ketamine-special-k\" rel=\"noopener\" target=\"_blank\">On an anecdotal basis</a>, the drug has proven remarkable, with suicidal people reporting that the drug saved their lives.</p><p class=\"graf graf--p graf-after--p\" id=\"d11b\" name=\"d11b\">Researchers, though, are much more measured. \u201cI think any hope that this is a new wonder drug should be tamped down,\u201d says Steven Meisel, director of medication safety at Fairview Health Services and a member of the FDA advisory committee that initially recommended ketamine. \u201cThis is a drug that will benefit a minority of people greatly, and a majority of people not at all. For those it does help, it could be dramatic, but it\u2019s going to be a minority.\u201d</p><p class=\"graf graf--p graf-after--p\" id=\"ee2c\" name=\"ee2c\">In its review, the FDA evaluated esketamine based on five clinical trials presented by Janssen. However, only two of the studies showed significant positive results compared to a placebo. In one, roughly 53 percent of people who used esketamine twice a week for a month had a significant improvement in their depression scores, compared with 39 percent of people who took a placebo. The other study showed that people who initially responded to esketamine relapsed when they were switched to a placebo, whereas people who remained on the drug did not.</p><p class=\"graf graf--p graf-after--p\" id=\"afe8\" name=\"afe8\">Many health professionals are concerned about ketamine\u2019s notable side effects, particularly the ones that gained it notoriety as a party drug. Ketamine was first developed as an <a class=\"markup--anchor markup--p-anchor\" data-href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126726/\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126726/\" rel=\"noopener\" target=\"_blank\">anesthetic in the 1960s</a>. By the 1990s, ketamine had become a popular club drug for its dissociative qualities. At high doses, people are so sedated they become out of touch with their surroundings, feel unable to speak or move, and can start to hallucinate\u200a\u2014\u200aan experience often referred to as a \u201ck-hole.\u201d But if you\u2019re not looking to get high, these psychoactive effects might be off-putting.</p><p class=\"graf graf--p graf--startsWithDoubleQuote graf-after--p\" id=\"beab\" name=\"beab\">\u201cThis drug is known as a pretty nasty drug,\u201d says Meisel. \u201cOne of the well-known side effects is what\u2019s called dissociation, which means that you don\u2019t feel a part of your body anymore, you feel like you\u2019re in a different place. And that could be very troublesome for some folks.\u201d</p><p class=\"graf graf--p graf-after--p\" id=\"e6ba\" name=\"e6ba\">Other side effects include long-term changes in blood pressure and bladder problems. Ketamine also activates the opioid system in the brain, which has led many researchers and clinicians to worry about the drug\u2019s potential for abuse.</p><p class=\"graf graf--p graf-after--p\" id=\"d84b\" name=\"d84b\">Because of these concerns, as well as its side effects, the FDA committee recommended a strict risk mitigation plan for the drug. Ketamine will only be available at specialty pharmacies, clinics, and doctor\u2019s offices, and it has to be administered on-site. The patient must wait for a minimum of two hours for the drug\u2019s psychoactive effects to wear off before they can go home.</p><p class=\"graf graf--p graf-after--p\" id=\"a559\" name=\"a559\">The FDA hopes the plan will help prevent ketamine from being abused by patients or diverted into the community for recreational use on the black market. But the need to visit a clinic for several hours every week will likely be a burden for many people and could limit access for people who live in more rural areas.</p><p class=\"graf graf--p graf-after--p graf--trailing\" id=\"49e6\" name=\"49e6\">While the risk for side effects and abuse is not insubstantial, Meisel, Friedman, and the FDA believe the benefits outweigh them. People with treatment-resistant depression are 15 times more likely to attempt suicide than people without depression, so a new effective form of treatment could be a literal lifesaver. \u201cThe risk is there. On the other hand, the risk of untreated treatment-resistant depression is far greater. I mean, the risk of suicide is orders of magnitude higher in those people,\u201d says Friedman. \u201cSo you\u2019re balancing the risk and the benefit. The risk of the drug is real, but the risk of the untreated disease is far greater.\u201d</p></div></div>", "content": "The Party Drug That Could Help Stop DepressionThe anesthetic ketamine receives official FDA approval to treat depression. Is the tradeoff worth\u00a0it?Dana G SmithBlockedUnblockFollowFollowingMar 5 Credit: Florian Gaertner/Getty Images\u00a0Plus The U.S. Food and Drug Administration (FDA) on March 5 approved a form of ketamine to be prescribed for treatment-resistant depression. The drug, called esketamine, is administered as a nasal spray and is the first version of ketamine to be cleared to treat depression. It\u2019s also the first new type of antidepressant drug since Prozac was released over 30 years ago. Many psychiatrists and pharmacists see the ruling as a win for desperate patients with few options, but others have raised concerns about the drug\u2019s possibly serious side effects and have questioned its efficacy.\u201cOn the whole, I think they made the right choice,\u201d says Richard Friedman, a professor of psychiatry at Weill Cornell Medical College who was not involved in the decision. \u201cThis is a group of people who are really ill and for whom there are limited therapeutics. There\u2019s no question ketamine has antidepressant efficacy, and it\u2019s a new target.\u201dEsketamine will be sold under the brand name Spravato and is made by Janssen Pharmaceutical Company, a subsidiary of Johnson & Johnson. \u201cBecause of safety concerns, the drug will only be available through a restricted distribution system and it must be administered in a certified medical office where the health care provider can monitor the patient,\u201d said Dr. Tiffany Farchione, acting director of the Division of Psychiatry Products in the FDA\u2019s Center for Drug Evaluation and Research in a statement.The FDA said that people who take the drug must be monitored by a health care provider for at least two hours after receiving it. Patients cannot take the spray home.An estimated 30 to 40 percent of people with depression fail to respond to traditional antidepressant drugs like Prozac (a selective serotonin reuptake inhibitor or SSRI) and Cymbalta (a serotonin-norepinephrine reuptake inhibitor or SNRI), classifying them as \u201ctreatment resistant.\u201d These patients have few alternative options, as all current antidepressants act on the same three neurochemicals: serotonin, dopamine, and norepinephrine. Ketamine, by contrast, acts on an entirely different pathway: the glutamate system, which is the brain\u2019s primary excitatory neurochemical and is involved in learning.Scientists aren\u2019t exactly sure how ketamine acts as an antidepressant, but it may do so by increasing the number of connections, or synapses, between cells in the brain, particularly in the prefrontal cortex. Stress and depression degrade these connections, and ketamine could reverse the damage, regrowing the lost synapses. \u201cIt\u2019s like fertilizer in the brain,\u201d says Friedman.\u201cThere\u2019s no question ketamine has antidepressant efficacy, and it\u2019s a new target.\u201dThe first study of ketamine as an antidepressant was published in 2000, with a single dose of the drug dramatically improving depression symptoms in a majority of people. A rush of clinical trials followed, in addition to the opening of ketamine clinics where doctors provide people with the drug off-label. On an anecdotal basis, the drug has proven remarkable, with suicidal people reporting that the drug saved their lives.Researchers, though, are much more measured. \u201cI think any hope that this is a new wonder drug should be tamped down,\u201d says Steven Meisel, director of medication safety at Fairview Health Services and a member of the FDA advisory committee that initially recommended ketamine. \u201cThis is a drug that will benefit a minority of people greatly, and a majority of people not at all. For those it does help, it could be dramatic, but it\u2019s going to be a minority.\u201dIn its review, the FDA evaluated esketamine based on five clinical trials presented by Janssen. However, only two of the studies showed significant positive results compared to a placebo. In one, roughly 53 percent of people who used esketamine twice a week for a month had a significant improvement in their depression scores, compared with 39 percent of people who took a placebo. The other study showed that people who initially responded to esketamine relapsed when they were switched to a placebo, whereas people who remained on the drug did not.Many health professionals are concerned about ketamine\u2019s notable side effects, particularly the ones that gained it notoriety as a party drug. Ketamine was first developed as an anesthetic in the 1960s. By the 1990s, ketamine had become a popular club drug for its dissociative qualities. At high doses, people are so sedated they become out of touch with their surroundings, feel unable to speak or move, and can start to hallucinate\u200a\u2014\u200aan experience often referred to as a \u201ck-hole.\u201d But if you\u2019re not looking to get high, these psychoactive effects might be off-putting.\u201cThis drug is known as a pretty nasty drug,\u201d says Meisel. \u201cOne of the well-known side effects is what\u2019s called dissociation, which means that you don\u2019t feel a part of your body anymore, you feel like you\u2019re in a different place. And that could be very troublesome for some folks.\u201dOther side effects include long-term changes in blood pressure and bladder problems. Ketamine also activates the opioid system in the brain, which has led many researchers and clinicians to worry about the drug\u2019s potential for abuse.Because of these concerns, as well as its side effects, the FDA committee recommended a strict risk mitigation plan for the drug. Ketamine will only be available at specialty pharmacies, clinics, and doctor\u2019s offices, and it has to be administered on-site. The patient must wait for a minimum of two hours for the drug\u2019s psychoactive effects to wear off before they can go home.The FDA hopes the plan will help prevent ketamine from being abused by patients or diverted into the community for recreational use on the black market. But the need to visit a clinic for several hours every week will likely be a burden for many people and could limit access for people who live in more rural areas.While the risk for side effects and abuse is not insubstantial, Meisel, Friedman, and the FDA believe the benefits outweigh them. People with treatment-resistant depression are 15 times more likely to attempt suicide than people without depression, so a new effective form of treatment could be a literal lifesaver. \u201cThe risk is there. On the other hand, the risk of untreated treatment-resistant depression is far greater. I mean, the risk of suicide is orders of magnitude higher in those people,\u201d says Friedman. \u201cSo you\u2019re balancing the risk and the benefit. The risk of the drug is real, but the risk of the untreated disease is far greater.\u201d", "read_time": 322.5, "title_html": "<h1 class=\"graf graf--h3 graf--leading graf--title\" id=\"9595\" name=\"9595\">The Party Drug That Could Help Stop Depression</h1>"}